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Abstract 
 
The induction of senescence in response to persistent stress induces major 
phenotypic changes in senescent cells, including the secretion of a host of 
inflammatory factors and reactive oxygen species. Recent evidence has implicated 
senescent cells in the diseases of ageing and cancer; however, the mechanism by 
which this occurs is still unknown. This thesis uses a reporter cell line with cells 
expressing a fluorescent conjugate that allows real time live cell imaging of a sub set 
of cells within a co-culture, to provide the first evidence that senescent cells can 
induce a DNA damage response in healthy cells, and thus implicates a potential 
mechanism by which senescent cells could non-autonomously contribute to the 
ageing process. The use of specific inhibitors, stimulation, and targeted repression 
indicate that gap junctions, reactive oxygen species, p38, mTOR and NF-κB all play 
a key role in this observed bystander effect of senescent cells, and offer potential 
targets for therapies designed to reduce the damaging effects of senescent cells. 
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1 Introduction 
 
1.1 The Discovery of Cellular Senescence 
 
In 1961 a seminal study by Hayflick and Moorehead dismissed the old myth that 
cells in culture could continue replicating indefinitely. By culturing old and young 
cells together it was proved that the old cells ceased replicating before the 
young cells, demonstrating that it was not adverse culture conditions that had 
prevented continued replication, and that cells had an intrinsically limited 
capacity for producing progeny (Hayflick, 1965, Hayflick and Moorhead, 1961). 
Although some cells underwent more divisions than others, and there was a 
strong stochastic determinant, most cells would enter a state of replicative 
arrest after a similar number of population doublings and, once arrested, they 
would never re-enter the cell cycle (Hayflick, 1965, Hayflick and Moorhead, 
1961). This state of permanent arrest has since been termed cellular 
senescence (Goldstein, 1990), and the evidence that this process may have 
relevance to the ageing process is mounting.  
The focus of this project was to examine whether senescent cells have non-
autonomous effects that are detrimental to surrounding cells which could be 
abrogated by mechanistic intervention. To introduce the topic it is important to 
describe how cells become senescent and the importance of DNA damage, 
both in the initial stimulus and to maintain the signal. Then the senescent 
phenotype will be described along with its implications to bodily function in 
health and disease, to give insight to the relevance and importance of this work 
to medicine, gerontology and cancer biology. 
One important clarification for this thesis is that although the terms senescence 
and senescent can be used to describe the ageing of, and the state of being 
aged, in organisms respectively. In this text these words are used exclusively to 
describe cells. Further, a senescent cell is not simply an old cell, as it would be 
for an organism. Cellular senescence occurs as a result of replication; the 
length of time a cell spends quiescent in between divisions has little effect on 
when it will enter cellular senescence (Hayflick, 1965, Hayflick and Moorhead, 
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1961). Thus, old cells are not necessarily senescent if they have not been 
dividing, and old organisms need not necessarily accrue senescent cells.  
 
1.2 The Causes of Cellular Senescence 
 
1.2.1 Telomeres and Replicative Senescence 
 
Hayflick and Moorehead had discovered replicative senescence in 1961 
(Hayflick and Moorhead, 1961). However, it was not until 1972 when the DNA 
end replication problem was laid out in the context of linear phages, that a 
potential causal mechanism for replicative senescence was elucidated (Watson, 
1972). Whilst the leading strand can be replicated up to the end of the 
chromosome, the replication of the lagging strand from RNA primers ahead of 
the replicated region will leave the primer bound region and anything beyond it 
unreplicated (Olovnikov, 1973, Watson, 1972), causing the chromosome to 
shorten with each cell division. The potential implication of the end replication 
problem was such that it had to be circumvented to prevent the eventual 
extinction of all eukaryotic life from loss of DNA, as was exemplified by some 
mutant single celled organisms (Lundblad and Szostak, 1989, Yu et al., 1990). 
The discovery of telomerase enzyme which uses an RNA template to bind a 
specific telomeric repeat and lengthen the telomere 5’-3’ (Greider and 
Blackburn, 1985), demonstrated that the end replication problem could be 
overcome, and therefore did not need to induce replicative senescence, or 
eukaryotic extinction. However, it was found that in many somatic tissues 
telomerase is inactivated (Bacchetti and Counter, 1995, Kim et al., 1994), 
including human fibroblasts (Counter et al., 1992, Kim et al., 1994), and many 
organisms only retain telomerase expression in the germline (Kim et al., 1994, 
Tan et al., 2012), where telomere length must be, and is, maintained (Allsopp et 
al., 1992). Although some somatic tissues do have low level telomerase activity 
(Broccoli et al., 1995, Counter et al., 1995, Hiyama et al., 1995b), these cells 
still undergo telomeric loss with both donor age and passage number (Hastie et 
al., 1990, Kitada et al., 1995, Vaziri et al., 1994, Vaziri et al., 1993), indicating 
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that there is little difference between these and telomerase negative cells. 
Therefore, although organisms have mechanisms to lengthen telomeres and 
prevent the end replication problem, these are generally only active and 
effective in a very small number of cells, leaving the majority of the somatic cells 
to have a limited replicative capacity.  
In several studies using human fibroblasts, genomic DNA was digested to 
produce terminal fragments containing both telomeric and subtelomeric DNA 
called terminal restriction fragments (TRFs) (Brown, 1989, Cross et al., 1989), 
and it was found that replicative lifespan correlated with initial length of average 
TRF (Allshire et al., 1988, Counter et al., 1992, Cross et al., 1990, Harley et al., 
1990). Additionally, one study showed that regardless of what size the TRF was 
in proliferating cells when the cells reached senescence there was little 
difference in TRF length (Allsopp et al., 1992), indicating that senescence was 
associated with specific average telomere length. However, a later study 
showed that firstly the average telomere length at senescence was strain 
specific; secondly that it was highly variable at senescence; and thirdly that 
average telomere length at explantation did not significantly correlate with 
replicative lifespan (Serra and von Zglinicki, 2002). Notably, they also observed 
that the strain specific threshold at which telomere shortening would induce 
senescence was not affected by increasing oxidative stress (Serra and von 
Zglinicki, 2002), although addition of antioxidants had been previously shown to 
cause cells to senesce with longer telomeres (von Zglinicki et al., 2000).  
Early ideas about replicative senescence suggested that the loss of specific 
lengths of DNA with each cell division was a type of program, which was termed 
the mitotic clock, by which cells had a certain number of divisions before they 
entered the senescent state (Olovnikov, 1971, Olovnikov, 1973). However, 
there were several aspects of the senescence phenomenon that were 
inconsistent with such an idea. Firstly, there was large variance between TRF 
length at senescence: the average length of fragment was approximately 4kb 
which left 2kb of telomeric repeat DNA, but the variance was high enough so 
that some of the chromosomes could have little or no telomeric repeat DNA 
remaining (Levy et al., 1992). Secondly, the discovery that oxidative stress 
accelerated telomere shortening (von Zglinicki et al., 1995) added a strong 
stochastic mechanism to the process. Combined, the data suggested that 
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senescence was not as simple as an end replication problem, and other factors 
such as reactive oxygen species (ROS), exonuclease activity and unequal 
recombination could also play a role in telomere shortening (Makarov et al., 
1997). 
The first causal evidence that telomere loss was responsible for replicative 
senescence came from the immortalisation of human fibroblasts expressing 
telomerase (Bodnar et al., 1998, Vaziri and Benchimol, 1998). One study 
showed that these cells could reach 250-400PDs without significant change in 
growth rate when normal cells would senesce between 60-70PDs (Morales et 
al., 1999). Importantly, in this study the average TRF length reached as low as 
4Kb in the immortalised cells whilst the average in normal senescent cells was 
found to be 6-8Kb in this study. The immortal cells did not senesce because the 
variance between telomere lengths was much smaller than in senescent cells 
and stabilised at 4kb. Consistently, an earlier study showed much less telomeric 
variance in immortalised cells, but in this study the telomeres remained longer 
on average in immortalised cells than unimmortalised cells at senescence 
(Bodnar et al., 1998). This difference possibly results from increased loss of 
telomerase expression in the former study (Morales et al., 1999). It was 
suggested that senescence was prevented in these cells by a preferential 
activity of telomerase for short telomeres, which was later confirmed in a yeast 
study following a single telomere showing that telomeres switch from non-
extendable to extendable states when they become shorter (Teixeira et al., 
2004). Regardless, senescence is most likely induced by one or a few 
telomeres becoming critically short. 
The eukaryotic telomere is bound by a series of proteins which form the 
shleterin complex, including TRF1 which induces bending to assist the 
formation of the t-loop (Griffith et al., 1999), and TRF2 which facilitates the 
invasion of the 3’ overhang into an internal site in the double stranded telomeric 
DNA forming the D-loop (Griffith et al., 1999). Along with other proteins such as 
Pot1, which binds to single stranded DNA, the complex protects the telomere 
from enzymatic and signalling molecules that would otherwise bind. Several 
observations indicated the importance of this structure in replication: Its 
inhibition or deletion induced senescence (van Steensel et al., 1998, Denchi 
and de Lange, 2007); overexpression of TRF2 extended replicative lifespan 
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(Karlseder et al., 2002, Smogorzewska et al., 2000); and loss of the 3’ G-rich 
overhang induces senescence (Stewart et al., 2003). Importantly, these 
mechanisms were found to be independent of telomere length, as 
overexpression of TRF2 shortened telomere length (Karlseder et al., 2002, 
Smogorzewska et al., 2000), whilst its inhibition had no effect on telomere 
length (Denchi and de Lange, 2007, van Steensel et al., 1998). Although this 
might have suggested that uncapping and shortening induced senescence 
independently, the observation that shortening induced uncapping (Blackburn, 
2000), suggested that it was the telomere cap that was important, and telomeric 
shortening was just one mechanism by which the cap could be lost. Two recent 
studies have identified the presence of telomere associated foci, which were 
induced by damaging agents independently of telomerase expression, 
suggesting that they resulted from telomere uncapping without shortening, and 
were highly important in the induction of senescence (Fumagalli et al., 2012, 
Hewitt et al., 2012).  
When a telomere becomes uncapped by the loss of the shelterin complex, it 
becomes bound by factors associated with the DNA damage response (DDR) 
such as 53BP1, NBS1, MDC1, γ-H2AX and CHK2, which indicated that they 
were recognised as double strand breaks (d'Adda di Fagagna et al., 2003, 
Takai et al., 2003, Herbig et al., 2004), thus indicating that telomere uncapping 
induces replicative senescence through the induction of a DNA damage 
response. Because of the absence of telomerase the progressive telomere 
shortening eventually causes the loss of protective proteins and recognition as 
irreparable damage inducing a persistent DNA damage response. 
 
1.2.2 DNA Damage and Premature Senescence 
 
Non-telomeric damage can also induce cellular senescence if the source is 
sufficient to overwhelm the repair capacity of the cell. The more severe the 
damage, the more likely it is to induce senescence; thus, double strand breaks 
are potent inducers of cellular senescence (Di Leonardo et al., 1994). Base 
substitutions and alterations probably play a very minor role, if any. 
Monoadducts induced by low energy UVA do not induce senescence, however 
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higher energy UVB induces senescence through thymine dimers and 
interstrand crosslinks which generate single stranded (ss)DNA (Hovest et al., 
2006). ROS induced senescence is thought to occur mainly through the 
formation of single strand breaks (SSBs), as DSBs account for a much lower 
proportion of the damage (Land, 2002). Conversely, in ionising radiation 
induced senescence the main type of damage is DSBs. The non-homogeneous 
energy distribution causes clusters of complex lesions, even at lower doses 
(Nikjoo et al., 1999). These clusters are very difficult to repair; however, it is 
unlikely that they could arise under physiological conditions at appreciable 
levels. Low doses of these stressors reduce the replicative capacity of the cells 
so that they will senesce after fewer population doublings, whereas high doses 
can cause cells to undergo immediate senescence before they have reached 
their full replicative capacity (Toussaint et al., 2000). After a high dose of X-
irradiation around three quarters arrest within the first 1.5 hours, and <1% are 
still incorporating BrdU after 24 hours (Rodier et al., 2011), suggesting that it is 
cell cycle dependent, and very few cells undergo more than one round of 
division, whilst the majority arrest immediately. This is called premature 
senescence.  
A comparison between telomeric and non-telomeric foci showed that they share 
many of the same response elements inducing very similar DNA damage 
responses (d'Adda di Fagagna et al., 2003, Takai et al., 2003), and yeast with 
critically short telomeres and ones exposed to DNA damaging agents have 
significantly overlapping global gene expression profiles (Nautiyal et al., 2002). 
Importantly, the induction of replicative senescence was also found to involve 
non-telomeric foci, and cells exhibited a similar number of foci irrespective of 
their chromosomal location (Nakamura et al., 2008), indicating that all foci 
contributed equally to the senescence signal. Additionally, telomeres are 
particularly susceptible to exogenous stresses such as oxidative stress (von 
Zglinicki et al., 1995), and two recent studies have demonstrated the 
importance of telomeric damage in radiation and oxidative stress induced 
senescence. Whilst the non-telomeric foci are generally repaired, the telomeric 
foci persist for longer, and thus may be of particular importance in maintaining 
the DNA damage response in replicative and premature senescence (Hewitt et 
al., 2012, Fumagalli et al., 2012).  
 7 
 
 
1.2.3 Oncogene Induced Senescence 
 
Chemical mutagens and radiation are forms of stress which induce DNA 
damage in cells, and result in cellular senescence. Another inducer of 
senescence is the aberrant expression of an oncogene, known as oncogenic 
stress. Most studies have focused on the RAS pathway, and ectopic activation 
of RAS, RAC1, RAF, MOS and MEK (Braig et al., 2005, Debidda et al., 2006, 
Lin et al., 1998, Michaloglou et al., 2005, Serrano et al., 1997, Zhu et al., 1998), 
and even endogenous levels of RAS or BRAF (Collado et al., 2005, Dankort et 
al., 2007, Guerra et al., 2003, Guerra et al., 2007, Michaloglou et al., 2005) all 
induce senescence, as does the inactivation of PTEN (Chen et al., 2005), which 
is an inhibitor of the same pathway. Additionally, ectopic expression of positive 
regulators of the cell cycle such as E2F transcription factors, MYC, CDC6 and 
cyclin E all induce senescence (Bartkova et al., 2006, Grandori et al., 2003, 
Johnson and Degregori, 2006, Lazzerini Denchi et al., 2005), as does ectopic 
IFN-β (Moiseeva et al., 2006) and TGF-β signalling (Katakura et al., 1999, 
Vijayachandra et al., 2003, Zhang and Cohen, 2004).  
Several oncogenes including RAS (Abulaiti et al., 2006, Di Micco et al., 2006, 
Mallette et al., 2007), MOS (Bartkova et al., 2006), and RAC (Debidda et al., 
2006), as well as several of the positive cell cycle regulators (Bartkova et al., 
2005, Bartkova et al., 2006, Vaziri et al., 2003), have been shown to induce the 
phosphorylation of H2AX and other factors associated with the DDR. More 
importantly, some oncogenes cannot induce senescence in the absence of the 
DDR (Bartkova et al., 2006, Di Micco et al., 2006, Mallette et al., 2007), and 
cells that have become fully senescent in response to RAS can re-enter the cell 
cycle upon DDR inactivation (Di Micco et al., 2006). 
RAS and BRAF (Dankort et al., 2007, Di Micco et al., 2006, Jones et al., 2000, 
Michaloglou et al., 2005, Sarkisian et al., 2007), as well as E2F and MYC 
(Grandori et al., 2003, Lazzerini Denchi et al., 2005, Dominguez-Sola et al., 
2007), have been shown to induce a state of hyperproliferation during which the 
cell begins to exhibit several markers of replication stress including regions of 
single stranded DNA (Bartkova et al., 2006), stalled and collapsed replication 
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forks (Bartkova et al., 2006, Di Micco et al., 2006), and loss of heteroygosity at 
fragile sites (Abulaiti et al., 2006, Di Micco et al., 2006, Jones et al., 2000, 
Mallette et al., 2007). Re-replication, where the cell initiates a second round of 
DNA replication before it has divided, can also occur in response to RAS, which 
increases the level of DNA damage (Blow and Dutta, 2005, Davidson et al., 
2006). Thus, similar to replicatively senescent and stress induced premature 
senescence, oncogene induced senescence also appears to occur mainly as a 
result of DNA damage initiating the DNA damage response.  
 
1.3 The Senescence Signalling Pathways 
 
1.3.1 The Formation and Dynamics of DNA Damage Foci 
 
Both telomeric and non-telomeric lesions induce senescence through a 
persistent DNA damage response activating two phosphatidyl 3-kinase related 
kinase (PIKK) family proteins; Ataxia Telangiectasia Mutated (ATM) and ATM-
Rad3 Related (ATR).  
DSBs can arise from diverse stimuli including ionising radiation (Rogakou et al., 
1998), other external damage (Rogakou et al., 1999, Paull et al., 2000), 
telomere uncapping (d'Adda di Fagagna et al., 2003, Takai et al., 2003) and 
replication fork collapse (Furuta et al., 2003, Ward and Chen, 2001). 
Canonically, the DSBs are initially sensed by PARP, which recruits the Mre11-
Rad50-Nbs1 (MRN) complex to bind and unwind the DNA (D'Amours and 
Jackson, 2002), allowing NBS1 to recruit ATM (Falck et al., 2005). ATM then 
autophosphorylates itself forming active monomers (Bakkenist and Kastan, 
2003), which then phosphorylate a host of factors including Mre11, BRCA1, 
MDC1, p53, Chk2, Smc1, FANC D2, 53BP1 and NBS1 (Banin et al., 1998, 
Cortez et al., 1999, Dong et al., 1999, Gatei et al., 2000, Goldberg et al., 2003, 
Kim et al., 2002, Matsuoka et al., 2000, Rappold et al., 2001, Taniguchi et al., 
2002), depending on what molecules are present at the focus. Importantly, ATM 
also phosphorylates histone H2AX forming γ-H2AX (Burma et al., 2001, 
Fernandez-Capetillo et al., 2002), and allowing the binding of MDC1 scaffold 
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protein (Stucki et al., 2005). Up until this point the binding of MRN to the DNA 
has been transient (Lukas et al., 2003), but when NBS1 binds the MRN 
complex it stabilises it at the DNA (Stucki and Jackson, 2006). This amplifies 
ATM activity, stimulating further MRN recruitment and the spread of γ-H2AX 
along the chromatin (Stucki and Jackson, 2006, Lukas et al., 2004, Bekker-
Jensen et al., 2006, Bekker-Jensen et al., 2005), as summarised in figure 1.1. 
The amount of phosphorylation spans for megabases around the DSB 
corresponding to thousands of nucleosomes (Rogakou et al., 1998), thus 
forming what have become known as nuclear foci (Rogakou et al., 1999). Γ-
H2AX foci are static in the genome (Siino et al., 2002), and have been found to 
have a 1:1 ratio with the number of DSBs (Sedelnikova et al., 2002), which has 
caused them to be described as the “gold standard to detect the presence of 
DSBs” (Fernandez-Capetillo et al., 2004). Although it is not responsible for the 
recruitment of DDR factors, γ-H2AX is required for these proteins to be 
maintained at the DSB in activated state (Celeste et al., 2002). Many of these 
factors form a positive feedback loop with ATM to maintain the foci.  
 
Figure 1.1| The activation of the DDR by agents inducing double strand 
breaks.  
 
Alternatively, RPA coated single stranded DNA caused by replication stress or 
UV irradiation causes ATR and its DNA-binding subunit ATRIP to bind the DNA 
which activates a less well defined feedback loop through the activation of the 
RAD9-HUS1-RAD1 (9-1-1) and RAD17-RFC complexes, as well as TOPBP1 
(d'Adda di Fagagna, 2008). Although recruited ATR alone can phosphorylate 
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most of its targets, it still requires RAD17 to assemble claspin at the site of 
damage in order to activate Chk1 (Kumagai and Dunphy, 2000, Wang et al., 
2006a). Similar to ATM, ATR stimulates phosphorylation of H2AX and the 
formation of DNA damage foci. Notably, end resection of DSBs also generates 
RPA coated ssDNA which activates ATR (Cortez et al., 2001, Zou and Elledge, 
2003). 
It has also been suggested that DSBs can cause the exposure of histone cores 
causing the direct association of 53BP1 to the site of damage (Huyen et al., 
2004). However, alternative evidence suggests that 53BP1 requires the histone 
H2A and H2AX ubiquitination activity of RNF8/RNF168/HERC2 (Stewart et al., 
2009) which helps expose the methyl groups of histones around broken DNA to 
allow 53BP1 binding (Wu et al., 2011). MDC1 may also allow 53BP1 binding 
through inducing similar histone methylation through MMSET histone 
methyltransferase (Pei et al., 2011).  
Like γ-H2AX, 53BP1 forms foci of sufficient size to be visualised using widefield 
microscopy, due to its ability to oligomerise whilst bound to DNA (Iwabuchi et 
al., 2003, Adams et al., 2005). Like many of the DDR proteins, 53BP1 is 
recruited to sites of damage by PARP (Celeste et al., 2002). Amongst the 
earliest elements recruited to these sites (Bekker-Jensen et al., 2005, Mochan 
et al., 2004), 53BP1 is hyperphosphorylated by ATM (Anderson et al., 2001, 
Rappold et al., 2001, Xia et al., 2001), and plays an important role in activating 
ATM substrates (Wang et al., 2002, DiTullio et al., 2002, Fernandez-Capetillo et 
al., 2002). Additionally, 53BP1 is involved in DNA repair by non-homologous 
end-joining (Nakamura et al., 2006), and inhibits homologous recombination by 
preventing DNA resection and formation of ssDNA through CtIP and BRCA1 
(Bunting et al., 2010, Bouwman et al., 2010). Notably, BRCA1, and 53BP1 
rarely co-localise at DNA damage foci (Mok and Henderson, 2010), due to their 
opposing functions in promoting and inhibiting homologous recombination 
respectively. This is regulated according to the stage of the cell cycle so that 
DNA resection occurs mainly in S and G2 phases where sister chromatids can 
be used for homologous recombination (You and Bailis, 2010). 
Once the damage is repaired the cell can re-enter cell cycle and enter mitosis. 
Although the processes of checkpoint recovery are not well understood, the 
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recovery of the G2 checkpoint is thought to involve β-TrcP adaptor protein, 
which targets claspin (Mailand et al., 2006), and Wee1 to the SCF ubiquitin 
ligase complex for labelling for proteasomal degradation (Watanabe et al., 
2004) to allow cell cycle progression. Conversely, during checkpoint activation 
β-TrcP has the recovery opposing role of targeting Chk1 phosphorylated CDK-
activating phosphatase Cdc25A to the same complex, inhibiting cell cycle. 
However, both processes are dependent on phosphorylation (Cardozo and 
Pagano, 2004), so that during checkpoint activation Chk1 promotes 
ubiquitylation of Cdc25A, and the stabilisation of claspin, whilst in recovery the 
re-activation of Plk1 causes the phosphorylation and targeting of claspin and 
Wee1 to SCF (van Vugt et al., 2004, Mailand et al., 2006). Additionally, the 
activation of Wip1 and PP2A phosphatases are thought to play a role in 
checkpoint recovery after DNA repair (Chowdhury et al., 2005, Keogh et al., 
2006, Lu et al., 2005, Shreeram et al., 2006).  
Many small foci are produced by low and high doses of irradiation. At low doses 
these foci are generally resolved and if the cells had become quiescent they re-
enter the cell cycle. At high doses, whilst the majority of these foci are still 
resolved, a small fraction of them become enlarged and persist for months 
(Rodier et al., 2011). In some cells the 53BP1 foci initially co-localise with 
RPA70 which suggests that the damage is being repaired by homologous 
recombination, suggesting that these cells were in S-phase. However, this co-
localisation did not persist for longer than 24 hours after the initial pulse, 
suggesting that either the damage was repaired or the cell continued through 
G2 anyway. The combined demonstration that all cells developed persistent 
foci, but not all incorporated BrdU suggested that S-phase and the associated 
replication stress was not essential for the generation of these foci (Rodier et 
al., 2011), as some cells have arrested in G1 without entering S phase. 
If the damage is not repaired and the foci persist, then the foci stimulate the 
activation of the tumour suppressor molecules and cell cycle arrest.  
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1.3.2 The DNA Damage Response (DDR) Signalling to Tumour Suppressor 
Proteins 
 
ATM can directly phosphorylate p53 at Serine (Ser) 15 (Banin et al., 1998, 
Canman et al., 1998), which stimulates the transactivating function of p53 
through binding of its coactivator p300, but does not affect the association of 
p53 with human double minute 2 (HDM2) (Dumaz and Meek, 1999). Despite a 
threefold increase in dissociation of p53 from HDM2 through combined Ser15 
and Ser18 phosphorylation, ATM mainly exerts its effects on p53 indirectly via 
Threonine (Thr) 68 phosphorylation of Chk2 (Ahn et al., 2000, Melchionna et al., 
2000); however, it may also directly modify HDM2 (Maya et al., 2001). Chk2 can 
also be phosphorylated by ATR (Wang et al., 2006b), which also 
phosphorylates and activates Chk1 (Jazayeri et al., 2006).  
Chk1 and Chk2 transiently localise at the DNA damage foci to be 
phosphorylated by ATR and ATM respectively, but once activated these 
proteins dissociate and freely diffuse throughout the nucleus (Smits et al., 2006, 
d'Adda di Fagagna, 2008), at least at early time points. Both kinases are 
involved in the S and G2 checkpoints, phosphorylating the Cdc25A 
phosphatase causing its ubiquitin dependent degradation, thus preventing 
formation of replication origins as well as entry into mitosis (Falck et al., 2001, 
Xiao et al., 2003). Chk1 also phosphorylates Cdc25C mitosis-promoting 
phosphatase, making it essential for G2 arrest (Liu et al., 2000). However, their 
main role in cellular senescence is considered to be through the activation of 
p53 (Chehab et al., 2000). 
In its inactive form p53 tumour suppressor protein is associated with HDM2, 
which functions doubly to inhibit transcriptional activity by binding the N-terminal 
transactivation domain, and also as an E3 ubiquitin ligase targeting both p53 
and itself for degradation (Li et al., 2003). However, signalling through the DDR 
causes the activation and stabilisation of p53, preventing HDM2 from binding. 
As a major transcriptional regulator, p53 has multiple downstream targets which 
inhibit the cycle, as well as several genes involved in negative feedback, such 
as HDM2 (Barak et al., 1993). This leads to pulses of p53 activation (Hunziker 
et al., 2010), where the mean number of pulses rather than the amplitude 
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corresponded to the dose of IR, and thus the fate of the cell (Lahav et al., 
2004). A persistent signal will induce senescence or apoptosis, whilst loss of 
p53 pulses will allow re-entry into the cell cycle. 
The main transcriptional target of p53 is p21Cip1 which also has multiple targets, 
amongst which it inhibits cyclin E/CDK2 complex function from phosphorylating 
pRb and its two paralogues p107 and p130, resulting in checkpoint activation 
(Resnitzky and Reed, 1995, Sherr, 1994, Weinberg, 1995). Notably, the effects 
of p21 are partially dependent on the cellular environment as p21 can also 
activate CDKs 4 and 6 (Sherr and Roberts, 1999), both of which induce 
phosphorylation of pRb, as well as sequestering p21, preventing it from 
repressing CDK2, thus stimulating further phosphorylation of pRb and entry into 
S-phase (Cheng et al., 1999). Similarly to p53, the dynamics of p21 are not 
straightforward; however, both function mainly as cell cycle inhibitors.  
When pRb is hypophosphorylated it becomes active and inhibits transcriptional 
activity of E2F transcription factors, which prevents the production of genes 
essential for cell cycle progression (Nevins, 1992, Weinberg, 1995). The 
pathway is summarised in figure 1.2. 
 
Figure 1.2| Activation of tumour suppressor proteins by the DDR. 
 
Thus, DNA damage in the form of telomere dysfunction or double strand breaks 
(DSBs) can induce cellular senescence by the activation of p53 and pRb tumour 
suppressor proteins through ATM, ATR, CHK1 and CHK2. However, 
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senescence does not result from a single pathway, but from many interacting 
factors which in combination decide the fate of the cell. The cell has multiple 
redundant pathways to ensure the induction of senescence even if the damage 
has knocked out others. Thus, the knockout or knockdown of any factor only 
increases the likelihood of cells escaping senescence, creating a 
heterogeneous population of arrested and cycling cells. For example, 
microinjection of dominant negative kinase dead mutants of ATM, ATR, CHK1 
and CHK2 combined allowed a few TRF2 knockout senescent cells to re-enter 
the cell cycle and incorporate BrdU (d'Adda di Fagagna et al., 2003). Equally, in 
RAS induced senescence individual knockdown of each of these factors 
allowed similar percentages to re-enter cell cycle (Di Micco et al., 2006), as has 
been shown in related studies using other cell types (Gire et al., 2004, Bartkova 
et al., 2006). Importantly, in some of these studies the cells still may arrest in 
G2 or M phase after replicating the DNA (d'Adda di Fagagna et al., 2003), 
because they only examined BrdU, whilst other studies clearly demonstrate that 
at least some cells do revert to cell cycle, allowing unrestrained growth at the 
same time as accumulating DNA damage.  
In human cells the level of redundancy is higher than in mice, as mouse 
embryonic fibroblasts require only the loss of either p53 or pRb signalling in 
order to allow some cells to bypass (Harvey et al., 1993)1 or escape (Dirac and 
Bernards, 2003) senescence, whereas in human fibroblasts the inactivation of 
both genes is necessary (Shay et al., 1991, Smogorzewska and de Lange, 
2002). Redundancy is also dependent on the senescence stimulus; p21 knock 
out mouse embryonic fibroblasts (MEFs) senesce in response to RAS (Pantoja 
and Serrano, 1999, Takeuchi et al., 2010), but not 20% oxygen (Takeuchi et al., 
2010), when both stimuli would induce senescence in wildtype MEFs, if much 
less stably in response to 20% O2 (Coppe et al., 2010). Importantly, these data 
indicate that there is a stochastic element to cellular senescence influenced 
partially by the presence of the milieu of inductive and preventative factors, but 
also by the nature of the damage, which is itself highly stochastic.  
 
                                                          
1
 Notably, although homozygotic p53 knockout mouse cells bypassed senescence, heterozygotic cells 
still senesced even if they lost their remaining wildtype allele, which suggests that mouse cells can 
senesce without p53, but it is more difficult, and may be dependent on the level of molecular damage, 
which is likely higher in the homozygotic cells. 
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1.3.3 The Independent Pathways of p53 and pRb in Senescence 
 
As described above, whilst p53 and pRb may fit into a linear pathway in mice, in 
humans they can induce senescence independently of each other. Independent 
of pRb, p53 directly induces transcription of 14-3-3σ (Hermeking et al., 1997), 
which sequesters Cdc25C phosphatase in the cytoplasm preventing it from 
activating cyclin B-Cdc2 causing stable G2/M arrest (Chan et al., 1999). 
Inhibition of 14-3-3σ results in immortalisation of human keratinocytes 
(Dellambra et al., 2000). Another possible pRb independent mechanism is the 
inhibition of PCNA by p21; however, whilst it has been shown to induce both G1 
and G2 arrest (Cayrol et al., 1998), p21 mutant cells lacking the ability to bind 
PCNA can still senesce (Macip et al., 2002). It has also been suggested that 
p21 could induce senescence through increasing ROS levels, independent of 
both PCNA binding, and cyclin/Cdk inhibition (Macip et al., 2002). 
pRb can be activated by p16INK4a, hereafter p16, independently of p53 (Alcorta 
et al., 1996). Upon activation, p16 is translocated to the nucleus from the 
perinuclear cytoplasm where it functions as a cyclin D/Cdk4,6 inhibitor (Serrano 
et al., 1993, Spallarossa et al., 2010), thus preventing the inhibitory 
phosphorylation of pRb (Resnitzky and Reed, 1995, Sherr, 1994, Weinberg, 
1995). In mice, one study showed that MEFs lacking p16 underwent 
senescence indistinguishably from wildtype cells in response to γ-irradiation, 
replication and oncogene activation (Krimpenfort et al., 2001). However, 
another study showed p16 knockout MEFs were more prone to immortalization 
(Sharpless et al., 2001). Importantly, when knockout of p16 was combined with 
p19ARF (p14ARF in humans), which is an important activator of p53 in mice, the 
absence of both pathways causes a marked increase in tumour formation over 
the lack of each individual factor (Krimpenfort et al., 2001), as is the case for 
double p16, p21 knockout MEFs (Takeuchi et al., 2010). Thus, in mice as in 
humans it appears that these pathways have some independence and therefore 
compensatory ability. In humans, p16 is not essential for most types of 
senescence. Different strains of human fibroblasts mutant for p16 proliferated 
for longer than wildtype cells, but still senesced at a later population doubling 
(Brookes et al., 2004). Equally, p16 is not essential for senescence induced by 
N-RAS, H-RAS and BRAFv600E (Denoyelle et al., 2006, Haferkamp et al., 2009, 
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Zhuang et al., 2008). However, this is also to be expected if the p16 and p53 
pathways can induce senescence independently. Importantly, when p53 was 
inactivated, the strains of fibroblast with low levels of p16 robustly resumed cell 
cycle (Beausejour et al., 2003), and additionally the overexpression of p16 
alone is sufficient to induce cellular senescence (Coppe et al., 2011, Kato et al., 
1998, McConnell et al., 1998, Pospelova et al., 2009).  
Interestingly, unlike p21 which accumulates at the initiation of senescence and 
declines after the cells become senescent, p16 accumulates gradually, with 
almost none present at the early stages, and then persists for at least two 
months after induction (Alcorta et al., 1996, Hara et al., 1996, Stein et al., 1999). 
The expression of p16 coincides with aspects of the senescent phenotype such 
as increased cell size and expression of senescence associated β- 
galactosidase (Alcorta et al., 1996, Hara et al., 1996, Stein et al., 1999), and 
may be responsible for the permanency of senescence (Beausejour et al., 
2003, Stein et al., 1999).   
p16 expression has been shown to increase as a result of oncogene induced 
senescence (Serrano et al., 1997), oxygen radicals (Chen et al., 2004, Ito et al., 
2004), radiation (Meng et al., 2003), and telomere dysfunction (Jacobs and de 
Lange, 2004). Although the exact mechanism of p16 activation is not completely 
understood, one possibility is that these DNA damage signals activate p38 
MAPK signalling (Bulavin et al., 2004, Ito et al., 2006, Iwasa et al., 2003), which 
then activates p16 (Spallarossa et al., 2010).   
 
1.3.4 MAPK Signalling in Cellular Senescence 
 
There are three main types of MAPK; c-Jun N-terminal Kinase (JNK), ERK and 
p38, all of which have been implicated in senescence. Inhibition of p38 and JNK 
by specific inhibitors significantly reduced the induction of cellular senescence. 
However, p38 was found to be the main inducer of senescence, whilst JNK was 
an inhibitor of apoptosis and actually suppressed p16 (Spallarossa et al., 2010). 
Equally, ERK overexpression induced senescence, but this resulted because 
ERK is a mild oncogene downstream of RAS signalling (Boucher et al., 2004), 
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and exclusion of p-ERK from the nucleus is part of the senescent phenotype 
(Mallette et al., 2004). Additionally, in one study inhibition of ERK only had a 
minor effect on senescence (Courtois-Cox et al., 2006), though in another study 
in slowly proliferating or quiescent cells ERK inhibition prevented senescence 
induction (Probin et al., 2006). Thus, p38 is the main MAPK involved in 
senescence signalling, being sufficient, although predictably not essential, for 
induction (Freund et al., 2011). 
DNA damage activates p21 which signals through GADD45A (Kearsey et al., 
1995), and can activate p38 either directly or through MAP3K4 and MAP2K3 
(Bulavin et al., 2003). However, the dynamics of p38 after X-irradiation closely 
follow those of p16, increasing only slightly in the first 24 hours, rising 
substantially between 2-4 days and peaking at 8-10 days (Freund et al., 2011), 
which is consistent with p38 inducing p16 expression, and inconsistent, though 
not incompatible, with activation by p21. Notably, another study demonstrated 
that the inhibition of p53 actually increased the activation of p38 (Freund et al., 
2011). However, these results should be viewed with caution as p53 has 
multiple different roles which at times can appear paradoxical (Demidenko et 
al., 2010). It is likely that in the cases of severe stress and telomere dysfunction 
that it is DNA damage which leads to the activation of p38, even if the exact 
mechanism and timeframe are unclear, though in oncogene induced 
senescence RAS can directly activate p38 (Chen et al., 2000a, Li et al., 2000). 
Importantly, the activation of p38 by constitutive MKK6/2E causes the complete 
abrogation of RAS stimulated proliferation (Deng et al., 2004). Thus RAS could 
potentially induce senescence through p38. Consistent with this model, RAS 
more potently activates the pro-survival and proliferation MAPKs, ERK and JNK 
than p38 (Chen et al., 2000a), so it could be speculated that normal levels of 
RAS may trigger proliferation, whilst high levels begin to induce senescence 
through the increased induction of p38.  
Importantly, this process could be independent of DNA damage. p38 can 
activate the senescence inducer p16, and can even phosphorylate p53 through 
the activation of p38-regulated protein kinase (PRAK), which is essential for the 
transcriptional activity of p53 in response to RAS, and the senescence response  
(Sun et al., 2007). However, it should be noted that activation of p38 to the 
endogenous levels induced by RAS was not sufficient to completely abrogate 
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the proliferative response, and it was only with higher levels of p38 through 
MKK6/2E that this was achieved. Thus, it is still likely that p38 requires 
additional stimulation from other signals, such as DNA damage, in order to 
induce cellular senescence under physiological conditions.  
Through the combined use of modelling and experimental work it has been 
shown that p38 can also be involved in a positive feedback loop to induce 
senescence by the induction of further DNA damage (Passos et al., 2010). This 
was based on previous studies that p38 induces TGF-β which caused an 
increase in ROS through mitochondrial and non-mitochondrial sources (Koli et 
al., 2008, Torres and Forman, 2003), both of which have been implicated in 
senescence (Davis et al., 2005, Debacq-Chainiaux et al., 2005). Passos et al. 
(2010) demonstrated that ROS generated from these pathways caused further 
DNA damage and cyclic activation of p53 through the replenishment of the 
short-lived damage foci (Passos et al., 2010). Then, as described above, DNA 
damage could activate p38 through the activation of p21 and GADD45A 
(Bulavin et al., 2003, Kearsey et al., 1995). However, contrary to this, further 
evidence suggested that neither p38 induction using MKK6/2E, nor p38 
inhibition using SB203580, had any effect on activation of the DDR or activation 
of p53 as it would be expected to do if p38 induced senescence via inducing 
DNA damage (Freund et al., 2011). Notably, this latter observation does not 
contradict that p38 can be activated by DNA damage, only that p38 does not 
induce further DNA damage, although as discussed above the inhibition of p38 
by p53 is not entirely conducive to this idea (Freund et al., 2011).  
One possible reason for the contradiction between these two studies is the 
different cellular environments. Passos et al. (2010) used irradiated cells, which 
will have large amounts of DNA damage and therefore an active DDR and p53 
signalling, whereas Freund et al. (2011) used MKK6/2E stimulated cells which 
would not necessarily involve such signalling (Freund et al., 2011, Passos et al., 
2010). Speculatively, it is possible that in order to sustain the feedback loop 
between p38 and p53, both pathways require some initial activating stimulus. 
For example, some essential component of the TGF-β signalling pathway could 
require phosphorylation at two different sites; one by a DDR or p53 regulated 
kinase, and one by a p38 regulated kinase in order to become sufficiently 
actived to produce the required ROS for positive feedback via the pathway 
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suggested by Passos et al. (2010). However, what is clear is that senescence 
can be induced independently of DNA damage.  
 
1.3.5 DNA Damage Independent Senescence and mTOR 
 
Combined with all the reports that oncogene induced senescence is dependent 
on DNA damage, there are also reports that this can be done independently, 
though still requiring p53 (Wolyniec et al., 2009). Equally, the knockout of PTEN 
tumour suppressor gene, which inhibits the PI3K/Akt pathway, triggers arrest 
independent of hyperproliferation or DNA damage, but still dependent on p53 
(Alimonti et al., 2010). 
Notably, the use of shRNA against EZH2 to inhibit the Polcomb protein Bmi1 
can directly activate p16 and induce senescence (Bracken et al., 2007), which 
could potentially induce senescence independently of damage, though notably 
they also observe that DNA damage does cause depletion of EZH2.  
The activation of p16 and p21 using an IPTG inducible system was shown to 
activate the DDR and induce senescence without significant DNA damage as 
determined by a COMET assay (Pospelova et al., 2009). As well as the HDAC 
inhibitor sodium butyrate, these stimuli caused an increase in γ-H2AX 
disproportionate to the amount of DNA damage, which they contrasted to the 
induction of senescence by irradiation (Pospelova et al., 2009). Interestingly, 
when the IPTG is washed out, many of the cells re-entered cell cycle (Leontieva 
et al., 2012), thus indicating artificially maintained p16 or p21 cannot in 
themselves induce a stable senescent phenotype and still require other stimuli 
such as DNA damage to reinforce arrest and make it permanent. It should also 
be noted that the situations in these experiments are artificial. Were cells to be 
subjected to high levels of p16, p21, oncogenes or HDAC inhibition in vivo, the 
most likely cause, if not the only one, would be the instigation of DNA damage 
resulting in either the de-regulation of an oncogene or the upregulation of a 
tumour suppressor.  
It is widely believed that oncogenes induce senescence by a system of negative 
feedback along with the induction of tumour suppressor proteins (Deng et al., 
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2004); however, another hypothesis is that it is the continued expression of 
oncogenes which is important (Blagosklonny, 2003). Via this theory, if the 
oncogenes were suppressed quickly enough then senescence would fail and 
the cells would re-enter cell cycle. Interestingly, radiation has been shown to 
induce mitogenic signalling such as RAS, Akt and Raf1 (Kasid et al., 1996, Liu 
et al., 1996, Shaulian et al., 2000), and p53 stimulates MAPK and Akt signalling 
(Fang et al., 2001, Ishii et al., 1995). Thus these mitogenic signals might be 
important in all forms of senescence. 
Compared to quiescence, where the cell reversibly arrests in the absence of 
growth factors and therefore have low levels of cyclin D1, senescent cells have 
high levels of cyclin D1. Quiescent cells respond to growth factors by 
upregulating cyclin D1 and activation of the cell cycle (Blagosklonny and 
Pardee, 2002), whilst senescent cells are arrested despite high levels of cyclins 
including A, B, D and E (Darzynkiewicz, 2002, Gong et al., 1995), and further 
stimulation does not result in proliferation. Although at high concentrations 
cyclin D1 can paradoxically inhibit CDKs (Atadja et al., 1995, Wong and 
Riabowol, 1996), combined with the observation that RAS stimulates 
proliferation in cells lacking p16 and pRb (Sherr, 2004), this suggests that the 
presence of tumour suppressors makes the cell unresponsive to the pro-cell 
cycle activities of RAS. Importantly, stimulation of cell cycle inducers 
downstream of pRb should therefore still cause cell cycle progression, as it has 
been suggested that they do (Blagosklonny, 2006b). 
Interestingly, the activation of physiological levels of p53 using nutlin-3a, which 
is an HDM2 antagonist, can induce senescence in some cells (Efeyan et al., 
2007, Van Maerken et al., 2006), but only quiescence in others (Cheok et al., 
2010, Huang et al., 2009, Korotchkina et al., 2009), and has been shown to 
suppress cellular senescence in cells already expressing high levels of p21 
(Demidenko et al., 2010). The growth promoting functions of p53 have been 
implicated to work through its inhibition of mTOR signalling. 
The serine/threonine kinase mTOR forms two complexes with different 
functions. Both complexes contain mLST8/GβL, and the inhibitory deptor 
subunit (Peterson et al., 2009), whilst mTORC1 contains Raptor and Rheb, and 
mTORC2 contains Rictor and mSIN1 (Frias et al., 2006). The mTORC1 
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complex responds to both amino acid levels and growth factors, whereas 
mTORC2 responds to only the latter. The presence of amino acids stimulates 
the Ragulator to translocate mTORC1 to the lysosomal surface (Sancak et al., 
2010), where it can bind Rags which allow it to associate with Rheb, and 
become sensitive to stimulation via insulin (Sancak et al., 2010, Drummond et 
al., 2008). The activation of insulin receptor substrate (IRS) binds 
phosphoinositide 3-kinase (PI3K) producing phosphatidylinositol (3,4,5)-
triphosphate (PI(3,4,5)P3), which then binds Akt and PDK1 (Polak and Hall, 
2009). Akt then destabilises the tuberous sclerosis complex (TSC1/TSC2) (Inoki 
et al., 2002), allowing the binding of GTP-bound Rheb to bind and activate 
mTORC1 at the lysosomal membrane (Huang and Manning, 2009).  
mTORC1 activates p70-S6K1 causing the phosphorylation of numerous 
substrates including S6 ribosomal protein (Heinonen et al., 2008), and the 
translation initiation factor eIF4B. Combined with additional inactivation of 4E-
BP1, freeing eIF4E (Dann and Thomas, 2006), this results in increased 
translation through the eIF4F complex. mTORC1 also regulates ribosomal 
biogenesis and inhibits autophagy, the latter through the inhibitory 
phosphorylation of ULK1 (Lee et al., 2010). 
The reason mTOR is thought to be important in senescence is that its inhibition 
promotes quiescence, whilst its stimulation promotes senescence (Demidenko 
et al., 2010). Consistently, there is some evidence that rapamycin can inhibit the 
induction of senescence, and even allow cell cycle re-entry (Korotchkina et al., 
2010, Leontieva et al., 2012, Pospelova et al., 2009). Contrary to this idea, the 
stimulation of autophagy, which is inhibited by mTOR, has been shown to be 
necessary for senescence (Young et al., 2009, Cho et al., 2013), although 
autophagy controls multiple processes and can also inhibit senescence under 
some conditions (unpublished).  
The mTOR pathway is activated by RAS signalling (Kennedy et al., 2011), and 
thus may reflect an additional mechanism by which oncogenes can contribute to 
senescence induction. It has also been suggested that mTOR may induce 
senescence by maintaining an atypical DDR which is not associated with DNA 
damage or many of the molecules that are exclusive to the typical DDR, such 
as 53BP1 (Pospelova et al., 2009). However, these irregular foci have only 
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been shown to exist in response to a few atypical forms of stress (Pospelova et 
al., 2009), whilst the majority stimuli still induce damage and foci containing 
53BP1 (Rodier et al., 2011). Thus, although speculatively mTOR may maintain 
an atypical DDR, this has little implication for the role of damage in senescence, 
which is the primary inducer in most cases. One final way that mTOR may 
contribute to senescence is via the activation of NF-κB and the inflammatory 
pathways (Dan et al., 2008, Madrid et al., 2001). 
 
1.3.6 Inflammation, NF-κB and Senescence 
 
A key regulator of the inflammatory response is the transcription factor NF-κB, 
which regulates and is regulated by a complex network of interacting factors. 
There are five members of the NF-κB family, p65, RelB, c-Rel, p105/p50 and 
p100/p52, all containing a conserved Rel homology domain that allows them to 
dimerise, and bind both DNA and the inhibitory IκB molecules. The IκB 
molecules prevent the dimers from entering the nucleus to initiate transcription. 
Additionally, both p105 and p100 have ankyrin repeat domains similar to the IκB 
molecules which also prevent nuclear translocation. These molecules need to 
be cleaved to p50 and p52 respectively to lose the ankyrin repeats and allow 
nuclear translocation.  
Canonical NF-κB signalling occurs in response to inflammatory cytokines such 
as IL-1 and TNF-α or products of bacterial infection such as lipopolysaccharide 
(LPS).  As a result the IKK complex consisting of the two catalytic subunits IKKα 
and IKKβ bound to multiple copies of the regulatory subunit NEMO is activated 
by phosphorylation of IKKβ (Perkins and Gilmore, 2006), which phosphorylates 
IκBα deactivating it and causing its ubiquitination by the Skp1/Cul1/F-box 
protein-β-TrCP ubiquitin ligase complex, and targeting it for degradation by the 
proteasome (Hayden and Ghosh, 2004). This induces the translocation of p65-
p50 heterodimers within minutes of the stimulus (Perkins and Gilmore, 2006), 
and can result in transcription of a host of different factors depending on activity 
of different co-factors. Its main targets include TNF-α/β, IL-1β, IL-2, IL-6, IL-8, 
IL-12 and IFN-β (Blackwell and Christman, 1997). Similar to p53, canonical NF-
κB signalling is oscillatory as it stimulates the transcription of IκBα which returns 
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NF-κB to the cytoplasm (Hayden and Ghosh, 2004), as well as multiple 
proinflammatory cytokines for positive feedback. However, additional inhibitors 
such as IκBβ and IκBε are not regulated by NF-κB (Perkins and Gilmore, 2006), 
and thus dampen the oscillatory profile (Hoffmann et al., 2002). 
Non-canonical signalling occurs via the activation of NIK, which activates IKKα 
causing the phosphorylation and proteolytic cleavage of p100 to p52 (Bonizzi 
and Karin, 2004, Hayden and Ghosh, 2004). Then p52 protein mostly 
associates with RelB (Bonizzi et al., 2004, Bonizzi and Karin, 2004), forming a 
heterodimer which translocates to the nucleus and targets promoters containing 
distinct κB elements (Bonizzi et al., 2004). The promoters of RelB, c-Rel, p100 
and p105 all contain κB elements, and are thus transcribed as a result of NF-κB 
activation (Hayden and Ghosh, 2004, Pahl, 1999), which results in changes in 
NF-κB signalling over time.  
Evidence for a role of inflammation in senescence was demonstrated by the 
prevention of both induction and maintenance of oncogene induced senescence 
by the inhibition of the inflammatory cytokines IL-6 and IL-8 (Kuilman et al., 
2008). In the same issue of Cell another study showed that the IL-8 receptor 
CXCR2 was important for both OIS and replicative senescence, and 
overexpression of CXCR2 could induce senescence dependent on p53 (Acosta 
et al., 2008). Importantly, they found that CXCR2 depletion inhibited ATM 
activation and DDR signalling, consistent with the idea that inflammation 
contributes to senescence via activation of the DDR.  
With regards to the role specifically of NF-κB, one study showed that senescent 
cells had increased active phospho-p65 (S536) (Rovillain et al., 2011), and 
others that p65 was noticeably more nuclear in senescent than proliferative 
cells with markedly increased DNA binding activity (Freund et al., 2011, Chien 
et al., 2011), although an earlier study showed the opposite effect, including 
decreased nuclear and increased cytoplasmic levels of p65 with reduced NF-κB 
binding to promoter regions (Helenius et al., 1996). Notably, repression of NF-
κB signalling can result in bypass of senescence (Rovillain et al., 2011), 
extends replicative lifespan in culture (Tilstra et al., 2012), and c-Rel 
overexpression can induce senescence (Bernard et al., 2004). Combined these 
data suggest that NF-κB is important for senescence. However, another group 
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found that constitutive activation of IKKβ delayed Ha-RasV12 oncogene 
induced senescence of primary human fibroblasts by suppressing the DDR 
(Batsi et al., 2009), although this may be down to NF-κB independent functions 
of IKKβ including the induction of autophagy (Criollo et al., 2010b, Criollo et al., 
2010a). 
Notably, in contrast to tumour suppressors such as p53 and p16, NF-κB is 
frequently overactive in cancer cells (Karin, 2009, Meylan et al., 2009, Pikarsky 
et al., 2004), and is thought to play a role in tumour promotion, though not 
initiation (Pikarsky et al., 2004). This is likely a result of the pro-survival 
pathways of NF-κB by the inhibition of apoptosis rather than specifically 
inducing proliferation (Barbie et al., 2009, Pikarsky et al., 2004), though it also 
has other relevant effects (Bennett, 2008, Karin, 2009). Indeed in vivo, both 
senescence associated-β-galactosidase (SA β-gal) and p16 expression are 
reduced by NF-κB inhibition (Adler et al., 2007), and its suppression is also 
associated with tumour development (Dajee et al., 2003, Maeda et al., 2005). 
Importantly, the high levels of chromosomal amplifications and translocations in 
p65 knockout cells has implicated a role in maintaining senescence of mouse 
and human immortalised cells through the maintenance of genomic stability by 
an undescribed mechanism of activating DNA repair (Wang et al., 2009b). 
Thus, the tumour promoting and inhibiting effects of NF-κB is context dependent 
(Jing et al., 2011), as NF-κB appears to prevent DNA damage, increase cell 
survival and contribute to clearance by the immune system by increasing 
inflammation. Notably, in cells with effective tumour suppressor mechanisms all 
these pathways will help the activation of cell senescence, but may have the 
opposite effects in cells with defective senescence machinery, although some 
studies are still contradictory (Batsi et al., 2009).  
How NF-κB is activated in senescence is still unclear. Genotoxic stress has 
been shown to activate NF-κB via a pathway involving PARP-1 and ATM which 
converge to monoubiquitinate NEMO and allow activation of the IKK complex by 
TAK1 (Hinz et al., 2010, Stilmann et al., 2009). In irradiation induced 
senescence, the DNA-binding of NF-κB had begun to rise 24hrs after irradiation 
and peaked 8-10 days later, which was decreased by inhibition of p38 (Freund 
et al., 2011).  Whilst constitutive activation of p38 was sufficient to stimulate the 
increased NF-κB DNA binding activity found in senescent cells, inhibition by 
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ATM also decreased NF-κB activity to the same level as p38 inhibition, and the 
effect of dual inhibition was synergistic suggesting that both affect NF-κB via 
different pathways (Freund et al., 2011). Consistently, supraphysiological but 
not endogenous p38 activation can induce IL-6 levels to those of senescent 
irradiated cells, suggesting that p38 requires co-operation with the DDR under 
physiological conditions (Freund et al., 2011). 
NF-κB is essential in the production of the SASP (Chien et al., 2011, Freund et 
al., 2011), and its inhibition by shRNA or the inhibitor Bay 11-7082 reduces both 
the inflammatory molecules as well as several matrix metalloproteinases, 
producing a similar effect to p38 inhibition, suggesting that the effect of p38 on 
the SASP results from its activation of NF-κB. Importantly, co-suppression of 
p65 and p53 allowed significant bypass of senescence and failure to 
accumulate p16 in IMR-90 fibroblasts in response to oncogenic Ras, where 
each individual suppression had very little effect. As BJ fibroblasts bypassed 
senescence with p65 inhibition alone, this suggests that these two hub 
molecules work in different but interconnected networks that co-operate to 
induce senescence dependent on cell type (Chien et al., 2011). 
Acting downstream of p38, which can under some circumstances have little 
effect on DNA damage levels (Freund et al., 2011), there may be DNA damage 
independent mechanisms by which NF-κB contributes to senescence. However, 
NF-κB is involved in several pathways which increase levels of ROS, and its 
inhibition has been shown to improve mitochondrial function and reduce 
oxidative stress (Mariappan et al., 2010), through which it might be expected to 
contribute to senescence via the instigation of DNA damage.  
 
1.3.7 Reactive Oxygen Species as Mediators of Senescence through DNA 
Damage 
 
Senescent cells have been shown to have significantly higher ROS levels 
(Hagen et al., 1997), and higher levels of oxidative DNA damage, but not 
protein carbonyls (Chen et al., 1995), than healthy replicating cells. However, 
other studies also suggest that high levels of protein oxidation and cross-linking 
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are features of senescent cells, which is consistent with the deterioration of 
proteasomal and lysosomal function (Sitte et al., 2000c, Sitte et al., 2000b). As 
ROS can either be produced as byproducts of metabolic processes or 
deliberately as part of signalling pathways, there are multiple sources by which 
ROS can be induced in senescent cells.  
Many of the ROS producing enzymes are regulated by NF-κB, including 5-
lipoxygenase enzyme (Chopra et al., 1992), the NADPH oxidase NOX2 
(Anrather et al., 2006), COX-2 (Deng et al., 2003, Inoue and Tanabe, 1998), 
and the reactive nitrogen species producing complex, iNOS (Kolyada et al., 
1996). However, NF-κB also upregulates many antioxidant enzymes including 
SOD2 (Djavaheri-Mergny et al., 2004, Jones et al., 1997), SOD1 (Rojo et al., 
2004), thioredoxins (Djavaheri-Mergny et al., 2004), glutathione S-transferase-
pi, and Gpx-1, the latter two in response to oxidative stress (Schreiber et al., 
2006, Xia et al., 1996). Thus, although NF-κB is involved in the production of 
ROS during inflammation, it is also involved in their clearance once ROS levels 
become too high and/or resolution is required. Whether NF-κB is essential for 
the ROS production in senescence is controversial. The induction of 
senescence by overexpression of c-Rel was dependent on oxidative damage 
(Bernard et al., 2004), and p65 knockout both reduced oxidative damage and 
delayed the onset of replicative senescence (Tilstra et al., 2012), but contrarily 
another study found no differences in endogenous hydrogen peroxide and 
oxidative DNA damage between p65-/- and p65+/+ MEFs (Wang et al., 2009b). 
Other mechanisms by which ROS could be induced in senescence include the 
activation of p66Shc by p53 (Trinei et al., 2002). p66Shc is upregulated in 
senescent cells (Zhang et al., 2010), but in contrast to its clear role in the 
induction of apoptosis (Trinei et al., 2002), there is currently little evidence for a 
causal relationship in cellular senescence. Notably p53 also promotes 
expression of several antioxidants (Olovnikov et al., 2009), which may help 
account for the dual role of p53 in suppressing senescence (Demidenko et al., 
2010). Another study showed that knockout of p21, but not p16, caused a 
reduction in ROS levels in RAS expressing cells, but the level was not reduced 
to that of controls (Takeuchi et al., 2010). Contrarily, p16 has been shown to 
increase ROS in some cells (Takahashi et al., 2006).  
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p21 could mediate ROS levels by the negative regulation of peroxiredoxins 
through the repression of sestrins (Kopnin et al., 2007), or the ROS generating  
5-lipoxygenase enzyme (Catalano et al., 2005). However, it is also consistent 
with the idea that ROS production may be induced by the activation of TGF-β 
via p38 (Passos et al., 2010), which can stimulate both mitochondrial and non-
mitochondrial sources of ROS (Koli et al., 2008, Torres and Forman, 2003).  
Mitochondria can also be a large source of ROS during senescence. 
Breakdown of mitochondrial membrane potential and increased ROS has been 
shown in senescent cells (Passos et al., 2007), as has impaired metabolism 
and low nucleotide triphosphate levels including ATP (Zwerschke et al., 2003).  
Importantly, treatment with antioxidant enzymes and hypoxia increases 
replicative lifespan (Chen et al., 1995), whilst hydrogen peroxide (Chen et al., 
1998), and hyperoxia (von Zglinicki et al., 1995) induce premature senescence. 
ROS are also essential for RAS induced senescence (Catalano et al., 2005, 
Lee and Paull, 2005, Nicke et al., 2005, Wu et al., 2004), p21 overexpression 
induced senescence (Macip et al., 2002), and the initiation, but not 
maintenance, of senescence induced by IR (Hong et al., 2010). Thus, there is 
strong evidence that ROS play a causal role in senescence. 
Mitochondria may play a prominent role in senescence. They have been 
implicated in replicative senescence through the production of ROS as a result 
of dysfunction (Passos et al., 2007, Passos and Von Zglinicki, 2006), and also 
in OIS in response to p53 or pRb activation (Moiseeva et al., 2009). Additionlly, 
the induction of mitochondrial dysfunction using antimycin A, oligomycin (Stockl 
et al., 2006), and the mitochondrial Rieske iron sulphur protein (RISP) 
(Moiseeva et al., 2009) is sufficient to induce senescence. The mitochondrial 
uncoupling agent DNP reduced ROS levels and increased yeast replicative 
lifespan (Barros et al., 2004), and fibroblast replicative lifespan (Passos et al., 
2007). Additionally, telomere dysfunction has been shown to induce 
mitochondrial compromise in mice (Sahin et al., 2011). Therefore, it is likely that 
mitochondrial function is an important factor in senescence. 
The overexpression of PGC1α has also been shown to accelerate senescence 
(Xu and Finkel, 2002), indicating biogenesis plays an important role. If this 
results from increased ROS production due to the higher numbers of 
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dysfunctional mitochondria, then this could also implicate mTOR in the induction 
of DNA damage through activation of PGC1α and ROS, as suggested by a 
recent study (Marques et al. unpublished).  
Exactly how ROS contribute to cellular senescence is still controversial. One 
possibility is that ROS are part of a positive feedback loop generating small 
short lived foci, which still account for about half of those present even in deep 
senescent cells. In this feedback loop, p38 stimulates ROS production through 
TGF-β, thus maintaining a continual DDR (Passos et al., 2010). Notably, the 
contrary study implicating a DDR-independent role for p38 in senescence did 
not examine whether p38 overactivation affected ROS levels (Freund et al., 
2011), whilst another study found that p38 did induce ROS production in 
chondrocyte senescence (Hong et al., 2010). Thus, p38 may induce 
senescence through the production of ROS. Interestingly, ROS signalling 
activates PKCδ-CF (Bey et al., 2004, Konishi et al., 1997, Talior et al., 2005), 
which is increased during replicative senescence in HDFs (Wheaton and 
Riabowol, 2004), though not in MEFs (Takahashi et al., 2006), and is known to 
stimulate NADPH oxidase, thus generating a positive feedback loop to increase 
ROS (Bey et al., 2004, Talior et al., 2005). As in the same cells inactivating p53 
and pRb function did not induce cell cycle unless ROS are also depleted, it was 
suggested that ROS may stimulate their own positive feedback loop maintaining 
senescence even independently of damage, possibly through the suppression 
of the cytokinesis initiator, WARTS (Takahashi et al., 2006); however, this 
would be specific to G2 arrest. Equally, ROS could stimulate positive feedback 
by inducing damage to mtDNA (Dumont et al., 2000b), reducing mitochondrial 
function and inducing further ROS production (Pitkanen and Robinson, 1996, 
Wong et al., 2002). 
Alternatively, several studies have suggested that ROS may contribute to 
senescence through the activation of p38 (Hong et al., 2010, Xiao et al., 2012). 
Equally, under multiple conditions ROS can activate NF-κB either through the 
degradation of IκBα (Schieven et al., 1993, Schoonbroodt et al., 2000, Takada 
et al., 2003), activation of the IKK complex (Kamata et al., 2002), or stabilisation 
of NIK (Li and Engelhardt, 2006). However, ROS can also inhibit NF-κB through 
the stabilisation of IκBα by inhibiting the proteasome (Wu et al., 2009) and the 
inactivation of the IKK complex (Panopoulos et al., 2005, Reynaert et al., 2006). 
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Whether ROS activate NF-κB in cellular senescence is currently unknown, but 
as they activate p38, which is in a positive feedback loop with NF-κB, it is likely 
that they do.  
 
1.3.8 Summary 
 
Cellular senescence is a stress response, which the current evidence suggests 
is instigated primarily by DNA damage. This induces an activation cascade 
known as the DNA damage response, which has several downstream effects. 
Most importantly it activates the tumour suppressor protein p53 which then 
activates the cyclin dependent kinase inhibitor p21, and further downstream 
pRb, to prohibit the cell cycle. However, senescence is not a linear process. It 
has multiple redundant and interacting pathways which help to regulate the 
cellular response to damage. At least partially independent of damage p38 can 
activate p16 to induce senescence, and the mTOR pathway may also play a 
role. 
In nearly all cases senescence is dependent on the presence of an active DDR. 
Thus, although some stimuli can induce senescence independently of the DDR, 
an important mechanism in the large majority of senescence induction and 
maintenance is ensuring that the DDR persists. Whilst some pathways exist that 
can activate the DDR without the induction of damage, there is a host of 
evidence suggesting that senescing or senescent cells reinforce the DDR with 
the stimulation of further DNA damage to prevent cell cycle re-entry.  
The result of inducing this system of positive feedback loops integrating 
molecular damage, induces radical changes in senescent cells, which helps to 
produce the resultant phenotype. The pathways are summarised in figure 1.3. 
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Figure 1.3| Network of factors interacting to induce senescence and 
inhibit the induction of apoptosis. 
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1.4 The Senescent Phenotype 
 
1.4.1 Apoptosis and Alternatives to Senescence 
 
If a cell is responding properly to stress in the form of damage or oncogenic 
activation it will inhibit proliferation. Minor damage results in quiescence whilst 
the damage is repaired; however, if the stress is more severe the cell must 
permanently stop cycling and either enter permanent senescence or induce one 
of the many pathways of cell death. It should be noted here that despite many 
early papers referring to senescence as “cell death”, that this is not the case. 
Senescent cells remain viable and metabolically active for as long as has been 
measured (Matsumura et al., 1979, Pignolo et al., 1994), and may be more 
resistant to cell death than proliferating cells (Wang et al., 1994).  
Despite its importance, senescence is only one possible fate of damaged cells. 
The mechanisms that inhibit cellular senescence and promote cell death are 
highly important in understanding the senescent phenotype and its implications 
The main programmed alternative to senescence is apoptosis, which is 
generally categorised by cell shrinkage, nuclear condensation and 
fragmentation, as well as membrane blebbing (Collins et al., 1992). Although a 
detailed description is beyond the scope of this thesis, apoptosis can be 
activated through intrinsic or extrinsic pathways, or through the absence of 
survival signals (Lowe et al., 2004), and, similarly to senescence, many of these 
pathways are regulated by p53 (Espinosa, 2008, Haupt et al., 2003) and redox 
signalling (Polyak et al., 1997). However, proteins such as Bax, bid puma and 
noxa, which are often downregulated in senescence are highly active in 
apoptosis (Vaseva and Moll, 2009), as well as the pro-apoptotic miRNA mi-34a 
(He et al., 2007, Hermeking, 2007), which inhibits mTOR-dependent PI3K-Akt 
signalling via the inhibition of Notch1 (Mungamuri et al., 2006). A possible 
determinant of cell fate is the localisation of p53 to mitochondria, which can 
trigger apoptosis independently of transcription (Marchenko et al., 2000, Mihara 
et al., 2003, Vaseva and Moll, 2009). 
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There are multiple factors that can influence cell fate decision. Whilst oncogenic 
RAS promotes senescence (Serrano et al., 1997), Myc preferentially induces 
apoptosis (Zindy et al., 1998). Equally fibroblasts and epithelial cells are 
resistant to apoptosis, whilst lymphocytes are intrinsically predisposed to it 
(Zuckerman et al., 2009). From an early study exposing fibroblasts to different 
concentrations of hydrogen peroxide, it would appear that the cell fate decision 
was partially dependent on the dosage. The lowest concentrations failed to 
induce permanent growth arrest, the medium concentrations induced 
senescence, and the higher concentrations induced apoptosis (Bladier et al., 
1997). However, there was still a stochastic determinant, and even at the 
highest concentration 6% of the cells managed to survive by becoming 
permanently arrested (Bladier et al., 1997). 
Current evidence suggests that cell fate is dependent on the conformation, 
localisation, activity and stability of p53, which is involved in both senescence 
and apoptotic responses. p38 phosphorylation of p53 at Ser46 promotes 
apoptosis (Bulavin et al., 1999), and the mitochondrial localisation of p53 was 
found to be associated with radiosensitive organs and cell cultures that 
preferentially underwent apoptosis (Erster et al., 2004). Additionally, severe 
damage can induce apoptosis through acetylation of p53 (Sykes et al., 2006, 
Tang et al., 2006), though it is site dependent as the acetylation of some loci 
can activate pro-senescence p21, as can monoubiquitination (Le Cam et al., 
2006). Importantly, the activation of p21 is not essential for p53 induced 
apoptosis (Deng et al., 1995), and can be protective against it (Bunz et al., 
1999, Mahyar-Roemer and Roemer, 2001).  
There are now several lines of evidence to suggest that cell fate is dependent, 
or directly related to, the level of p21 induced by p53. Doxorubicin induced 
apoptosis paralleled the downregulation of p21 (Martinez et al., 2002), and pro-
apoptotic proteins such as Myc silence the p21 promoter altering the outcome in 
response to damage in favour of apoptosis (Wu et al., 2003). p21 is also 
regulated at the epigenetic level by acetylation and methylation, both of which 
influence cell fate towards apoptosis or senescence (Rebbaa et al., 2006). 
Thus, although there are likely to be mechanisms independent of p53 and p21 
that regulate the cell decision to enter senescence rather than cell death, these 
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proteins are likely to be primary regulators, which are heavily influenced by the 
level of stress, most likely translated by the severity of the damage. 
 
1.4.2 Markers of Senescent Cells 
 
The induction of senescence is associated with the expression and activation of 
multiple genes. However, some of these changes are transient, difficult to 
detect, or highly unspecific, making them bad markers of senescence. Several 
persistent easily observable markers of senescent cells have now been 
identified. Firstly and most importantly, these cells are permanently arrested, 
incapable of responding to physiological signals with cell cycle re-entry, despite 
the presence of normal growth factor receptors (Goldstein and Shmookler Reis, 
1985). Replicative senescence is generally associated with the G1/S checkpoint 
just preceding DNA synthesis (Rittling et al., 1986, Pignolo et al., 1998), as is 
RAS induced senescence (Serrano et al., 1997); however, another study found 
that a significant fraction of RAS expressing cells arrested with partially 
replicated DNA (Mao et al., 2012), indicative of S-phase or G2 arrest. Indeed, 
ATM mutant cells induced G2 arrest (Herbig et al., 2004), and several studies 
have shown large fractions of cells arrested in G2 in some cell types (Campisi, 
1996, Mao et al., 2012). Thus, whilst cells most likely attempt to arrest before 
DNA synthesis, some if not many of them clearly fail, and still manage to 
permanently arrest before mitosis. 
Therefore, markers such as the absence of BrdU (Bromodeoxy-uridine) which 
shows whether the DNA has been replicated, and Ki67 and PCNA which are 
present in proliferating cells, are good markers to demonstrate that the cells are 
not proliferating, but do not necessarily indicate that the cells have become 
senescent. However, this does not mean that they cannot be used to validate 
other markers of senescence, for which they are frequently employed. 
Perhaps the easiest way to observe senescent cells is through their 
morphological changes. Senescent fibroblasts have an enlarged, flattened, and 
irregular morphology (Hayflick, 1965). One study found senescent cells can 
have around 10 times as much volume and can triple in diameter (Chen et al., 
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2000b). Although they found that actin protein was not increased in senescent 
cells there was a huge increase in the amount of stress fibrils, many of which, in 
contrast to proliferating cells, spanned right across the cell (Chen et al., 2000b). 
Additionally, the focal adhesion plaques, made up of proteins such as paxillin 
and vesiculin, which are normally found at the cell membrane connecting the 
cell to the ECM, are found sporadically in senescent cells (Chen et al., 2000b). 
Importantly, although morphological changes are a good marker for 
senescence, they are not essential for growth arrest (Chen et al., 2000b).  
Senescence is also accompanied by an increase in nuclear size (Narita, 2007), 
and an increase in the density of nuclear pore complexes (Maeshima et al., 
2006), which allow transport of macromolecules between the nucleus and 
cytoplasm. In addition to size, the nucleus undergoes a host of changes during 
cellular senescence, the most prominent of which is the formation of 
senescence-associated heterochromatic foci (SAHF), which have a strong 
correlation with the irreversibility of senescence arrest (Beausejour et al., 2003, 
Narita et al., 2003). Importantly, SAHF formation is significantly reduced by 
knockdown of p16 or pRb but not p53, whilst all knockdowns remain 
permanently arrested (Narita et al., 2003).  
The lamin proteins, which connect the nuclear envelope to the chromatin, also 
change during senescence. Both lamins A and B have been implicated in the 
senescence process (Varela et al., 2005, Liu et al., 2005, Dreesen et al., 2013); 
however, the overexpression of lamin B1 can either repress or induce 
senescence depending on the study (Dreesen et al., 2013, Shimi et al., 2011, 
Barascu et al., 2012). Lamin B1 levels are decreased in senescent cells, 
potentially contributing to the formation of SAHF which are repressed by the 
protein (Sadaie et al., 2013). Equally, lamin A repression activates the DDR and 
induces 53BP1 and γ-H2AX foci (Liu et al., 2005), which could potentially help 
to reinforce the senescent phenotype, if lamin A follows the same expression 
pattern as lamin B during senescence.  
The most commonly used marker of senescence is senescence associated-β-
galactosidase (SA-β-gal) (Dimri et al., 1995) activity. As a lysosomal enzyme, β-
galactosidase is most active in acidic conditions at pH4-4.5, with markedly 
reduced activity at pH 6 (Zhang et al., 1994). However, whilst β-galactosidase 
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activity can only be detected at low pH in proliferating cells, in senescent cells it 
is additionally detectable at pH 6, and this is thought to correspond to increased 
β-galactosidase activity (Kurz et al., 2000). It was suggested that due to the 
increase in size, and the number of the lysosomes in senescent cells (Robbins 
et al., 1970, Brunk et al., 1973, Lee et al., 2006), that β galactosidase activity 
surpasses a threshold causing observable activity at higher pH (Kurz et al., 
2000). Importantly, the GLB1 gene which encodes β-galactosidase, has 
increased expression in senescent cells and results in increased protein levels, 
though it is not necessary for senescence (Kurz et al., 2000). 
The implication of lysosomal expansion in senescent cells is that senescent 
cells are subject to large increases in molecular damage, which requires 
increased levels of degradation. Consistently, the increased numbers of 
dysfunctional mitochondria, which accumulate in senescent cells, produce high 
levels of reactive oxygen species (Passos et al., 2007), which cause oxidative 
damage to both nuclear and mitochondrial DNA (Passos et al., 2007), as well 
as proteins and lipids, forming oxidative modifications and carbonyls (Ahmed et 
al., 2010), and lipofuscin (Sitte et al., 2000a, Sitte et al., 2000c, Sitte et al., 
2000b, Sitte et al., 2001). Lipofuscin is the product of severe oxidative 
modifications leading to protein aggregation, and accumulates in most post-
mitotic cells (Jung et al., 2007), and causes autofluorescence of senescent cells 
making it a useful marker (Katz and Robison, 2002), although it can also 
accumulate in reversibly arrested proliferation-competent cells (Sitte et al., 
2001). Recently it has also been used to identify senescent cells in vivo, in 
samples which are unsuitable for SA-β gal staining (Georgakopoulou et al., 
2013).  
 
1.4.3 DNA Damage as a Marker of Senescence 
 
It has already been described that DNA damage is the primary inducer of 
senescence in the majority of cases, although some specific stimuli may be able 
to induce senescence independently. However, except in this minority of cases, 
the evidence suggests that inhibiting the DNA damage response does allow a 
certain percentage of cells to escape senescence (Bartkova et al., 2006, d'Adda 
 36 
 
di Fagagna et al., 2003, Di Micco et al., 2006, Gire et al., 2004, Herbig et al., 
2004). It is likely that some cells also manage to maintain the senescent 
phenotype; however, this cannot be known for sure without using knockout 
rather than knockdown systems. Regardless, this still implies that maintenance 
of the DDR is an important part of the senescent phenotype.  
As described in section 1.3.1, the DNA damage is typically observed by either 
53BP1 or γ-H2AX foci, which result from the oligomerisation of these molecules 
at sites of DNA damage. If the lesions are repaired then the foci appear 
transient, and are thought generally not to persist for longer than 24 hours. In 
healthy replicating cells most foci disappear within five hours of arising (Passos 
et al., 2010). The induction of senescence is associated with the induction of 
irreparable damage which generates persistent foci leading to growth arrest 
(Beausejour et al., 2003, d'Adda di Fagagna et al., 2003, Herbig et al., 2004), 
although theoretically the individual foci do not need to persist as long as they 
are replaced by new foci to continue the signal for growth arrest. Consistently, 
the evidence suggests firstly that even in replicative senescence about half the 
foci persisted for less than 15 hours, and secondly that the generation of these 
short lived foci is equally important as the persistent foci in maintaining the 
growth arrest of senescent cells, at least for the first nine days after the initial 
stimulus (Passos et al., 2010).  
This suggests that even in replicatively senescent cells not all the foci are 
telomere associated (Nakamura et al., 2008, Passos et al., 2010, Wang et al., 
2009a), and therefore could be expected to be repaired if the break is not too 
complex. Consistently, after X-irradiation induced senescence about half the 
foci were associated with telomeres, and these accounted for all of the 
persistent foci. Thus even the highly complex breaks induced by 20Gy X-
irradiation can be repaired by the cell, except where they happen at a telomere 
(Hewitt et al., 2012), and recent evidence suggests that telomeric DNA and 
associated proteins, even when placed elsewhere in the genome, may inhibit 
repair (Fumagalli et al., 2012).  
Unlike the initial foci the persistent foci are not associated with repair proteins 
such as RAD51 and RPA70. It has been suggested that this results from 
changes at the focus, when the cell ceases attempting to repair them (Rodier et 
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al., 2011). However, they offer no evidence that these foci were ever associated 
with these proteins. Importantly, both proteins are involved in homologous 
recombination, and the recent evidence that all persistent foci are the result of 
telomeric damage suggests that these foci should not associate with these 
proteins, in order to prevent breakage fusion bridge cycles and genomic 
instability. Indeed, the telomeric foci of replicatively senescent cells share many 
of the same properties as the persistent foci after X-irradiation (Rodier et al., 
2011). 
The solubility of 53BP1 in persistent foci decreases compared to early foci 
(Rodier et al., 2011), which likely reflects the increased oligomerisation, that is 
observed by the increase in size of the focus. Additionally, although about 7-10 
days after the stimulus, the cells decrease p53 and p21 (Rodier et al., 2011), 
hypothetically because the importance of positive feedback to maintain 
senescence decreases (Passos et al., 2010), the foci begin to associate with 
p53 and Chk2 which are not present at early foci (Rodier et al., 2011). 
Potentially this localisation could help to maintain a persistent signal with greatly 
reduced protein levels, thus losing the requirement for positive feedback.  
PML (promyelocytic leukemia protein) bodies are dynamic, heterogeneous 
subnuclear domains that form in response to genotoxic stress (Bernardi and 
Pandolfi, 2007, Varadaraj et al., 2007), and are found at DNA damage foci 
(Carbone et al., 2002; Xu et al., 2003) where they facilitate the senescence 
growth arrest by the activation of p53 (Ferbeyre et al., 2000; Pearson et al., 
2000). Also absent at initial foci, PML bodies co-localise with persistent foci 
after X-irradiation and telomere associated foci in replicatively senescent cells 
(Rodier et al., 2011). Thus, persistent/telomeric foci are a good marker for cell 
senescence and can be indicated best by the presence of p53, Chk2 and PML, 
but focus size is also an indication. Although the evidence suggests that these 
foci would be insufficient in small numbers to induce senescence, which also 
depends on the induction of smaller short lived foci by ROS (Passos et al., 
2010), only the persistent ones are thought to be exclusive to senescent cells. 
Importantly, the DNA damage response is one of the most proximal phenotypes 
of senescent cells, and has been shown to be necessary for the induction and 
maintenance of growth arrest (d'Adda di Fagagna et al., 2003), as well as the 
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formation of the senescence associated secretory phenotype (Rodier et al., 
2009). Additionally, depletion of H2AX with shRNA, which destabilises foci, but 
does not affect formation (Celeste et al., 2003), also reduces the SASP at 2-3 
days when the phenotype begins, and at 9-10 days later when the phenotype is 
robust (Rodier et al., 2011). Thus, persistent foci were concluded to be 
necessary for multiple aspects of the senescent phenotype. However, it is likely 
that the shRNA also affected the lifespan and functionality of the short-lived foci, 
which still normally contain γ-H2AX.  
Another potential marker of senescence is the number of foci within a cell. The 
data in this thesis suggest that senescent MRC5 cells have around three foci on 
average, whereas young replicating cells have between 1-2 foci (figure 5.1). 
Another study showed that different cell lines had between 2-4 γ-H2AX foci at 
senescence, which was between 1-3 foci above the number found in the 
corresponding young cells, suggesting that the number of foci is cell type 
dependent, but always higher than that found in replicating cells (Sedelnikova et 
al., 2004), making it a good marker of senescence providing the cell type is 
taken into account.  Importantly, the same study demonstrated the almost 
complete co-localisation of γ-H2AX and 53BP1. However, as is observable 
within the above study and elsewhere, 53BP1 foci are generally larger and 
clearer. 
Unsurprisingly, as the agents inducing much of this damage, ROS are also 
upregulated in senescent cells, and provide a good marker of senescence 
(Correia-Melo et al., 2013, Lawless et al., 2012, Lawless et al., 2010, Passos et 
al., 2013). Though as none of these markers are infallible, most studies will 
analyse at least two in order to increase the likelihood that the observed 
phenotype is actually senescence.  
 
1.4.4 The Senescence Associated Secretory Phenotype 
 
In 2008 a study screened the secreted proteins of replicatively, irradiated and 
RAS induced senescent cells and compared them to each other as well as to 
replicating controls. Over 40 proteins from the array of 120 proteins were found 
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to be significantly increased in the secretions of senescent cells compared to 
young cells, which was therefore named the senescence activated secretory 
phenotype (SASP) (Coppe et al., 2008). The SASP included inflammatory 
cytokines such as IL-6, IL-7, and IL-8, TNF receptors, growth factors such as 
GRO, HGF and IGFBPs, shed cell surface molecules such as ICAMs, survival 
factors (Coppe et al., 2008), and matrix remodelling factors (Liu and Hornsby, 
2007, Parrinello et al., 2005, Coppe et al., 2010). Importantly, although these 
SASPs had differences between cell types and senescence stimuli, they were 
relatively conserved across both (Coppe et al., 2008). However, RAS induced 
senescence did stimulate increased production of many of the factors compared 
to irradiated or replicatively senescent cells. Equally, the SASP of irradiated 
senescent cells developed between 4-7 days after the dose, whereas RAS 
induced the SASP 2-4 days after oncogene expression. 
Importantly, if p53 was knocked down before the induction of senescence in 
irradiated cells then it produced a SASP quantitatively similar to that of RAS 
induced cells, although, RAS expression in p53 knockdown cells induced the 
most potent SASP (Coppe et al., 2008), so there is a combinatorial effect. If p53 
is knocked down after senescence induction then it has no significant effect on 
the SASP, and if it is knocked down in cell lines that do not express p16, then 
p53 abrogation induces reversion to cell cycle, but still does not abrogate the 
SASP (Coppe et al., 2008), suggesting the two are independent. 
Another study examining the SASPs of mouse cells found that when they 
senesced in response to irradiation, after being cultured at 3% oxygen, they 
produced human-like SASPs, but when they were cultured to replicative 
senescence at 20% oxygen they did not (Coppe et al., 2010). It should be noted 
that whilst the majority of these latter cells expressed SA-β-gal and arrested, a 
large minority were still undergoing DNA replication, despite no change in cell 
numbers.  
Whilst the irradiated cells were grown at 3% oxygen giving two variables that 
could have been responsible for the difference in phenotype (either the growth 
conditions or the irradiation stimulus), compared to the unirradiated cells grown 
at 20% O2, what is clear is that both arrest and SASP are at least partially 
dependent on the persistency of the DDR (Coppe et al., 2010). Exactly why 
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some stimuli do not produce a persistent DDR or SASP is not clear, and 
warrants further investigation, but these data clearly suggest that the SASP is a 
good marker of senescence. 
The function of the SASP in vivo has not been properly tested; however, a 
closer look at some of the SASP components can provide some insight.  
 
1.4.4.1 IL-6 
IL-6 is one of the most prominent members of the SASP. It binds to the 
membrane associated receptor IL-6R, which then forms a complex with two 
gp130 proteins, which then binds JAK1 and JAK2 (Lutticken et al., 1994). 
Without JAK1, IL-6 signalling is greatly impaired (Guschin et al., 1995). The 
phosphorylated JAKs remain associated with the receptor and activate STATs, 
most potently STAT3, but also to a minor extent STAT1 (Heinrich et al., 1998). 
The STATs dimerise allowing them to be actively translocated to the nucleus 
(Bromberg et al., 1999), where they induce the transcription of multiple genes 
including NF-κB family members providing positive feedback. Additionally, IL-6 
can activate the MAPK cascade through the recruitment of SHP2 (SH2-domain-
containing tyrosine phosphatase) (Schiemann et al., 1997) or Shc (SH2-and 
collagen-homology-domain-containing protein). These two proteins are 
phosphorylated by JAK1 (Schaper et al., 1998), and bind Grb2 which recruits 
SOS and activates Ras-Raf-ERK signalling (Hermanns et al., 2000). Both p38 
and JNK are also activated by IL-6, but by a less well defined mechanism (Bode 
et al., 2001b, Zauberman et al., 1999). Lastly, IL-6 can also induce the PI3K/Akt 
pathway resulting in the activation of mTOR and inhibition of Bad (Bcl2/Bcl-XL-
antagonist, causing cell death), contributing to cell survival and proliferation (Shi 
et al., 2002). Signalling is inhibited by protein tyrosine phosphatases (PTPs), 
including SHP2. PIAS3 also inhibits IL-6 induced activity of STAT3 (Chung et 
al., 1997), and SOCS1, 2 and 3 have been observed to be induced by IL-6 as a 
negative feedback mechanism to cease STAT signalling (Starr et al., 1997). 
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1.4.4.2 Other Important SASP Molecules 
 
IL-7 is another cytokine highly expressed within the SASP (Coppe et al., 2008). 
By binding the IL-7 receptor of B cells it stimulates development in the latter 
from the pre- and pro-B cell stages. In T cells IL-7 is important in the V(D)J 
rearrangement of the T cell receptor beta (Muegge et al., 1993), and knockout 
mice suggest that it is essential for development and survival of lymphoid cells 
(Maeurer and Lotze, 1998). 
Similar to IL-7, granulocyte macrophage-colony stimulating factor (GM-CSF) is 
involved in white blood cell development, but contrarily stimulates the innate 
immune response by inducing haematopoietic stem cells to develop into 
granulocytes and monocytes (Hamilton, 2002). GM-CSF has been implicated in 
several immune diseases including atherosclerosis (Fleetwood et al., 2005). 
GRO-alpha, encoded by the CXCL1 gene in humans, is structurally related to 
IL-8, both of which are highly secreted in the SASP (Coppe et al., 2008). Both 
are important inducers of neutrophil chemotaxis, intracellular calcium peaking, 
and respiratory burst, though IL-8 is more potent (Geiser et al., 1993). Equally 
both play key roles in angiogenesis (Lane et al., 2002). As a result both proteins 
are tumorigenic and contribute to cancer development and metastasis (Owen et 
al., 1997).  
ICAM-1 is an intercellular adhesion molecule which binds integrins, specifically 
the LFA-1 receptor found on leukocytes (Rothlein et al., 1986), which allows the 
immune cells to transmigrate into the tissues (Yang et al., 2005). 
TGF-β has also been identified as an important SASP protein (Coppe et al., 
2008), and can diverse and contrary roles depending on the cellular context 
(Ashcroft et al., 1999), including arrest and proliferation, in accordance with the 
level RAS signalling (Oft et al., 1996). When TGF-β binds its receptor it triggers 
phosphorylation of type I receptors by type II receptors which activates the 
kinase domain of type I receptors (Huse et al., 1999). This causes 
phosphorylation and activation of the R-Smads 2 and 3, which bind Co-Smad 4 
and translocate to the nucleus. Importantly, TGF-β has key tumour suppressor 
functions, both in suppressing the activity of c-Myc and the CDKs as well as 
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activating tumour suppressor genes such as p15 and p27 (Datto et al., 1995, 
Hannon and Beach, 1994, Polyak et al., 1994). However, in the absence of 
functional tumour suppressors TGF-β can also promote metastasis (Cui et al., 
1996), and even under some circumstances tumour growth (Levy and Hill, 
2006). Like many of the SASP factors it also plays a key role in the immune 
response, controlling the activation and survival of lymphocytes, and inhibiting 
the development of reactivity to self-antigens without compromising immunity to 
non-self (Li et al., 2006). 
 
1.4.4.3 TNF-α 
TNF-α is a potent inflammatory cytokine regulating the immune response, 
apoptosis, proliferation and differentiation. Interestingly, its importance in 
senescence is equivocal. An initial study suggested that TNF-α, was not a large 
factor in the SASP of most cell types (Coppe et al., 2008), whereas a later study 
suggested that it was upregulated at least at the transcriptional level (Acosta et 
al., 2013). It can bind two receptors: TNF-R1 which is ubiquitously expressed 
across all tissues and is responsible for the bulk of TNF-α induced signalling; 
and TNF-R2 which is only expressed in immune cells and is tightly regulated 
(Wajant et al., 2003). When TNF-α binds, it causes conformational change 
allowing receptor trimerisation (Chan et al., 2000) and release of the inhibitory 
Silence of Death Domain (SODD) protein. TNF Receptor-Associated Death 
Domain (TRADD) then binds to the membrane associated complex and binds 
Receptor interacting Protein (RIP) (Ting et al., 1996), localising it to the lipid 
rafts (Legler et al., 2003). RIP recruits NEMO (Zhang et al., 2000), and the 
MAP3Ks TGF-β activated kinase (TAK1) and mitogen activated protein kinase 
kinase kinase 3 (MEKK3) (Blonska et al., 2004), thus allowing them to 
phosphorylate IKKβ (Shinohara et al., 2005), and activating canoninical NF-κB 
signalling. TNF-R associated factor 2 (TRAF2), which is necessary for NF-κB 
activation by TNF-α (Tada et al., 2001), also plays a role in activation of p38 
and JNK, which may help activate AP-1 (Karin et al., 1997), an important co-
factor in the transcription of many NF-κB responsive genes.  
The additional binding of FADD and caspase 8 causes the cytoplasmic 
localisation of the TRADD-RIP complex, which activates the caspase cascade 
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to initiate apoptosis (Micheau and Tschopp, 2003). TNF-α is only weakly 
apoptotic because NF-κB causes the transcription of many anti-apoptotic 
genes. TNF-α signalling as  whole is mainly inhibited by two deubiquitinating 
enzymes A20/TNFAIP3 (Lee et al., 2000) and the tumour suppressor CYLD 
(Reiley et al., 2007), but protein phosphatase 2A (PP2A) enzymes may also 
play a role.  
It has already been discussed in the previous section how the cells induce a 
SASP and the mechanisms by which this process helps to reinforce 
senescence. In the next two sections, it will be discussed firstly how these 
phenotypes help senescent cells to carry out their functions, and secondly how 
these effects can also have detrimental consequences.  
 
1.5 The Functions of Cell Senescence  
 
1.5.1 Senescent Cells Function in Wound Healing and Immune Clearance 
 
Senescence is not an unavoidable by-product of cellular stress. It is a program 
orchestrated by the cell, and as such is likely to have some function. One 
possibility is that senescent cells are important in wound healing. Senescent 
fibroblasts adopt an active secretory phenotype similar to activated fibroblasts 
(Bernard et al., 2004), and one study showed that mice with defective p53 
and/or p16 had elevated levels of liver fibrosis (Krizhanovsky et al., 2008b). At 
sites of fibrosis some of the cells became senescent and produced the SASP 
(Krizhanovsky et al., 2008a), where they aided in the resolution of fibrosis by 
both inhibiting synthesis of matrix proteins and inducing their degradation, as 
well as reducing fibroblast numbers by ceasing replication and promoting 
clearance by natural killer cells (Krizhanovsky et al., 2008a, Xue et al., 2007). In 
apparent contradiction, fibrosis is increased in older individuals, as are the 
number of senescent cells. However, this is just a correlation, and despite the 
many potentially negative phenotypes of senescent cells, their increase in 
wounds could hypothetically be a compensatory mechanism to limit fibrosis in 
older people. Additionally the SASP may also contribute to immune surveillance 
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at the site of the wound (Krizhanovsky et al., 2008a, Krizhanovsky et al., 
2008b). In cutaneous wounds, cells are also induced to senesce at the later 
stages when they cease proliferation and upregulate matrix remodelling factors 
to induce an anti-fibrotic effect (Jun and Lau, 2010). Thus, whilst senescent 
cells are not required for wound healing (Jun and Lau, 2010, Krizhanovsky et 
al., 2008b), they play a role in reducing the level of fibrosis that was stimulated 
by their activated non-senescent predecessors.  
Contrarily, senescent cells have been implicated in chronic wounds (Telgenhoff 
and Shroot, 2005). Although senescent fibroblasts are present in high numbers 
at chronic wounds (Vande Berg and Robson, 2003), there is little evidence of a 
causal relationship as chronic wound fluid induces senescence at these sites 
(Vande Berg and Robson, 2003, Mendez et al., 1999). However, MMPs which 
are secreted by senescent cells, are increased in chronic wounds compared to 
healthy wounds (Lobmann et al., 2002), have been implicated in growth factor 
degradation (Yager and Nwomeh, 1999), and have been shown to be 
detrimental to the healing of chronic wounds (Ladwig et al., 2002). Therefore, it 
is likely that the same anti-fibrotic properties that make senescent useful in the 
healing of healthy wounds are detrimental in the healing of chronic wounds, 
possibly due to increased numbers of them induced by the increased 
inflammatory nature of the wound (Telgenhoff and Shroot, 2005), or through 
their interactions with other factors at these sites.  
 
1.5.2 Cellular Senescence in Development 
 
Importantly, there is growing evidence for senescent cells in embryonic 
development. Senescent cells have been identified at the apical ectodermal 
ridge and the closing neural tube, and it has been observed that p21 and p53 
mutants can have developmental abnormalities (Keyes, Serrano, unpublished). 
Therefore, at least in these circumstances, cell senescence is unlikely to be an 
unwanted byproduct of stress, but is instead a programme that the body 
institutes for specific functional goals. 
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1.5.3 Blocking Senescence Causes Crisis 
 
Currently the main function of senescence is thought to be as a tumour 
suppressor mechanism. In the case of aberrant oncogene expression the role 
for senescence is clear. As oncogenes generally have pro-cell cycle and pro-
survival functions, the result of letting the signal continue unrestrained would be 
the formation of a continually growing mass of cells, which would effectively be 
a benign tumour. Thus, the cell must inhibit the growth signal with negative 
feedback. In the case of RAS overexpression, cells have suppressed the signal 
within 30 minutes of induction which is maintained at 24 hours, indicating both 
short term and long term suppression (Courtois-Cox et al., 2006). Downstream 
PI3K signalling was inhibited; p53 and pRb were activated, and cells were 
induced to become senescent (Courtois-Cox et al., 2006). However, the 
negative feedback pathway is not quite that simple, and generally requires the 
induction of DNA damage (Bartkova et al., 2006). Thus, an interesting 
speculation would be that cells with mutant oncogene expression might be more 
susceptible to transformation if they have higher DNA repair capacity.  
In the case of replicative and irradiation induced senescence the reason for 
arrest is also mainly as a barrier to tumourigenesis. When cells become 
damaged either by telomere loss through replication or through damaging 
agents such as ROS or radiation, copying the DNA becomes more difficult due 
to the breaks and other lesions preventing the replication enzymes from 
carrying out their function. As a result, some parts may not be copied causing 
deletions, and others may be copied incorrectly causing mutations. Additionally, 
homologous recombination may cause duplications or transversions, and 
together these effects result in genomic instability. Therefore, when cells fail to 
enter senescence they enter a state of crisis called mitotic catastrophe, where 
the rate of cell death is approximately equal to the rate of proliferation (Shay et 
al., 1991), maintaining a relatively constant number of cells. 
When cells bypass replicative senescence they induce a specific type of 
genomic instability called breakage-fusion-bridge cycles. Once the chromosome 
replicates during S-phase the uncapped telomeres of the two sister chromatids 
are recognised as double strand breaks and joined together. Then when they 
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are pulled apart during metaphase they will break, but not necessarily at the site 
of fusion. Thus, the two daughter cells will inherit unequal chromosomes, which 
may be lethal to one or both of the cells (McClintock, 1941). 
As the cell population remains relatively constant the surviving cells are 
becoming increasingly damaged. Eventually some of the cells may acquire the 
correct mutations to transform into neoplastic cells and form tumours, which is 
highly detrimental to the organism. The reason that somatic cells have 
inactivated telomerase is likely to be in order to induce senescence in cells 
which are undergoing abnormal proliferation. Thus, cells which have acquired 
cancerous mutations must acquire further mutations to reactivate telomerase 
before they can immortalise (Kim et al., 1994, Hiyama et al., 1995a, Hiyama et 
al., 1995c). Consistently, telomerase expression enhances transformation in 
vitro (Hahn et al., 1999). 
These data, combined with the much faster formation of tumour formation in 
mice, which have fewer independent tumour suppressor mechanisms to prevent 
senescence bypass, is good evidence for the importance of senescence as a 
tumour suppressor mechanism. However, as was seen with the wound healing, 
senescence can have antagonistic effects. There are several lines of evidence 
to suggest that senescence might be detrimental to the ageing process. 
 
1.6 Senescence in the Promotion of Ageing, Cancer and Disease 
 
1.6.1 Cell Senescence in Ageing 
 
Simply because a phenomenon has function, does not mean that it will not also 
have unwanted or detrimental effects as well. The two main theories of ageing 
currently suggest that firstly if something is beneficial to fitness it does not 
necessarily mean that it is beneficial to organismal lifespan, and secondly that if 
something has benefit earlier in life, then such a trait would still undergo positive 
selection even if it was detrimental later in life when the selective forces are 
weaker. Thus, cell senescence could have both positive and negative 
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consequences, and the latter could be more severe as long as they happen 
later in life.  
Initially it was doubted whether the finite replicative lifespan of cells in culture 
would have any relevance to cells and organisms in vivo. However, several 
studies have since shown that not only are senescent cells present in vivo, but 
also that they accumulate with age (Dimri et al., 1995, Pendergrass et al., 1999, 
Mishima et al., 1999), and at sites of age-related pathology (Collado et al., 
2005, Dimri et al., 1995, Erusalimsky and Kurz, 2005, Jeyapalan et al., 2007, 
Price et al., 2002). There has been correlative evidence for a role of 
senescence in ageing as far back as the 1970s, when they showed that cells of 
older individuals senesced after fewer replications than cells of young 
individuals (Martin et al., 1970, Le Guilly et al., 1973), and cells from progeroid 
patients senesced after fewer divisions than cells from healthy individuals 
(Goldstein, 1978). However, recent studies using more stringent controls have 
contested some of these results (Cristofalo et al., 1998, Serra and von Zglinicki, 
2002). The first causal evidence that senescent cells contributed to the ageing 
process was demonstrated in 2011 by a group that used a construct combining 
a p16 promoter with an inducer of apoptosis, thus allowing the selective killing 
of p16 expressing cells in progeroid mice (Baker et al., 2011). The result was a 
significant delay in the onset of age related pathologies in the eye, muscle and 
adipose tissue, and, in the latter two cases, late-life clearance could attenuate 
these phenotypes in mice that had already started to develop them.  
 
1.6.2 The Cell Autonomous Hypothesis of Senescence in Ageing 
 
It is possible that senescent cells could contribute to ageing autonomously 
through the loss of normal tissue function. The main way that this has been 
suggested to occur is through the depletion of stem cell reserves. As 
differentiated cells have little or no replicative potential anyway, their 
senescence is unlikely to have significant autonomous effect on organ 
regeneration, whereas stem cells are responsible for producing large numbers 
of cells of many types to replace those that are damaged or lost. Theoretically, 
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therefore stem cell senescence could autonomously reduce organ function and 
induce ageing. 
One initial problem with this theory was the finding that some adult stem cells 
expressed telomerase, which was thought to immortalise them and prevent 
senescence. However, many adult stem cells either express telomerase at very 
low levels, or not at all, and in both cases have a finite replicative capacity in 
culture (Vaziri et al., 1994, Wagner et al., 2008). Additionally, haematopoietic 
stem cells from older individuals also had shorter telomeres (Vaziri et al., 1994), 
indicating that they also have a finite replicative lifespan in vivo. Consistently, 
there are signs of stem cell ageing; the stem cells of older mice were shown to 
be significantly less functional than those in younger individuals (Chen et al., 
1999, Morrison et al., 1996), and differentiation was skewed towards the 
myeloid lineage away from T and B cell production (Spangrude et al., 1995, 
Sudo et al., 2000).  
However, more importantly, the majority of data suggest that stem cell numbers 
increase with age rather than decrease (Morrison et al., 1996, Harrison et al., 
1989, de Haan et al., 1997), which is difficult to reconcile with the idea of 
autonomous stem cell loss due to senescence contributing to ageing. Indeed 
the progeny of a single transplanted haematopoietic stem cell can maintain 
haematopoiesis over the lifespan of a recipient mouse (Jordan and Lemischka, 
1990), and they can be serially passaged to recipients for up to five generations 
(Siminovitch et al., 1964).  In 2006 it was claimed that “no one common disease 
of ageing is directly caused by exhaustion of cell divisions” (Blagosklonny, 
2006a). Whilst this has by no means been proved, the increase in stem cells 
with ageing is entirely inconsistent with a depletion of stem cells through cell 
senescence contributing to ageing. There is good evidence that stem cells age, 
and this may contribute to ageing, but this is unlikely to reflect a decline in their 
replicative capacity due to stress induced senescence of the stem cell pool. 
Another possible mechanism by which senescent cells could autonomously 
induce ageing is based on the observation that some organs can accrue large 
numbers of senescent cells (Wang et al., 2009a, Wang et al., 2010, Jurk et al., 
2012). Aside from ROS and the SASP, senescent cells have >1000 genes 
differentially expressed compared to healthy replicating cells, and could 
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theoretically autonomously contribute to organ decline, if enough cells were 
behaving aberrantly. 
Alternatively senescent cells could contribute to ageing through inducing 
detrimental effects on the surrounding non-senescent cells, and even 
systemically. Although there has been suggestions that this might be the case 
(Rodier and Campisi, 2011, Coppe et al., 2008), the evidence to date is 
currently lacking. However, there is substantial evidence for paracrine effects of 
senescent cells in tumorigenesis.  
 
1.6.3 Cellular Senescence in Cancer and the Non-Autonomous Hypothesis 
 
The observation in 2001 that senescent cells could stimulate preneoplastic and 
neoplastic cells to form tumours (Krtolica et al., 2001), initially seemed to 
contradict the role of senescence as a tumour suppressor. However, the study 
clearly demonstrated that senescent cells stimulated the growth of four strains 
of preneoplastic immortalised cells harbouring p53 mutations more than pre-
senescent cells. Importantly, the same study found that normal keratinocytes 
grew similarly on senescent and pre-senescent cells, suggesting that the effect 
was unique to damaged cells. Both matrix deposition and secretion of soluble 
factors from senescent cells triggered preneoplastic cell growth, although it was 
not nearly as effective as direct cell contact. These cells would not ordinarily 
form tumours in immunocompromised mice, but the addition of pre-senescent 
fibroblasts to the xenograft induced some tumour formation, which was 
increased by the presence of senescent cells, as was the size of the tumours. In 
one cell line the tumours remained benign even when injected with senescent 
cells, whilst in another cell line senescent cells triggered progression to 
malignancy (Krtolica et al., 2001).  
A later study showed that at early stages of tumour xenograft the presence of 
senescent fibroblasts stimulated the induction of large fluid filled edema, 
indicative of tissue damage, which then regressed but resulted in much larger 
tumours (Liu and Hornsby, 2007). The use of a matrix metalloproteinase 
inhibitor reduced this fluid accumulation and slowed the growth rate of the 
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tumour, without directly affecting proliferation in culture. It is therefore possible 
that the proliferation of preneoplastic cells, which lack functional tumour 
suppressor mechanisms, might be induced to grow by some genotoxic stimulus, 
which is reinforced by the observation that healthy keratinocytes did not 
respond with increased growth. However, contradictory to this idea hepatocyte 
growth factor (HGF), which is upregulated in senescent cells was shown to 
have directly mitogenic effects (Liu and Hornsby, 2007). Secondly, another 
study examining prostate epithelial cells demonstrated that senescent 
fibroblasts could stimulate the proliferation of healthy cells, in a mechanism 
partially dependent on amphiregulin (AREG), and possibly FGF-7 and HGF 
(Bavik et al., 2006). Thus, it is likely that the pro-tumorigenic effect comes at 
least partially from the stimulation of proliferation. The induction of DNA damage 
by RAS stimulated hyperproliferation (Bartkova et al., 2006) is consistent with 
this idea. 
Despite the apparently paradoxical pro and anti-tumour effects of senescent 
cells, it should be noted that current cancer therapies such as radiotherapy are 
also thought to induce transformation or tumorigenicity of preneoplastic and 
neoplastic cells (Lagadec et al., 2012, Zhao et al., 2001, Toda et al., 2009). 
Similarly, it appears that the mechanisms the body uses to inhibit cancer initially 
can likewise promote it later on.  
Importantly, a later study identified that the epithelial-mesenchymal transition in 
cancer cells induced by senescent cells was partially dependent on pro-
inflammatory IL-6 and IL-8 (Coppe et al., 2008). Interestingly, they showed that 
the SASPs of both RAS induced senescent cells and from cells lacking p53 
function prior to senescence were more potently transforming than the SASPs 
of irradiated or replicatively senescent cells with functional p53 (Coppe et al., 
2008). Although this contradicted the previous observation that RAS senescent 
cells were less potent transformers than both other types of senescent cell 
(Krtolica et al., 2001), the authors had noted problems with the RAS expressing 
cells which could explain this difference (Krtolica et al., 2001).  
Another study found that in three sets of mice given a carcinogen known to 
cause RAS mutation, both genetically obese mice and ones fed a high fat diet 
were more likely to develop liver cancer than lean controls. More interestingly, 
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they found firstly that treatment with siRNA against HSP27 (shown to reduce 
numbers of senescent/senescing liver cells (Sato et al., 2008)), significantly 
reduced liver cancer, and secondly that when IL-1β was knocked out, which is a 
prominent feature of the SASP, the number and size of the tumours was also 
significantly reduced (Yoshimoto et al., 2013). Mechanistically they suggested 
that toxins produced by the gut microbiota of mice on high fat diet including 
deoxycholic acid (DCA) induced both cell senescence and liver cancer 
(Yoshimoto et al., 2013).  
 
1.6.4 Summary 
 
Cellular senescence has important functions in tumour suppression and 
immune clearance. Despite these, senescent cells have detrimental effects on 
pre-neoplastic and tumour cells, stimulating transformation, malignancy and 
tumour growth. Senescent cells have also been implicated in the ageing 
process, and it is unlikely that they do so autonomously by the depletion of 
functional cells. However, despite the evidence that senescent cells have 
potential to induce damage associated with ageing to the surrounding tissue, 
there is currently little evidence on whether this occurs or the mechanisms 
involved.  
 
1.7  Previous Evidence of Bystander Effects 
 
Broadly the term bystander effect applies to any phenotypic change in cells, that 
occurs indirectly as a result of treatments applied elsewhere. In gene therapy 
and toxicology the term is used to describe the passage of gene products from 
transfected cells to their neighbours. More relevant to this thesis is the study of 
the effects of radiation which have mostly examined the bystander effect in the 
form of multiple species of DNA damage and cell death. For 50 years it has 
been known that medium from irradiated cells can induce DNA damage in 
unirradiated cells, but it was not until 1992 that it was demonstrated that cells hit 
by high-LET radiation (α-particles) could induce sister chromatid exchanges 
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(SCEs) in bystander cells (Nagasawa and Little, 1992). In this study using 
Chinese hamster ovary (CHO) cells, the same level of SCEs was produced in 
bystander cells as by 1-2Gy direct X-irradiation. At very low doses of α-particles 
the bystander effect is dose dependent; however, it quickly plateaus (Nagasawa 
and Little, 1992), which has been replicated in HFL1 human diploid fibroblasts 
(Deshpande et al., 1996). Since this time, the study of the irradiation induced 
bystander effect has been done either with the use of targeted α-particles or via 
the use of irradiated cell conditioned medium (ICM) transferred from γ or X-
irradiated cells.  
 
1.7.1 The Radiation Induced Bystander Effect (RIBE) 
 
Unlike the effect of α-particles, the initial study using ICM from irradiated 
fibroblasts failed to show any change in cell survival in fibroblasts at the dose of 
5Gy, whereas medium from keratinocytes significantly reduced survival of both 
keratinocytes and fibroblasts, indicating that it was the absence of signal rather 
than response that prevented the bystander effect in fibroblasts (Mothersill and 
Seymour, 1997). Another study analysing 53BP1 foci demonstrated a 2.5 fold 
increase in foci in bystander WI-38 fibroblasts receiving ICM (Sokolov et al., 
2005), and a later study showed the same was true of IMR-90 fibroblasts, 
showing a 4.5 fold increase in 53BP1 foci (Sokolov and Neumann, 2010), 
suggesting firstly that fibroblasts may still have received damage in the initial 
experiment (which did not significantly increase cell death), and secondly that 
even within fibroblast the magnitude of the effect was cell type specific.  
The types of foci in Hela cells appeared to differ between directly irradiated and 
bystander cells. A single α-particle to the nucleus induces a single large focus at 
the point where the particle hit and other foci localised around this area, whilst 
in bystander cells the foci were spread across the whole nucleus. When the α-
particle was targeted to the cytoplasm the hit cells showed the same focus 
pattern as the bystanders with similar numbers of cells having ≥4 foci (Tartier et 
al., 2007). Interestingly, the effects of cytoplasmic radiation are delayed for both 
directly irradiated and bystander cells compared to nuclear irradiation, and the 
percentage of directly hit cells showing ≥4 foci is halved. However, once the 
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effect appears, there is no difference in foci numbers of bystanders regardless 
of where the α-particles hit the inducer cells (Tartier et al., 2007).  
Human fibroblasts, carcinoma cells, and CHO cells all showed greater losses in 
clonogenic survival in response to ICM if they had some defect in DNA repair, 
and likewise induced increased damage in other bystanders compared to their 
repair proficient controls (Mothersill et al., 2004), suggesting that cells with less 
active repair induce a stronger bystander signal. Additionally, there is some 
evidence that these cells are more susceptible to the bystander signal than 
repair proficient cells. One repair deficient strain receiving ICM had increased 
cell death compared to the proficient control receiving the same medium, whilst 
the other strain showed no difference.  
In keratinocytes, the bystander effect of irradiated cell conditioned medium 
(ICM) depended on the number of cells irradiated, with the highest cell numbers 
producing a bystander effect similar to direct irradiation with 5Gy (Mothersill and 
Seymour, 1997). In another study by the same group using a different strain of 
human immortalised keratinocyte, the lowest dose used of 0.01Gy induced a 
similar reduction in survival compared to 5Gy, and direct irradiation of cells only 
started to reduce clonogenic survival above that of bystanders at 2.5Gy 
(Seymour and Mothersill, 2000). Additionally, in the progeny of these cells the 
clonogenic survival of the bystanders was consistently reduced from ICM of 
0.03Gy γ-irradiation, whereas the progeny of directly irradiated cells had no 
significant delayed effects (Seymour and Mothersill, 2000).  
The bystander dynamics using ICM suggest that there is little increased effect 
on leaving the medium on the irradiated cells for longer than 1 hour, and the 
effect is already apparent if the medium is removed 30 minutes after irradiation 
(Mothersill and Seymour, 1997). Importantly, if the medium was replaced 
immediately (30 seconds) after irradiation, and the new medium left for 1 hour 
as before, then the bystander effect was completely abrogated (Mothersill and 
Seymour, 1998). Additionally, removal of ICM from the bystander cells after 30 
minutes still induced full bystander effect in the recipient cells (Mothersill and 
Seymour, 1998).  
In a series of complicated experiments using combinations of direct dose and 
ICM, it was demonstrated that if directly irradiated cells were then exposed to 
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ICM from another culture of irradiated cells it had no additional bystander effect, 
suggesting that direct irradiation offers some protection from the bystander 
effect (Mothersill and Seymour, 2002). Perhaps more interestingly, if ICM which 
has been transferred onto irradiated cells is then transferred onto unirradiated 
cells, the bystander effect is also abrogated. Contrarily, if addition of ICM 
precedes irradiation it offers no benefit, and may be slightly worse than either 
treatment alone (Mothersill and Seymour, 2002), which suggests that the RIBE 
is not an adaptive response to protect cells from a future direct hit of radiation. 
Lastly, although fractionation of the dose to the directly irradiated cells was 
shown to have no effect on bystander cells, if instead the cells are irradiated 
twice with a change of medium in between, then the second ICM significantly 
increases the clonogenic survival of bystander cells over controls, suggesting a 
completely different cellular secretion from the second dose of irradiation 
(Mothersill and Seymour, 1998). 
 
1.7.2 Dynamics and Mechanisms of the RIBE 
 
In one study, the lowest dose of γ-irradiation from which ICM would significantly 
reduce clonogenic survival in keratinocytes was 3mGy, which was also the first 
dose to induce a calcium peak, suggesting that the radiation induced bystander 
effect (RIBE) is an all or nothing response (Liu et al., 2006b). Bystander cells 
induce a spike in intracellular calcium within 30 seconds of addition of ICM, 
which has dissipated again by 100 seconds. Chelation of extracellular calcium, 
or blockage of voltage-dependent calcium channels, prevents this spike, and 
reduces the levels of apoptosis to control levels (Lyng et al., 2006), 
demonstrating the importance of calcium signalling in the bystander effect.   
Within 1 hour of exposure to ICM there is a large increase in ROS, which has 
increased further by six hours and persists for at least 24 hours, and 
concomitantly mitochondrial membrane potential has decreased by six hours 
and remains low for at least 24 hours. Interestingly, the increase in ROS 
appears to precede the fall in mitochondrial membrane potential (Lyng et al., 
2000). By 48 hours some of the cells have apoptotic morphology; however, this 
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fraction does not fully account for all of the clonogenic cell death (Lyng et al., 
2000). 
ICM induces significant activation of both ERK and JNK at 30mins and 24hours 
of exposure, whereas p38 was not significantly activated at either timepoint. 
The use of specific inhibitors against the three MAP kinases showed that ERK 
inhibition increased apoptosis, JNK inhibition decreased levels of apoptosis and 
p38 had no effect in cells exposed to ICM (Lyng et al., 2006).   
The use of Bay 11-7082 to inhibit NF-κB activation significantly reduced the 
bystander effect, whilst having no effect on directly irradiated cells (Zhou et al., 
2008). The effect was greater in cells with functioning mitochondria, as po cells, 
which have no mtDNA, also have reduced basal and stimulated levels of p65-
p50 and p50-p50 dimers, suggesting both that mitochondria induce NF-kB 
activation in bystander cells, and NF-κB may induce mitochondrial ROS 
production, consistent with the idea of positive feedback being involved in the 
bystander effect. Additionally, the targets of NF-κB such as iNOS and COX2 are 
also increased in bystander cells, and the addition of anti-TNF-α into the 
medium reduced NF-κB and COX-2 levels, and increased survival of bystander 
cells (Zhou et al., 2008).  
Exactly how the damaged cells transmit the bystander signal is not completely 
clear. However, a role for gap junctions has accumulating evidence. These 
small channels allow the passage of molecules and ions smaller than 485 
daltons between cells. They play key roles in inter-cellular homeostasis and 
electrical signalling (Robertson, 1981a, Robertson, 1981b). Consistent with 
bystander transmission, they are thought to play a key role in calcium 
homeostasis (Charles et al., 1992). Each gap junction is made up of two 
molecules of connexin43 which bind to the same molecules in the neighbouring 
cell, thus forming a continuous channel connecting their cytoplasm. Addition of 
the gap junction inhibitors lindane and octanol, as well as the use of dominant 
negative connexin43 can completely abrogate the bystander effect (Azzam et 
al., 1998, Azzam et al., 2001, Zhou et al., 2000), whilst the overexpression of 
connexin43 enhances it (Zhou et al., 2001). Equally, the exposure of various 
cell types to radiation or hydrogen peroxide was found to increase the 
expression of connexin43 (Azzam et al., 2003), suggesting that the bystander 
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effect was an adaptive response, although this did contradict previous data 
suggesting that gap junctions were downregulated in response to stress 
(Chipman et al., 2003). 
 
1.7.3 Biological Significance of the RIBE  
 
When human urothelium from different subjects is exposed to γ-irradiation, 
there is significant inter-individual difference in the resultant phenotype, which 
can be separated into two main groups; group1 describes cells which undergo 
little cell death in response to 0.5Gy or 5Gy irradiation, whilst group 2 describes 
cells which undergo higher levels of apoptosis and necrosis to the same doses 
(Mothersill et al., 1999). Smokers and males were much more likely to be in 
group 1, and non-smokers and females, especially non-smoking females were 
more likely to be in group 2 (Mothersill et al., 1999). Using the ICM from the 
group 1 irradiated urothelium had a much smaller bystander effect on 
keratinocyte survival than group 2 urothelium, and this difference was also 
apparent after several cell generations (Mothersill et al., 2001). Notably, the 
bystander effect of ICM from irradiated tumour cells, or the normal tissue 
around the tumour cells has a tendency to increase cell survival (Mothersill et 
al., 2001).  
The same differences were observed between the more radioresistant CBA/H 
and the radiosensitive C57/BL6 mice. Following bone marrow irradiation the 
CBA/H mice showed delayed chromosomal instability in their cells which was 
not present in the C57/BL6 mice (Mothersill et al., 1999), which are less 
susceptible to epithelial cancers and radiogenic malignancies. Importantly, 
irradiated mouse urothelium from C57/BL6 mice induced a bystander effect, 
whilst medium from CBA/H urothelium did not, thus demonstrating that the 
bystander effect predisposes mice to better long term prospects with lower 
cellular transformation and thus higher organismal survival in response to stress 
(Mothersill et al., 2001). Another study showed that the radioresistant effects 
might result from increased expression of Bcl-2 and decreased expression of 
p53 and Bax (Mothersill et al., 2005). 
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Interestingly, a different study showed that anti-apoptotic Bcl-2 is only 
significantly increased in the bystanders exposed to the high dose ICM. 
Additionally, caspase-9 inhibition only increased survival from low dose and not 
high dose ICM (Maguire et al., 2005). This may be an indication that, whilst low 
and high doses have similar effects on clonogenic survival, they are inducing 
different mechanisms of clonogenic death. Speculatively, one possibility is that 
the low dose bystander effect induces apoptotic cell death, dependent on 
mitochondria and membrane permeabilisation, whilst high doses prevent 
apoptosis via inducing Bcl-2, and as a result enter mitochondria-independent 
cell death, such as necroptosis.  
It is clear that the radiation induced bystander effect is a complex phenomenon, 
reliant on several signalling pathways, ROS, gap junctions and intracellular 
calcium, and importantly it has tumour preventative properties. Importantly, it is 
likely that bystander phenomena where the outcome is molecular damage will 
share similar characteristics, making the research into the RIBE useful for the 
study of the senescent cell induced bystander effect, which is the work of this 
thesis.  
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2 Aims 
 
1. The primary aim of this study was to elucidate whether senescent cells 
could induce a DNA damage response and spread cellular senescence 
to healthy replicative cells, ie. to look for a bystander effect of senescent 
cells. 
2.  After the primary aim was completed, the secondary aim was to 
understand the mechanisms of this “bystander effect”, and investigate 
potential routes to inhibiting it.  
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3 Materials and Methods 
 
3.1 Chemicals 
 
All chemicals were purchased from Sigma unless stated otherwise. 
 
3.2 Cell Lines and Culture 
 
3.2.1 Mammalian Cell Lines 
 
MRC5 human embryonic lung fibroblasts (ECACC, Salisbury, UK), and HEK 
293FT lentiviral packaging cells (Invitrogen, Paisley, UK) were cultured ex vivo 
at 37oC in a humidified atmosphere of 95% air with 5% CO2 in Dulbecco’s 
modified eagle’s medium (DMEM) supplemented with 10% foetal bovine serum 
(BioSera, Ringmer, UK), 100 units/ml penicillin, 100 μgml-1 streptomycin and 2 
mM glutamine (complete medium).  
Medium was replaced on cells three times a week, and were split at roughly 
90% confluence using trypsin EDTA. Control inducer and young reporter cells 
ranged from PD 19-30. Cells were counted using a Fuchs-Rosenthal 
haemocytometer, and population doublings were calculated using the formula: 
ln(X/(X-1)/ln2, where X and X-1 are the current and previous counts 
respectively. Cells were defined as senescent after they had passed at least 38 
PD, had two consecutive weeks of negative growth, and had been left for a 
further two weeks.  
Cells were plated at a subconfluent density of 150,000 cells/35mm dish (IWAKI, 
NELS, Newton Aycliffe, UK). In co-culture 75,000 senescent cells were plated 
with 75,000 reporter cells (ratio of 1:1). Co-cultures were continued up to 21 
days, with measurements at 1, 2-4, 7, and 14 days depending on the 
experiment.   Medium was changed on the cells three times per week, providing 
fresh inhibitors if any were present at the concentrations shown in table 3.1. All 
inhibitors were dissolved in DMSO. 
 60 
 
 
Inhibitor Target Concentration Manufacturer 
Bay 11-7082 IKK complex 1μM Calbiochem 
Octanol Gap Junctions 1μM Sigma 
Torin1 mTOR 10nM Tocris 
Biosciences 
UR-13756 P38 1μM Gift from 
Terrance Davis 
lab (Bagley et 
al., 2010) 
Table 3.1| Inhibitors added to co-culture, dissolved in DMSO. 
 
3.2.2 Prokaryotic Cell Lines 
 
Cell Line Manufacturer Plasmids used to transform cell line 
NEB10β NEB pENTR2B-53BP1, pENTR2B-mCherry-53BP1, 
pENTR2B-ΔIκBα-IRES-EGFP 
NEB5α NEB pLP1, pLP2, pLP/VSVG 
One Shot 
OmniMAXTM 
2T1 Phage-
Resistant Cells 
Invitrogen pLenti6-mCherry-53BP1, pLenti6-ΔIκBα-IRES-
EGFP 
Table 3.2| Prokaryotic Cell Lines. 
 
3.3 Solutions 
 
Solution Ingredients 
PBS Dulbecco’s phosphate buffered saline 10× (Sigma) 1 in 10 in RO 
H2O 
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PBS-Mg 5mM MgCl2 in PBS 
Iron Bru 100ml PBS-Mg, 2.11g (50mM) Potassium ferrocyanide, 1.65g 
(50mM) Potassium ferricyanide 
Staining 
Solution 
8.5ml PBS-Mg, 0.5ml pre-warmed X-gal, 1ml Iron Bru. pH 5.5-6 
TBS 24.2g Tris Base, 80g NaCl. Make up to 1litre and adjust to pH 
7.6 with HCl 
TBST TBS with 0.3% Triton (v/v) 
PFA Heat 400ml RO H2O to 62-64
oC. Add 100μl 10N NaOH and 40g 
of paraformaldehyde to 980ml of PBS, then add to heated 400ml 
RO H2O. As temperature returns to 62-64
oC the fixative will 
clear. Cool to room temperature and filter. Check pH is around 
7.3 
TAE 400ml RO H2O, 121g Tris Base, 28.55ml glacial acetic acid, 9.3g 
EDTA. Adjust to 500ml with RO H2O (50×). Then 1 in 50 in RO 
H2O for working solution 
LB 10g bacto-tryptone, 5g bacto-yeast extract, 10g NaCl made up 
to 1L RO H2O 
LB agar 
selection 
plates 
Add 15g agarose to 1L LB and autoclave. Once cool enough to 
hold, add 50µg/ml ampicillin or kanamycin selection agent, mix 
thoroughly and pour plates 
Table 3.3| Solutions used in experimental protocols.  
 
3.4 Creating Reporter Cells 
 
An initial reporter line of MRC5 fibroblasts had been transduced with a 
fluorescent reporterAcGFP-53BP1c, described previously (Nelson et al., 2009). 
Although this vector was used very successfully in the initial in depth analysis of 
small numbers of cells, the fraction of visibly fluorescent cells was too few for 
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large scale analysis. Due to the time consuming nature and low success rate of 
tracking cells for long periods of time it was deemed that larger numbers of 
reporter cells were required. Initially transducing cells with a higher MOI of GFP-
53BP1c was attempted; however, this produced equally few fluorescent cells. 
Analysis of the plasmid using restriction digests revealed several unexpected 
bands that were believed to be the result of recombination, although 
interpretation was difficult. It was therefore decided to construct a new plasmid 
by fusing mCherry to 53BP1c. 
 
3.4.1 53BP1-pENTR2B 
 
The pENTR2A vector containing 53BP1c constructed by Glyn Nelson had been 
recombined with pG-AcGFP vector to produce GFP-53BP1c fusion protein. This 
had then been inserted into pENTR2B and recombined into pLenti6 destination 
vector (Nelson et al., 2009). This produced the additional recombination sites in 
the pENTR2B and pLenti6 plasmids, which were believed to have caused the 
mixed population of plasmids described above. Therefore, it was decided to re-
insert 53BP1c into pENTR2B (Invitrogen), the latter of which is shown in figure 
3.1. 
 63 
 
 
Figure 3.1| Plasmid map of pENTR2B with restriction sites in the multiple 
cloning site (MCS). Map is copied from product description (Invitrogen).   
 
3.4.1.1 Restriction Enzyme Digestion 
Both pG-AcGFP-53BP1c and pENTR2B were digested with a BamHI XhoI 
double digest. This had the advantage that none of the recombination sites 
were within the fragment to be inserted into pENTR2B. 1μl of each enzyme from 
the NEB stock solutions was added to 0.5μg plasmid DNA in the presence of 
1μl BamHI buffer and made up to 10μl with RO H2O. The digests were 
incubated at 37oC for 2-3 hours, due to the decreased efficiency of XhoI in 
BamHI buffer.  
The products were then run on a 0.8% agarose gel, next to a 1KB ladder (NEB). 
To construct the gel, 0.8% research grade agarose (SERVA) was added to TAE 
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and heated until completely melted with intermittent stirring. The liquid was then 
cooled and a 1 in 10000 dilution of SYBER SAFE (Invitrogen) was added and 
mixed thoroughly, before pouring the gel. The gel was run at 90V for 10 minutes 
and 110V thereafter. Bands were checked and imaged under UV illumination 
using an AlphaInnotech MultiImageTM Light Cabinet. 
BamHI XhoI digestion of pENTR2B produces 0.45Kb and 2.25Kb fragments, 
and the same digestion of pG-AcGFP-53BP1c produced a 2.77Kb fragment 
containing 53BP1c, and a 4.73Kb fragment. Therefore, the small fragment of 
pG-AcGFP-53BP1c, and the large fragment of pENTR2B were excised from the 
gel using a scalpel and a UV illuminator. They were cleaned using QIAquick gel 
extraction kit (Qiagen) as per manufacturer’s instructions, before eluting into 
50μl buffer EB. 
 
3.4.1.2 Ligation 
Concentration of DNA was determined with a nanodrop to calculate the 
quantities required for ligation. A 3:1 insert to vector ratio of molar ends were 
combined, using 50ng vector, in a PCR tube and incubated overnight at 16oC 
with 1U T4 DNA ligase and provided buffer. Volume of ligation mix was kept as 
low as possible, to increase the efficiency of bacterial transformation. 
 
3.4.1.3 Bacterial Transformation  
1-5μl of ligation mix was added to a 50µl vial of NEB10β highly competent E. 
coli (NEB) and incubated on ice for 30 minutes, before heat shocking at 42oC 
for 30 seconds. After another five minute incubation on ice, 450μl SOC medium 
(NEB) was added and cells were incubated at 37oC for 1 hour with shaking at 
250rpm. The cells were then spread on agar selection plates containing 
kanamycin, and incubated overnight. 
Colony formation was compared to bacteria transformed with vector only (no 
insert), and was found to be significantly higher indicating both ligation and 
transformation had been successful. Individual colonies were then grown 
overnight in 5ml selective LB. DNA was purified using the QIAprep Spin 
Miniprep kit (Qiagen) as described in the provided protocol.  
 65 
 
 
3.4.1.4 Plasmid Analysis 
A BamHI digest was used to test potential mCherry-53BP1c bacterial clones. 
Restriction digests followed the same protocol as above, with 1μl Bam HI and 
0.5μg plasmid DNA in the presence of 1μl Bam HI buffer made up to 10μl with 
RO H2O. As shown in figure 3.2A, the digest produces a band between 5 and 
6Kb, and 53BP1-pENTR2B is 5.32Kb, whilst pENTR2B alone is only 2.7Kb, 
suggesting that 53BP1c had inserted. The plasmid map of 53BP1-pENTR2B is 
shown in figure 3.2B. 
 
 
 
A| 
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B| 
Figure 3.2| pENTR2B-53BP1c. (A) Plasmid cut with Bam HI restriction 
enzyme, which cuts once in the MCS prior to the 53BP1c insert yielding 
5.32Kbp band. As the bands are not clear on this gel white lines have 
been drawn next to them to better indicate their position. (B) Plasmid map 
of correct clones, created using PlasMapper Version 2.0: 
http://wishart.biology.ualberta.ca/PlasMapper/jsp/librarySeq.jsp?id=Clonte
ch15. 
 
3.4.2 pENTR2B-mCherry-53BP1c 
 
The next stage in the cloning process was to insert mCherry in front of 53BP1c. 
Because the restriction sites in the MCS of the pRSET B plasmid containing 
mCherry, donated by Roger Tsien, were largely unknown, it was decided that 
mCherry would be amplified using PCR. 
pENTR2B-
53BP1c 
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3.4.2.1 Primer Design and Amplification 
Primers were designed to add Sal I restriction sites either side of mCherry 
during amplification. Although this would allow mCherry to insert the wrong way 
around in some clones, there were no other restriction sites that were suitably 
placed without also cutting at unwanted locations. The forward primer started 
from 20 bases before the Kozak sequence within the pRSET B plasmid, and the 
reverse primer bound to the end of the mCherry gene minus the stop codon, as 
shown in figure 3.3. 
Forward Primer: 
5’ GTC GTCGAC T AGATCT CGCCACCATGGTGAGCA 3’ 
Reverse Primer:  
5’ ATC GTCGAC T CTG GTT TTG CTTGTACAGCTCGTCCATG 3’ 
Figure 3.3| Primers for amplifying mCherry. Blue highlight identifies bases 
added to the end to allow more efficient SalI enzyme binding. Yellow 
highlight shows SalI restriction sites. Red highlight identifies a base 
added to increase the melting temperature. Cyan highlight shows a BglII 
restriction site. Pink highlight identifies the linker region to allow correct 
protein translation and folding. Green highlight is the region 
complementary to the plasmid.  
 
BglII was added 5’ for analysis purposes described later. Additionally, three 
bases were added outside of the SalI sites to improve SalI enzyme binding PCR 
fragments, and an additional base was added to the front primer to increase the 
melting temperature. Lastly, a linker region of 10 bases was added to the 
reverse primer that would function to separate mCherry from 53BP1 by 
hydrophilic amino acids, thus allowing both proteins to adopt their normal 
conformations, and also to ensure that 53BP1 was in the correct frame after the 
addition of mCherry.  
Primer designs were checked using http://www.basic.northwestern.edu/ 
biotools/oligocalc.html. They contained no potential hairpins or self-
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complementarity, although there were two sites where the primers could bind to 
each other. Melting temperatures of the initial primer binding sites (the green 
highlighted region in figure 3.3), as well as the total primer were within 0.5oC 
difference of each other. 
PCR was carried out according to the guidelines of Pfu polymerase (Thermo 
Scientific): Add 5μl Buffer with MgSO4, 5μl dNTPs (0.2mM each), primers 
0.5μM each, 500pg template DNA, and 1.5U Pfu polymerase to a total volume 
50μl, made up with nuclease free water in a PCR tube. Initial denaturation was 
set at 95oC for 3 minutes, then amplification involved 25 cycles of 30s 
denaturation at 95oC, 30s annealing at 57oC, then a 120s extension at 72oC. 
The final extension was allowed to continue for seven minutes at 72oC, before 
the reaction was reduced to 4oC until products were removed.  
 
3.4.2.2 DNA Preparation 
The PCR product containing mCherry was cleaned using QIAquick gel 
extraction kit (Qiagen) and eluted into 50μl buffer EB, to which 6μl Sal I buffer, 
3μl Sal I enzyme, and 1μl water was added. This was incubated at 37oC for 24 
hours due to the markedly decreased efficiency of Sal I enzyme working within 
3 base pairs from the end of the fragment.  The 53BP1c pENTR2B plasmid was 
also digested with Sal I for 1 hour with 1μl  buffer, 1μl enzyme in a 10μl 
reaction. 
The PCR product and 53BP1c pENTR2B vector were run on 0.8% agarose gel, 
next to a 1KB ladder (NEB) as described above. The 500bp fragment from the 
mCherry digest and the 5.5Kbp band from the 53BP1c pENTR2B digest were 
both excised from the gel and cleaned using the QIAquick gel extraction kit 
(Qiagen). The sticky ends of the vector backbone were then dephosphorylated 
using calf intestinal alkaline phosphatase: 1.5μl enzyme, 6μl buffer made up to 
60μl with RO H2O for 30 minutes at 37
oC. After dephosphorylation the vector 
DNA was cleaned and the two fragments were ligated as described above.   
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3.4.2.3 Plasmid Analysis 
After bacterial transformation, colony selection, and DNA purification using 
QIAprep Spin Miniprep kit as described above, the DNA was tested with a SalI 
digest to determine which clones contained the insert. As shown in figure 3.4A, 
clones 1-4 all have mCherry inserted and are the right size, with 5.5Kb and 
0.7Kb fragments. Secondly a BglII BamHI double digest was used to determine 
the orientation of the insert. The correctly inserted fragment yielded a 0.7Kb 
band whilst the other digest produced a non-detectable band of a few base 
pairs, as shown in figure 3.4B. The plasmid map is shown in figure 3.4C. 
 
 
A| 
 
B| 
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C| 
Figure 3.4| pENTR2B-mCherry-53BP1c. (A) Plasmid digest with BglII and 
SalI separately. BglII cuts once producing a 6Kb band, whilst SalI cuts 
twice excising mCherry producing 5.5Kb and 0.7Kb bands. (B) Double 
digest with BglII BamHI restriction enzymes shows that clones 2 and 4 
have mCherry inserted the correct way around as they both produce 
0.7Kb bands. Clones 1 and 3 do not produce a similar band as they have 
BglII and BamHI within a few bases of each other as mCherry has inserted 
the other way around. The ladder bars, as for all gels throughout this 
thesis, are 10000, 8000, 6000, 5000, 4000, the large band is 3000, then 
2000, 1500, 1000, 500bp. (C) Plasmid map of correct clones, created as 
described in figure 3.2. 
 
 
 
pENTR2B-
mCherry-
53BP1c 
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3.4.3 pLenti6-mCherry-53BP1c 
 
For lentiviral transduction pLenti6/UbC/V5-DEST (Invitrogen) was used. This 
drives ectopic expression of the inserted gene from a human promoter, as 
shown in figure 3.5. 
 
 
Figure 3.5| pLenti6/UbC/V5-DEST vector map, copied from product 
description (Invitrogen).  
 
 72 
 
3.4.3.1 Recombination and Analysis 
Following the instructions provided with LR clonase II enzyme mix (Invitrogen), 
pENTR2B-mCherry-53BP1c was recombined with pLenti6/UbC/V5-DEST to 
create pLenti6-mCherry-53BP1c.  
Bacterial transformation, selection and DNA purification were carried out as 
described in section 3.4.1.3, except 50μg/ml ampicillin was added to the 
agarose plates for selection. As the empty pLenti6 vector contains the toxic 
ccdB gene, which inhibits topoisomerase II causing cell death (Bernard and 
Couturier, 1992), and pENTR2B containing E. coli are still susceptible to 
ampicillin, most of the colonies should contain recombinant DNA. However, 
some bacteria survived the ccdB toxicity but their colonies were generally 
smaller than those of recombinants. As shown in figure 3.6A, DNA was 
analysed using a Sal I digest, demonstrating that mCherry was present and 
recombination had taken place in all four of the selected clones. The plasmid 
map is shown in figure 3.6B. 
  
 
A| 
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B| 
Figure 3.6| pLenti6-mCherry-53BP1c. (A) Sal I digest produces a >10Kb 
band and a 0.7Kb band indicating the excision of mCherry. (B) Plasmid 
map of correct clones, created as described in figure 3.2.  
 
3.4.3.2 Sequencing 
Using a primer binding approximately 50bp away from the 3’ end of mCherry, 
the pLenti6-mCherry-53BP1c plasmid was sent for sequencing at Genevision 
http://www.genevision.co.uk/index.html. The results demonstrated that mCherry 
had inserted in the correct frame and place relative to 53BP1c. Although there 
is one missing base near the end of mCherry in sequence read 1, this is likely 
because of the low fidelity of polymerases in the first 30-50bases sequenced; in 
all other respects both reads were identical to the desired sequence, as shown 
in figure 3.7. 
pLenti6-
mCherry-
53BP1c 
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Sequence Read 1: 
5’ AG CTG TAC AGC AAA ACC AGA GTC GAC TGG ATC CCC CCA CCA 
CAC CCA TCA GGG GG 3’ 
Sequence Read 2: 
5’ CA AGC AAA ACC AGA GTC GAC TGG ATC CCC CCA CCA CAC CCA 
TCA GGG GG 3’ 
Desired Sequence: 
5’ AGC TGT ACA AGC AAA ACC AGA GTC GAC TGG ATC CCC CCA CCA 
CAC CCA TCA GGG GG 3’ 
Figure 3.7| Two sequencing runs of pLenti6-mCherry-53BP1c from two 
different clones. Green highlight indicates bases are from mCherry, pink 
highlight represents the linker region, yellow highlight the SalI restriction 
site, cyan is the single base lying between the SalI site and BamHI site in 
the pENTR2B MCS, blue highlight is the Bam HI site, and red highlight is 
53BP1. 
 
3.4.3.3 Making Stocks 
Once DNA had been analysed and the colonies containing the correct plasmids 
identified, glycerol stocks were made of the bacteria by mixing 800μl LB 
containing the transformed bacteria with 200μl 80% glycerol, then flash freezing 
in liquid nitrogen, and storage at -80oC. 1ml of LB containing the correctly 
transformed bacteria was also grown overnight in 200-250ml LB containing 
ampicillin before purifying the DNA using the EndoFree Plasmid Maxi Kit 
(Qiagen) as per manufacturer’s protocol.  
 
3.5 Creating ΔIκBα Expressing Cells 
 
Glyn Nelson had already generated a mutant IκBα with a deleted N-terminus, 
which removed the IKKβ phosphorylation signal (S32 +S36). As a result the 
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ΔIκBα cannot be inactivated by IKKβ and is therefore not targeted to the 
proteasome, but instead remains constitutively active, inhibiting NF-κB as a 
result. The ΔIκBα gene lies upstream of an internal ribosome entry site (IRES) 
which causes the translation of GFP in a pIRES-EGFP plasmid (Clontech), 
shown in figure 3.8. However, in order to transduce human fibroblasts this had 
to be inserted into an entry vector and recombined into a destination vector, 
similar to the reporter construct described above.   
 
Figure 3.8| pIRES-EGFP Map, copied from product details provided 
(Clontech). 
 
As the location of the ΔIκBα gene inside the MCS was uncertain, several test 
digests were used to determine its position. ΔIκBα is 1064bp long and with the 
IRES and EGFP in a single fragment it makes 2.4Kb band. Without ΔIκBα the 
IRES-EGFP fragment is only 1.3Kb. Therefore, as NotI cuts downstream of 
EGFP a double digest containing NotI and another enzyme from the MCS will 
locate the ΔIκBα gene. As shown in figure 3.9, both BamHI and SalI cut 
downstream of ΔIκBα, whereas NheI cuts upstream. Therefore, a NheI NotI 
digest was selected. 
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Figure 3.9| Test digests of pΔIκBα-IRES-EGFP. A single cut produces a 
6.4Kb band; excising ΔIκBα-IRES-EGF from the backbone produces a 
2.4Kb band, and excising only IRES-EGFP produces a 1.3Kb band. 
Therefore, as expected all single digests tested cut the plasmid once, 
BamHI and SalI double digests with NotI excise IRES-EGFP, and NheI NotI 
double digest excises the full ΔIκBα-IRES-EGF fragment.  
 
As can be seen from figure 3.1, NheI does not digest pENTR2B in a suitable 
place, whereas NotI does. Therefore, digesting pΔIκBα-IRES-EGFP had to be 
done sequentially with a blunting step in between to allow ligation of the NheI 
site 5’ of ΔIκBα and the blunt EheI site chosen from pENTR2B. NheI digestion 
and cleanup were done as described in section 3.4.1.1. For blunting, 3μl T4 
DNA polymerase, 7μl buffer 2 + BSA (NEB), and 6μl NTPs, were added to the 
50µl elution, and made up to 70μl with RO H2O. This was again cleaned before 
a subsequent NotI digest. The pENTR2B vector was double digested with EheI 
and NotI. As EheI produces a blunt fragment a sequential digest was not 
necessary. Both digested plasmids were run on a gel and the smaller fragment 
was excised from the well containing pΔIκBα-IRES-EGFP, and the larger (and 
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only visible) fragment from pENTR2B. These were cleaned, ligated and used to 
transform NEB10β E. coli as described in section 3.4.1.1 and 3.4.1.2.  
The resultant purified DNA from selected colonies was analysed using AseI and 
BglII single digests, as shown in figure 3.10A. The 2.4Kb insert and 2.3Kb 
backbone produces a 4.7Kb band from a single cut. As both AseI and BglII cut 
once within the plasmid if the ligation has worked this should produce a 4.7Kb 
band. Clones 2,3,4 and 5 all have the correct sized bands. The plasmid map is 
shown in figure 3.10B. 
 
 
A| 
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B| 
Figure 3.10| pΔIκBα-IRES-EGFP-pENTR2B. (A) AseI and BglII digests 
reveals that clones 2,3,4 and 5 all have the correct band between 4-5Kb on 
the ladder, whilst clone 1 most likely results from the re-ligation of 
pENTR2B with itself. (B) Plasmid map, created as described in figure 3.2. 
 
ΔIκBα-IRES-EGFP-pENTR2B was then recombined with pLenti6/UbC/V5-DEST 
and the DNA was purified from selected colonies. The DNA was then analysed 
using a XhoI digest, as shown in figure 3.11A and B. XhoI cuts the correct 
plasmid four times; it cuts once in ΔIκBα, once in the MCS from pIRES2, once 
in the MCS transferred from pE2B and once in the pLenti6 backbone. However, 
because it cuts in the MCS of pIRES2 upstream of SalI, as shown in figure 9, it 
is unknown whether this lies before or after ΔIκBα. Therefore, there are two 
possible correct outcomes. If the XhoI site from the pIRES2 MCS lies upstream 
of ΔIκBα, then there will be a 7.8Kb band, a 2.2Kb band and two 0.1-0.2Kb 
bands. If it lies downstream of ΔIκBα, then the 2.2Kb band is split into a 1.3Kb 
and 0.9Kb band, and one of the small bands disappears.  
pENTR2B-
ΔIκBα-
IRES-EGFP 
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The results indicate firstly that some of the clones are correct, and secondly that 
they fit the former profile, producing a single band between 0.1-0.2Kb and a 
2.2Kb band rather than any bands around the 1Kb mark. The plasmid map is 
shown in figure 3.11C. 
 
 
A| 
 
B| 
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Figure 3.11| pLenti6-ΔIκBα-IRES-EGFP. (A) XhoI digest of four potential 
clones and ΔIκBα-IRES-EGFP-pENTR2B (pE2B), and pLenti6/UbC/V5-
DEST (pLenti6) controls. Clones 2, 3 and 4 all show the band between 2-
3Kb, and a band between 7-8Kb indicating that recombination has taken 
place. (B) An early image of the XhoI digest showing the 0.1-0.2Kb bands 
for clones 2, 3 and 4. (C) Plasmid map, constructed as described in figure 
3.2. 
 
3.5.1 Transfection and Transduction Protocols 
 
All lentiviral plasmid transfection and viral production was performed following 
class II safety procedures. 1.25×106 HEK293FT cells were incubated for two 
days in antiobiotic free medium in a 10cm dish to be at 90% confluency at time 
of transfection with 3μg of pLenti6 mCherry-53BP1c combined with either 9μg 
pLenti6-
ΔIκBα-IRES-
EGFP 
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ViraPowerTM Packaging Mix, or 3μg of each individual component (pLP1, pLP2, 
pLP/VSVG, Invitrogen).  
To separate the packaging mix, 1µl of DNA was added to NEB5α competent E. 
coli (NEB), which were then transformed as described above. The purified DNA 
from several colonies was analysed using a Bam HI digest. The pLP/VSVG 
plasmid is split into a 5Kb and 0.7Kb fragment, the pLP1 plasmid containing 
gag/pol is split into 8Kb and 0.8Kb fragments, and lastly the pLP2 plasmid 
containing Rev is cut once producing a 4.2Kb fragment. As shown in figure 
3.12, all plasmids were accounted for.  
 
 
Figure 3.12| Bam HI digest of viral gene plasmids produces distinct bands 
for each.   
 
One clone of each was purified using Maxi prep procedure described in section 
3.4.3.3, and combined in a 1:1:1 ratio during transfection, as determined by the 
three similar intensity bands produced by running the packaging mix on a gel, 
shown in figure 3.13. 
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Figure 3.13| ViraPowerTM Packaging Mix separates out into three similar 
size bands, indicating that each component is mixed in a 1:1:1 ratio.  
 
Transfection was achieved using lipofectamineTM 2000 as described in the 
ViraPower Lentiviral Expression systems user manual (Invitrogen).  
The day after transfection medium was removed and replaced with 10ml fresh 
medium without antibiotics. 48 hours after initial transfection, medium was 
collected and centrifuged at 4oC, before filtering through a 0.45μm pore PVDF 
filter. It was then added to MRC5 fibroblasts at 70-90% confluence. In young 
cells 10μg/ml polybrene was added, but this was avoided in the transduction of 
senescent cells due to its lethality.  
Blasticidin was added to cells at a final concentration of 4μg/ml for six days, as 
had been previously established (Nelson et al., 2009). After six days, the 
concentration was reduced to 2μg/ml to maintain selection.  
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3.6 Immunofluorescence and Imaging 
 
Cells were fixed with 4% PFA for 10 minutes at room temperature, then washed 
with TBS before the addition of 0.3% Triton Tris buffer saline (TBST) containing 
5% goat serum and a 1 hour incubation at room temperature with shaking. This 
was then removed and 100μl TBST solution containing primary NF-κB XP 
antibody (NEB) at 1:50 dilution was then added to the coverslip and incubated 
for two hours at room temperature under humid conditions. The coverslips were 
then washed three times with TBS for five minutes before addition of 1:1500 
secondary 633 goat anti-rabbit antibody (Invitrogen) in TBST, and incubation for 
one hour at room temperature in darkness. After three more five minute washes 
the coverslips were mounted in Prolong Gold antifade reagent with DAPI 
(Invitrogen) and imaged using a Leica DM5500B with 40×1.4 NA oil immersion 
objective, capturing fluorescent images with a DFC360FX camera, using 
LASAF software (Leica). To ensure consistency between slides the cells were 
selected randomly using the DAPI channel, and both the gain and exposure 
were kept constant. The settings were saved and used for subsequent 
experimental repeats with minor alterations for optimisation, but removing the 
requirement for normalisation. 
For live cell imaging, cells were plated on glass bottomed dishes (IWAKI, NELS, 
Newton Aycliffe, UK) at least 24 hours before imaging. Time lapse imaging was 
achieved using a Zeiss LSM 510 META confocal microscope with a 40×1.3NA 
phase contrast oil immersion objective, and LSM version 2.1 software (Zeiss, 
Germany). A 3×3 tile scan was used to follow cells over a wider area using z 
stacks across 4.5µm. Cells were imaged every ten minutes for up to 55 hours. 
Fixed time point live cell imaging was achieved using a Zeiss CSU-X1 spinning 
disk confocal microscope using a 40×1.3NA oil immersion objective, and 
captured using a QuantEM 5125C camera. Axiovision software (Zeiss) was 
used to capture cell images across a 11.9µm z stack, created from 7 images 
across the z plane. 
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3.7 Senescence Associated Β-galactosidase Staining 
 
Cells were washed twice with PBS-Mg before fixation with 2% PFA in PBS-Mg 
for five minutes at room temperature. Cells were then washed twice again with 
PBS-Mg before overnight incubation in staining solution at 37oC. The following 
day cells were washed four times with PBS-Mg before imaging, using the Leica 
DM5500B with 20× objective and a DFC420 camera using LAS AF software. 
 
3.8 Data Analysis 
 
Image analysis was performed using Image J (http://rsb.info.nih.gov/ij), and 
graph creation and statistical analysis were performed in Sigma Plot. Statistical 
tests include the Shapiro-Wilk test for normality of datasets, and ANOVA for 
normally distributed data, and Kruskal-Wallis ANOVA on ranks for non-normally 
distributed data. Holm-Sidak method for multiple comparisons vs control, and 
Dunn’s method were used for post hoc analysis. Gel images were annotated 
using GIMP 2.6 software (http://www.gimp.org).  
 
 
 
 
  
 85 
 
4 The Bystander Effect of Senescent Cells 
 
It has already been shown that senescent cells can induce growth and 
transformation of pre-neoplastic cells (Bavik et al., 2006, Liu and Hornsby, 
2007, Krtolica et al., 2001). However, the same study showed that these effects 
did not occur in healthy cells. Therefore, the aim of this thesis was to elucidate 
whether senescent cells had any non-autonomous detrimental effects on 
healthy cells. The implications being that if senescent cells contributed to the 
decline of the surrounding cells, that this could potentially contribute to the 
ageing process via a non-autonomous mechanism, contrary to current 
hypotheses regarding the autonomous depletion of stem cell reserves.    
 
4.1 An Increase in DNA Damage Foci in Bystander Cells Co-cultured 
with Senescent Cells 
 
Due to the importance of a DNA damage response in senescence and the bulk 
of evidence implicating DNA damage in the ageing process, the primary 
examination focused on whether senescent cells induced a DNA damage 
response in healthy cells. Therefore, as described in the methods section, 
reporter genes were used where fluorescent mCherry or GFP was fused to 
53BP1 DNA damage response protein. These genes were transduced into cells 
to create a stably expressing cell line with fluorescent 53BP1 foci at sites of 
DNA damage. Thus, these cells will henceforth be referred to as reporter cells. 
The reporter cells could then be co-cultured with non-fluorescent senescent or 
control cells, which will henceforth be referred to as inducers. As the inducer 
cells did not have fluorescent foci, these could then be observed exclusively in 
the reporter cells (Figure 4.1). 
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Figure 4.1| Illustration of fluorescent reporter cells in co-culture with a 
non-fluorescent senescent cell.  
 
For the purpose of this thesis, cells in co-culture with senescent cells have been 
termed bystander cells. Although reporter cells in co-culture with replicating 
cells are technically still bystander cells, the focus of this thesis is whether there 
is a senescent cell induced bystander effect. Thus, for clarity this latter group is 
referred to as control cells. The non-reporter cells in the co-culture are inducer 
cells, be they senescent inducers or replicative control inducers. 
Although observing 53BP1 foci did not provide a direct measure of DNA 
damage as would a COMET assay or TUNEL assay, or measuring oxidative 
lesions with 8-OHdG, it offered several advantages over these protocols. Firstly, 
it allowed repeated unintrusive measurement in live cells. Secondly, the assay 
was considerably more sensitive than several of these protocols, and thirdly and 
most importantly, the reporter protein was ideally suited to the co-culture 
situation, because it prevented confusion between reporter and inducer cells 
that would be difficult to avoid in assays that involved lysates. However, a 
recent study suggested that many DNA damage response proteins that had 
been previously associated with sites of DNA damage, could also form foci 
independently of damage under some stimuli (Pospelova et al., 2009). Whilst 
these cells were notably still undergoing a stress response, importantly 53BP1 
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was not associated with these foci, indicating that at least under these 
conditions it is specific to sites of damage.  
Initially GFP-53BP1 reporter cells were added to a culture of senescent cells 
and incubated for two days. As described in section 3.2.1.1, cells were plated at 
1:1 ratio, with 75,000 of each type of cell in a 35mm dish. They were then 
imaged every ten minutes for 55 hours using time lapse imaging, which allowed 
a detailed analysis of focus dynamics, including formation, number of foci, and 
lifespan (Figure 4.2).  
 
 
A| 
 
B| 
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Figure 4.2| The nucleus of a control (A) and bystander (B) cell followed for 
a period of 110 minutes with an image taken every ten. The time points are 
shown in the bottom corner of each box. The arrows indicate the presence 
of foci, with each colour used to follow a single focus over time. 
 
As shown in figure 4.3, focus formation rate was significantly increased in 
bystander cells compared to controls, whereas focus lifespan and the number of 
foci per cell were not significantly different between the two groups.  
 
          A|          B|      C| 
Figure 4.3| Senescent cells induce a DDR in bystander cells. (A) 53BP1 
foci in bystander cells (BYS), compared to controls. (B) Rate of formation 
of 53BP1 foci in bystander and control cells.  (C) Average lifespan of foci 
in bystander and control cells. All results were obtained between 48-103 
hours after the start of co-cutlure. Box plots show median, upper and 
lower quartiles (boxes), centriles (whiskers), and outliers (dots). Only 
focus formation rate was significantly different between bystanders and 
controls, as determined by Kruskal-Wallis ANOVA on ranks with Dunn’s 
post hoc test, P<0.05). Data are n=1-2, with 20-25 cells per group per 
experiment. 
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This can be combined with data from Glyn Nelson collected independently to 
give n=3 experiments for each group, with similar results (See Appendix). The 
focus formation rate is increased, whilst the number of foci remains constant 
within the cell, as shown in figure 4.4.  
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A|    B| 
Figure 4.4| Combined data from this thesis with that, independently 
collected, from Glyn Nelson, showing significant increase in focus 
formation in bystander cells as determined by Kruskal-Wallis ANOVA on 
ranks with Dunn’s post hoc test, P<0.05). Data are n=3, with 20-25 cells 
per group per experiment. 
 
Data from Glyn Nelson indicated that the number of foci per cell did start to 
increase when co-culture was extended between 10-12 days (Appendix). A new 
reporter construct with mCherry fused to 53BP1 was used to analyse the 
numbers of foci in much larger numbers of cells at single time points. Although 
this did not allow measurement of focus formation rates, it was much faster and 
produced larger quantities of data. After 14 and 21 days of co-culture, the 
* 
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numbers of foci significantly increased in bystander cells of both groups, as 
shown in figure 4.5. 
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Figure 4.5| Extended co-culture for 14 or 21 days causes the number of 
53BP1 foci to increase in bystander cells. At both time points bystander 
cells had significantly more foci on average compared to control cells, as 
determined by ANOVA with Dunn’s post hoc test. Data are mean ± SE 
(n=3-5), with approximately 100 cells per group.  
 
Whilst the number of foci was also significantly higher at 21 days than 14 days 
for both controls and bystander cells, at both time points there was a significant 
increase in the number of foci in bystander cells. The resultant conclusion was 
that senescent cells induce a DNA damage response in bystander cells, which 
after a delay causes the number of foci present to increase. 
* 
* 
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4.2 The Irradiation Induced Senescent Cell Bystander Effect 
 
Whilst the majority of this thesis concerns the bystander effect of replicatively 
senescent cells, it was also addressed whether this bystander effect was 
shared with cells that had become senescent under different stimuli.  
It has long been observed that a sufficiently high dose of irradiation can cause 
cells to senesce. Although the process takes a number of days, cells hit with 
high levels of X-rays generally do not undergo mitosis. Therefore, unlike 
replicative senescence, irradiation induced senescence is fairly homogeneous, 
with all the cells undergoing senescence at the same time. As a result, this 
system can be used to observe whether senescing as well as senescent cells 
induce a bystander effect.  
Here cells were irradiated with 20Gy which has been previously shown to be 
sufficient to induce senescence in MRC5 fibroblasts. Importantly, generally the 
data agree that the senescent phenotype matures by about day 9-10 (Passos et 
al., 2010, Rodier et al., 2009, Rodier et al., 2011), in most but not all cells. 
Another study indicated that although most cells were SA-β-gal positive by this 
time point, by 15 days the number had still increased (Nelson, unpublished). 
After irradiation cells were left for either seven, 14 or 21 days before starting the 
co-culture, which was then incubated for 14 and 21 days, as shown in figure 
4.6. 
 92 
 
 
Figure 4.6| Diagram demonstrating mechanism of pre-incubation and co-
culture of irradiation induced senescent cells.  
 
If senescing cells were incubated for seven days before co-culture, then 14 
days was not sufficient to induce a bystander effect, whilst cells pre-incubated 
for 14 and 21 days induced a bystander effect after both 14 and 21 days. 
However, as would be expected, the seven day pre-incubation did induce a 
bystander effect after 21 days co-culture. These results suggest that senescent 
cells regardless of stimulus induce a bystander effect. However, senescing cells 
do not induce a bystander effect, as shown in figure 4.7. 
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Figure 4.7| Irradiated senescent, but not senescing cells induce a DDR in 
bystander cells. A pre-incubation of seven days (7D Post IR) was not long 
enough to significantly increase the number of foci in bystanders after 14 
days. However, 14 day and 21 day pre-incubations (14D Post IR; 21D Post 
IR respectively) were sufficient to increase number of foci after 14 day co-
culture. All lengths of pre-incubation senescing cells significantly 
increased foci in bystanders after 21 days of co-culture, as determined by 
ANOVA with the Holm-Sidak method for multiple comparisons vs. a 
control group, P<0.05. Data are mean ± SE of n=3 with approximately 100 
cells per experiment.  
 
4.3 Medium Transfer from Senescent Cells does not Induce a 
Bystander Effect 
 
To test whether the bystander effect could be transferred purely by long lived 
secreted factors we compared the effect of medium from senescent cells to that 
of replicating cells. Senescent cells were incubated for one day so as not to 
exhaust the nutrients provided in the FCS, before the medium was transferred 
to reporter cells through a 0.45μm pore filter. The reporters were incubated for a 
* 
* 
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* 
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* 
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further 48 hours before the medium was changed to new medium from 
senescent cells, at which point the cells were imaged for a further 55 hours. As 
shown in figure 4.8, there was no significant effect of senescent cell conditioned 
medium.  
 
 
Figure 4.8| Senescent medium (SEN MED) has no significant effect on 
53BP1 focus formation. Data and statistics are as in figure 4.3. 
 
Thus, it can be concluded that the senescent cell bystander effect cannot be 
transmitted exclusively by long lived secreted factors.  
 
4.4 Gap Junction Mediated Transfer Contributes to the Bystander Effect 
 
Gap junctions have been shown to be highly important in the RIBE, and their 
inhibition using lindane and octanol has been shown prevent the signal inducing 
damage and cell death in bystander cells (Azzam et al., 1998, Azzam et al., 
2001, Zhou et al., 2000). To determine whether gap junctions play a role in the 
senescent cell induced bystander effect, octanol, was added to the co-culture. 
During the first 2-4 days of co-culture 1μM octanol was added at day zero and 
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day two before imaging began. As shown in figure 4.9, the presence of octanol 
had a tendency to reduce the focus formation rate in bystander cells, but the 
effect was not significant. 
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Figure 4.9| Octanol inhibition of gap junction mediated transfer does not 
reduce the induction of DDR in bystander cells in short term co-culture. 
Cells in the presence of octanol (OCT) did not have significantly reduced 
focus formation rate compared to DMSO in either bystander or control 
cells. Only focus formation rate in bystander cells in the presence of 
DMSO was significantly different to controls, as determined by Kruskal-
Wallis ANOVA on ranks with Dunn’s post hoc test, P<0.05). Data are n=1-
2, with 20-25 cells per group. 
 
With extended co-cultures gap junctions begin to play more of a role. After 21 
days of co-culture in the presence of octanol the number of foci in bystander 
cells was reduced to that of controls, as shown in figure 4.10.   
* 
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Figure 4.10| Octanol inhibition of gap junction mediated transfer does 
reduce number of foci in bystander cells in long term co-culture (21 days).  
Data are mean ± SE (n=3-5), with approximately 100 cells per group. As 
determined by ANOVA, the only group significantly different to control is 
the bystander cells in the presence of DMSO.  
 
4.5 Large and Long Lived Foci are Important in the Bystander Effect 
 
Whilst observing the DNA damage focus dynamics between 2-4 days of co-
culture, it was clear that some foci were substantially larger than others. 
Therefore, foci were divided into two groups, where foci ≤ 0.45μm2 were 
counted as small foci, and foci that persist above this size for at least two 
consecutive time points (20mins) were counted as large. Examining focus 
formation rate revealed that the difference between bystanders and controls 
was exclusively the result of the large foci, as shown in figure 4.11. 
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Figure 4.11| Large focus formation is significantly increased in bystander 
cells, whilst small focus formation is not significantly changed. Data are 
n=1-2, with 20-25 cells per group, analysed using two way ANOVA with 
Holm-Sidak method for multiple comparisons.  
 
Additionally, large foci persisted for significantly longer than small foci in both 
control and bystander cells, as shown in figure 4.12.  
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Figure 4.12| Large foci persist for significantly longer on average than 
small foci. Data are n=1-2, with 20-25 cells per group, analysed using two 
way ANOVA with Holm-Sidak method for multiple comparisons.  
 
Lastly, the literature suggests that in normal proliferating cells, most foci are 
cleared within five hours (Passos et al., 2010). Therefore, control and bystander 
groups were compared for the number of foci that persisted for longer than this 
length of time. Only cells that could be followed for at least ten hours were 
selected, so that if a cell did possess such a long lived focus, there was a 
reasonable chance that the cell would remain within the tile scan long enough 
for it to be correctly identified as such. The small number of cells that persisted 
for ten hours (10-20 in each group), made analysis difficult, but a two-tailed t-
test showed that the two groups were significantly different, as shown in figure 
4.13. 
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Figure 4.13| The number of foci that persist for longer than five hours is 
increased in bystander cells. Data are mean ± SD (n=1, 28 cells) and 
significance was determined by a two tailed t-test not assuming equal 
variance (p=0.038). 
 
Thus, bystander cells have an increase in large long lived foci, which can be 
indicative of the induction of cell senescence (Rodier et al., 2011). 
 
4.6 Senescent Cells Induce Senescence in Bystander Cells 
 
Consistent with previous studies (Passos et al., 2007), this thesis has found that 
senescent cells have more foci than healthy replicating cells (Figure 5.1.2). As 
discussed in sections 1.3.1 and 1.4.3, damage is important in both the induction 
and maintenance of senescence. Accounting for the fact that the main 
difference in bystander cells was due to large long-lived foci, which have also 
been shown to be associated with senescence (Rodier et al., 2011), it was 
hypothesised that senescent cells may induce senescence in bystander cells. 
The measure of senescence associated β-galactosidase (SA-β-gal) activity is 
the most widely accepted marker of senescent cells, both in vitro and to a lesser 
* 
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extent in vivo. However, because the reporter cells were in co-culture, it was 
important to distinguish between senescence in the reporter and inducer cells. 
Because senescence is a permanent phenotype, there was no possibility that, 
after the removal of the inducer cells, the reporter cells would revert to 
proliferation. Therefore, it was possible to kill the inducer cells using blasticidin, 
for which the reporter cells carried a resistance gene (figure 4.14).  
 
 
Figure 4.14| Addition of blasticidin (Blast) after up to 20 days of co-culture 
is used to kill the senescent inducer cells leaving only the bystander cells 
to measure for induction of senescence. 
 
Reporter cells were co-cultured with senescent cells or replicating controls for 
up to 20 days.  Blasticidin was then added to the co-culture for at least six days, 
and until all senescent cells in an equally plated control dish had died. 
Blasticidin was then removed and the cells were re-plated onto coverslips. After 
a further four days the cells were fixed and stained for SA-β-gal activity as 
described in the methods. The results demonstrated that six day co-culture was 
not sufficient to induce senescence in bystander cells, whilst 15 and 20 day co-
cultures caused a small but significant increase in the induction of senescence 
(Figure 4.15). The lack of response after six days is perhaps not surprising as 
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after direct irradiation under half show SA-β-gal after 4 days, around three 
quarters after 9 days, and almost all cells after 15 days (Nelson, unpublished).  
 
Figure 4.15| Senescent cells induce senescence in bystander cells. After a 
six day co-culture the number of senescent cells was not significantly 
different between bystanders and controls. After 15 and 20 day co-
cultures the number of senescent cells was significantly increased in 
bystanders compared to controls (n=3, 100-250 cells per group within 
each experiment), as determined by ANOVA with Tukey HSD P=0.048 and 
0.008 respectively.  
 
Additionally data from Glyn Nelson, published alongside these data (see 
Appendix) provide further evidence of senescence inductrion. The proliferation 
marker Ki67 is significantly reduced in senescent cells, as shown in figure 4.16; 
as is the co-localisation of γ-H2AX with PML bodies, both of which are 
established markers of senescence (Rodier et al., 2009, Rodier et al., 2011). 
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Figure 4.16| Data collected by Glyn Nelson after 10 day co-culture with 
senescent or control inducer cells. (A) Bystander cells have significantly 
reduced Ki67 staining compared to controls, and (B) significantly 
increased co-localisation of γ-H2AX with PML bodies. Data are mean ± SE 
(n=3). Analysis was determined by a two tailed t-test, and Mann-Whitney 
U-test for (A) and (B) respectively.  
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4.7 Discussion 
 
Prior to this work, the detrimental paracrine effects of senescent cells on healthy 
cells had not been investigated. Two previous studies demonstrated that 
senescent cells could stimulate proliferation of preneoplastic cells, and this 
could result in production of benign tumours or malignant transformation 
depending on the cell line (Krtolica et al., 2001, Liu and Hornsby, 2007). 
Notably, although one of these studies tested whether healthy keratincoytes 
were also stimulated to proliferate in the presence of senescent cells, this was 
found not to be the case (Krtolica et al., 2001), although another study found 
that the opposite was true of prostate epithelial cells (Bavik et al., 2006) 
These data provide the first evidence of a genotoxic effect of senescent cells 
upon healthy proliferative cells. These effects include, but are not limited to, an 
increase in 53BP1 focus formation, the number of foci per nuclei, and the 
induction of senescence as determined by staining for SA-β-gal. The results 
were published in Aging Cell (Nelson et al., 2012), and are shown in the 
appendix. 
 
4.7.1 Implications of 53BP1 Foci Formation and Numbers 
 
As mentioned in the introduction, 53BP1 is an important member of the DNA 
damage response. It was cloned in 1994, shown to interact with DNA-binding 
domain of p53 (Iwabuchi et al., 1994), and increase p53-mediated transcription 
(Iwabuchi et al., 1998). It has a tandem BRCT (BRCA1 C terminus) domain, 
and significant sequence homology to BRCA1 (Callebaut and Mornon, 1997). 
Several studies identified that 53BP1 forms distinct foci within minutes of 
exposure to ionising radiation (Anderson et al., 2001, Rappold et al., 2001, 
Schultz et al., 2000, Xia et al., 2001), and co-localises with other proteins, such 
as γ-H2AX, BRCA1, RAD51 and the MRN complex, known to bind to DNA 
lesions (Anderson et al., 2001, Rappold et al., 2001, Schultz et al., 2000). 
Specifically 53BP1 was found to bind to DSBs (Mochan et al., 2003), dependent 
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on a domain containing two tandem tudor folds and a deep hydrophobic pocket 
(Iwabuchi et al., 2003, Ward et al., 2003a). The resultant implication that 53BP1 
would bind histones containing hydrophobic methylated lysine/arginine residues 
lead to the identification of lysine 79 methylation on histone H3 which correlated 
with 53BP1 binding (Huyen et al., 2004). However, lys79 methylation is not 
increased at sites of DNA damage (Huyen et al., 2004). Because lys79 is at the 
nucleosome core and therefore not exposed in normal chromatin (Dorigo et al., 
2004), it is likely that DSBs cause nucleosome unstacking and exposure of 
methylated lys79 (Zgheib et al., 2005).  
Therefore, although 53BP1 foci do not represent direct measurement of DNA 
damage, it is known to be associated with DNA damage, and specifically DSBs. 
Interestingly, one study found that in transformed rodent cells, treatment with 
the HDAC inhibitor sodium butyrate (NaB) induced H2AX phosphorylation, 
which did not co-localise with phospho-ATM, or correlate with high levels of 
DNA damage as determined by COMET assay (Pospelova et al., 2009). This 
indicated that γ-H2AX foci might be forming at sites of undamaged DNA. 
Importantly, 53BP1 was not associated with these damage-independent foci, so 
whilst there is some evidence that other members of the DDR do not always 
associate with DNA damage, there is no evidence this is true of 53BP1. 
Notably, although retention of 53BP1 at DSBs is dependent on γ-H2AX, its 
recruitment is not (Ward et al., 2003a, Celeste et al., 2003).  
In this study a truncated form of 53BP1 is used, by excision of the carboxyl-
terminal fragment using a Bam HI site. This was necessary in order to allow the 
gene to fit into the large destination vector for viral transduction. Although the 
loss of the N-terminal fragment may potentially alter the binding and signalling 
of the fragment, the 2.77Kb end terminus still contained all the functional 
domains including the TUDOR and two BRCT domains, and has been shown to 
co-localise with γ-H2AX (Nelson et al., 2009), indicating that it still binds to DNA 
damage similar to wildtype 53BP1. Additionally, the expression of the 53BP1 
fusion protein should not affect the expression of cellular 53BP1, although it will 
competitively inhibit binding to sites of damage. The UbC promoter used to 
express the reporter gene is a constitutive human promoter for ubiquitin C, and 
therefore induces much lower level of expression than viral promoters such as 
CMV; will not be subject to viral promoter silencing; and is less likely to induce 
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artefacts of overexpression. However, it cannot be ruled out that the reporter 
cells have some altered signalling process which changes their susceptibility to 
the bystander effect.  
The precise mechanisms and role of 53BP1 in the DDR are unknown. It does 
co-immunoprecipitate with Chk2 (Wang et al., 2002), and 53BP1-/- cells have 
defective Chk2 activation; however, the phenotypes of Chk2 and 53BP1 
knockdown have little in common. Chk2-/- mice are resistant to IR and their 
thymocytes are resistant to apoptosis (Hirao et al., 2002, Takai et al., 2002), 
whilst the opposite is true of 53BP1-/- mice (Ward et al., 2003b). This being the 
case, the primary effect of 53BP1 still appears to be the activation of ATM. 
Although it also binds p53 (Iwabuchi et al., 1994), and p53 activity is decreased 
in 53BP1 inhibited cells (Wang et al., 2002), it does not activate p53 
transcription, which is impossible whilst p53 still binds 53BP1 (Derbyshire et al., 
2002, Joo et al., 2002). Thus, increasing 53BP1 foci will primarily result in an 
increase in ATM signalling. 
As discussed in section 1.3.2, ATM is a potent inducer of p53 and therefore the 
senescence response. Consistently, these data demonstrate that senescent 
cells cause a significant increase in the induction of senescence, to be 
discussed later. Notably, ATM is a hub molecule and has multiple targets 
outside Chk2, including HDACs and the IKK complex, and therefore the 
bystander effect is not limited to the effects of activated p53. Many of these 
other targets may contribute to both the induction of senescence and the 
resultant phenotype.  
Interestingly these data indicate that although focus formation increases very 
quickly in bystander cells with 2-4 days of co-culture (Figure 4.3), initially these 
cells can tolerate the increase in damage induction and the number of foci per 
cell does not increase. However, after a longer period of time somewhere in 
between 4-10 days the average number of foci per cell begins to increase. 
Potentially, the longer cells spend in the presence of senescent cells, the more 
susceptible they become to damage, or the longer senescent cells are in the 
presence of proliferating cells the more damaging they become. Potentially, a 
more likely possibility is that some parts of the DNA are easier to repair than 
others, and therefore, because the sites of damage are random it is only a 
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matter of time until a difficult to repair site is hit, thus causing the damage to 
persist. Additionally, damage to sites concerned with repairing DNA could also 
cause foci to persist longer and contribute to the cells deteriorating ability to 
repair damage. 
It is well established that telomeric uncapping induces senescence because the 
cells find it difficult to repair telomeric lesions. Two recent papers have 
suggested that senescence is maintained partially by persistent foci at the 
telomeres irrespective of telomere shortening or senescence stimulus 
(Fumagalli et al., 2012, Hewitt et al., 2012). Thus, it is possible that the number 
of foci begins to increase in bystander cells as a result of a telomere becoming 
damaged. The longer cells remain in co-culture the more likely their telomeres 
will be damaged, especially as telomeres are particularly susceptible to 
oxidative stress (von Zglinicki et al., 1995). 
 
4.7.2 The Irradiated Senescent Cell Bystander Effect 
 
The bystander effect is not limited to replicatively senescent cells. Here, these 
data indicate that cells induced to senesce by 20Gy X-rays also induce a 
bystander effect (Figure 4.7). Importantly, preincubating irradiated cells for 
seven days before a 14 day co-culture was not sufficient to induce a bystander 
effect. This raises the possibility that the factor(s) responsible for the bystander 
effect take longer than seven days before they are sufficiently expressed. 
Additionally, because the bystander effect can be achieved after ten days of co-
culture, this would imply that the factor was not sufficiently present at 11 days 
after irradiation, by which time the majority of the literature suggests that 
irradiated cells have adopted the full senescent phenotype (Passos et al., 
2010).  
An alternative is that being present during the senescence process provides the 
bystander cells with a relative immunity to the bystander effect. Inconsistent 
with this idea, a study examining oncogene induced senescence demonstrated 
that bystander cells in co-culture with cells undergoing senescence undergo a 
substantial bystander effect (Acosta et al., 2013). It is also unlikely that this 
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reflects a difference in the two systems, as multiple studies have indicated that 
bystander cells in co-culture with cells hit with α particles, or cells exposed to 
ICM from recently irradiated cells all induce a bystander effect. Thus, the reason 
for the lack of bystander effect in seven day pre-incubated cells warrants further 
investigation.  
A recent study examined the irradiated senescent cell bystander effect in 
primary mouse adult ear fibroblasts (MAFs) and found that they had significantly 
increased foci after two days of co-culture, but this returned to control levels by 
days 7-8 (Jurk et al., unpublished). The early increase in DNA damage is likely 
to reflect that the study used mouse cells which are known to be more 
susceptible to damage. However, it may also be a result of the radiation 
induced bystander effect (RIBE).  
It is important to distinguish between the RIBE, which has been 
comprehensively studied, and the irradiated senescent and replicatively 
senescent cell induced bystander effect, which have both been described for 
the first time in these data (Nelson et al., 2012).  
Interestingly, experiments using irradiated cell conditioned medium 
demonstrated that, whilst keratinocytes and immortalised fibroblasts were prone 
to the bystander effect, that healthy fibroblasts were unaffected (Mothersill and 
Seymour, 1997), which parallels the predisposition of immortalised cells to the 
bystander effect induced by senescence (Krtolica et al., 2001). However, the 
RIBE does not require that the inducer cells are senescent, and the effect 
plateaus long before the doses required to induce senescence (Liu et al., 
2006b).  
 
4.7.3 Senescent Cell Secretions and the Bystander Effect 
 
In this system neither medium transfer, nor matrix from senescent cells induced 
a significant bystander effect (Figure 4.8, latter not shown). However, in other 
systems both these treatments have been shown to induce a bystander effect. 
In one study, the ECM produced by senescent cells encouraged a 3-4 fold 
increase in growth of immortalised untransformed cells (Krtolica et al., 2001).  
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Notably, although the senescence bystander effect has not been directly 
compared between fibroblasts and epithelial cells, studies into the radiation 
induced bystander effect, observed that epithelial cells are more susceptible to 
damage and cell death (Mothersill and Seymour, 1997). Equally there are some 
differences between the SASP of epithelial cells and fibroblasts, although they 
do have significant overlap and both contain many of the same inflammatory 
factors (Coppe et al., 2008). Importantly IL-1α, which was found to be unique to 
epithelial cells, is a stimulator of TNF-α induced NF-κB canonical signalling 
(Yard et al., 1992), and may therefore, make epithelial cells induce a more 
potent signal. Consistent with this idea, studies examining the RIBE using 
medium transfer identified that although irradiated fibroblasts did not induce a 
bystander effect, they were still capable of receiving the signal from cells that 
did (Mothersill and Seymour, 1997).  
Another study looking at the bystander effect of oncogene induced senescent 
cells, also found that medium transfer induced a significant bystander effect 
including a decrease in BrdU, and induction of senescence as indicated by an 
increase in SA-β-gal staining (Acosta et al., 2013). The implications of this study 
are that oncogene induced senescent cells clearly induce a more potent 
bystander effect than replicatively or irradiated senescent cells. Consistently, 
there are several observations that indicate that this may be the case. The 
SASP of oncogene induced senescent cells is qualitatively very similar to that of 
IR and replicatively senescent cells, but some factors were significantly 
upregulated in oncogene induced senescent cells, and were expressed from an 
earlier time point (Coppe et al., 2008). These factors include GM-CSF, IL-1β 
GRO-α and MIP-1α, which may therefore be key molecules in the bystander 
effect of oncogene induced senescent cells. However, it should be noted that 
although the SASPs of senescent cells correlate, they are not the same, and 
the difference in the bystander effect could result from qualitative differences in 
SASP factors. Additionally, the levels of ROS, other non-protein or non-secreted 
components have not been compared between the different senescent 
inducers.    
Interestingly, the study examining the bystander effect in preneoplastic epithelial 
cells also looked into oncogene induced senescence, and despite using similar 
co-culture times found that these cells actually induced a weaker bystander 
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effect than replicatively senescent cells (Krtolica et al., 2001). However, they 
indicated problems with their RAS expressing cells which may explain this 
difference. It is also possible that it reflects a difference between fibroblasts and 
epithelial cells. 
 
4.7.4 Gap Junction Mediated Transfer 
 
Here we demonstrate that the inhibition of gap junction mediated transfer by 
1μM octanol abrogates the bystander effect induced by senescent cells (Figure 
4.10). The mechanism by which octanol inhibits gap junction mediated transfer 
is not precisely known; however, several studies have identified this effect 
across multiple cell lines (Pappas et al., 1996, Abou Hashieh et al., 1996). 
Notably, octanol at 1mM (1000× higher than concentration used here) has also 
been demonstrated to inhibit the activity of Cx46 and Cx50 connexins similarly 
to gap junctions, enhance GABA and glycine receptor activity and inhibit NMDA 
and AMPA receptors amongst others (Dowling-Warriner and Trosko, 2000). 
However, none of these molecules should play a large role in the bystander 
effect, other than perhaps the other connexins which form gap junction-like 
channels.  
It should be noted that, as with the other inhibitors discussed later, the inhibition 
of gap junction mediated transfer via octanol is not specifically tested within the 
cells utilised here, which may respond to the compound differently to other cell 
lines in which octanol has been tested. Additionally, the potential induction of 
cell death was not quantitated and may have affected the level of damage in the 
surviving cells, and could also be a confounding variable if octanol affects cell 
death in bystander cells differently to controls. 
The results suggest that gap junction mediated transfer is not necessary for the 
early bystander effect, but becomes important later once the number of foci 
begin to increase in bystander cells. One possible explanation is that the early 
and late bystander effects are transmitted by different signals that are initially 
not transmitted through gap junctions, but latterly reliant on them. Alternatively, 
the signal could remain constant but the bystander cells could change the 
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mechanism or level at which they receive it.  This could result because of the 
increase in confluency of the bystanders at late time points, causing them to 
transmit more of their signals via gap junctions, and/or less of them via the 
membrane. 
Importantly, several studies in multiple cell types including HUVECs and 
fibroblasts have demonstrated that gap junctions decrease in replicatively 
senescent cells (Naus, 2002, Wilson et al., 2000, Kelley et al., 1979). Although 
some studies suggested it might not have occurred specifically as a result of 
growth arrest (Xie et al., 1992), the same downregulation in stress induced 
senescent cells exposed to cisplatin suggested that it was a result of 
senescence (Zhao et al., 2004). Immunofluorescent staining revealed that 
senescent cells expressed less connexin43, the main component of gap 
junctions (Zhao et al., 2004), and more slowly received label from neighbours 
(Kelley et al., 1979). Another study found that knocking down connexin43 
increased the number of cells that underwent senescence in response to high 
glucose, whilst overexpression reduced it (Zhang et al., 2006). 
Despite these observations, gap junctions play a clear role in the 
communication of cellular damage. It is long established that gap junctions play 
a crucial role in cell communication after damage induced by irradiation 
(Autsavapromporn et al., 2011). Interestingly, one study demonstrated that α- 
and γ-irradiation, as well as oxidative stress, were accompanied by increased 
connexin43 expression, stabilisation, and activation in multiple cell types 
(Azzam et al., 2003). Contrarily, other studies have demonstrated 
downregulation of gap junctional communication in response to ionising 
radiation and oxidative stress. Additionally, oncogenic activation and 
transformation has been shown to inhibit gap junctional communication (Azarnia 
et al., 1988, Bignami et al., 1988). 
The effects of gap junctional communication in response to irradiation are 
dependent on both cell type and stimulus. Notably, the confluency of cells can 
alleviate the damage in response to low-LET radiation such as X rays or γ-rays 
(Little, 1969), and increase cell killing in response to α-particles (Azzam et al., 
2000). Importantly, whilst gap junction inhibition did not affect the survival of γ-
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irradiated cells, it did reduce the decrease in survival in response to α-particles 
(Autsavapromporn et al., 2011). 
The evidence suggests that, in general, when a cell is stressed it downregulates 
gap junctional communication. This is most likely to prevent the spread of 
whatever signalling molecules are inducing the stress, as overexpression of 
connexin43 increases bystander mediated cell killing (Estin et al., 1999).  
Importantly, further downregulation of gap junction mediated transfer, in cells 
which have already tried to suppress their activity, using octanol or dominant 
negative connexin43 still further reduces the bystander effect of irradiated cells 
(Zhou et al., 2001, Azzam et al., 1998). Likely, the same principle applies to 
senescent cells. These data intriguingly suggest that the bystander effect could 
have no function, but instead result from a cell’s inability to properly suppress 
gap junction mediated transfer.  
It should also be considered that gap junctions in the bystander cells are still 
present and active in high numbers, allowing easy transmission between these 
cells. Perhaps, gap junctions do not play such a large role in signalling between 
senescent and bystander, but between the bystanders and their neighbours. 
Notably, another study using oncogene induced senescent cells demonstrated 
that bystander cells do also transmit a signal to their neighbours (Acosta et al., 
2013). 
 
4.7.5 Focus Size and Lifespan in the Bystander Effect 
 
In section 1.3.1 it was discussed how it is not only the number of foci that is 
important in deciding cell fate, but also their size and longevity. Here, the 
separation of foci into two groups based on their size, demonstrated firstly that 
large foci are longer lived than the small foci (Figure 4.12), and secondly that 
formation of large foci but not small foci was significantly increased in bystander 
cells (Figure 4.11), although there was a tendency for the increased formation 
of small foci. Therefore, they may play a small role in the bystander effect, but 
are likely in the majority to represent easily repaired lesions which are 
unaffected by bystander signalling. Notably, these foci persisted for at least 20 
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minutes and were captured in at least two subsequent time-lapse images so are 
unlikely to represent high background fluorescence. 
It has been previously demonstrated that persistent foci, which are associated 
with cell senescence, are enlarged (Rodier et al., 2011). However, although the 
large foci found here are significantly longer lived on average than the small 
foci, this does not necessarily make them persistent/telomeric foci. Importantly, 
the average focus lifespan remained unchanged between control and bystander 
cells, when examining total foci or big and small separately (Figure 4.3, 4.13), 
which could indicate that the majority of these cells are not being induced to 
senesce by bystander signalling. 
Another possibility is that, whilst the number of long lived foci was increasing in 
bystander cells, the number of shorter lived foci was also increasing. Supporting 
this idea, there is a tendency of the small foci to increase in the bystander cells, 
which are all very short lived. Additionally, the significant increase in large focus 
formation at 2-4 days without increasing the number of foci per cell, suggests 
that many of these foci are short lived, thus bringing down the average focus 
lifespan.  
Therefore, it was examined whether bystander cells also have increased 
numbers of the longest lived foci. Using the literature it was observed that most 
foci in healthy proliferating cells are cleared within five hours of their formation 
(Passos et al., 2010), and the preliminary data collected here indicate that 
bystander cells have increased numbers of foci that persist for longer than this 
time. Thus, it appears that bystander cells are struggling to effectively repair 
damage induced by senescent cells, which is consistent with the induction of 
senescence in a fraction of them.  
 
4.7.6 Senescence Induced Senescence 
 
Here we provide the first evidence that senescent cells induce senescence in 
bystander cells (Figure 4.15). After fifteen days of co-culture with senescent 
cells, there was a significant increase in SA-β-galactosidase expression at pH6, 
which has been used extensively in the literature as a marker of cellular 
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senescence (Dimri et al., 1995). The fraction of SA-β-gal positive cells was 
significantly increased in the bystander population. It should be noted firstly, that 
these results cannot completely rule out that senescent cells induced reversible 
growth arrest in the bystander cells, and as a result the non-senescent cells in 
the population were not as proliferative, thus allowing the senescent cells to 
occupy a higher fraction of them at the point of measurement. This issue could 
be addressed by counting the number of SA-β-gal positive cells within a certain 
area, or by waiting until all reversibly arrested cells are likely to have repaired 
their damage and re-entered cell cycle before splitting them. In this respect, the 
six day blasticidin treatment to kill the senescent cells, and the following four 
days after replating should have been sufficient for most if not all of the 
quiescent cells to do this. Secondly, although it is highly likely that this 
senescence induction results from the DNA damage foci observed in the 
bystander cells, this is just a correlation, and they may be independent 
processes.  
A second observation is that the number of senescent cells has a tendency to 
increase between six and fifteen days in the control group. This could simply 
result from cells autonomously reaching the end of their replicative lifespan, or 
alternatively from a paracrine induction of senescence from the small number of 
senescent cells that are present in all cultures. Notably, even at six days the 
fraction of SA-β-gal positive cells is about 0.27 in the control group. At early 
PDs WI-38 fibroblasts have almost no positive staining. This increases 
exponentially until all cells are replicatively senescent. By mid-late PDs around 
half the WI-38s have positive staining (Dimri et al., 1995). At PD X+28, when 
the reporter cells were used in the co-culture, they had completed 
approximately 70% of their replicative lifespan. Compared to the WI-38s 0.27 is 
not an unexpectedly high level of positive cells this far through their replicative 
lifespan. Contrarily, in MRC5s some data suggests that positive SA-β-gal 
staining should not reach above 10% until around PD 40 (Passos et al., 2007). 
In a comparison to this study, the SA-β-gal staining showed here is quite high, 
and may reflect suboptimal conditions during the co-culture, freezing or thawing 
processes, or the long time spent at confluence. What remains clear is that the 
addition of senescent cells increases the level of positive staining.  
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Notably, SA-β gal positive cells are not necessarily senescent. The increased 
enzymatic activity can be induced by other stimuli such as confluency or serum 
starvation (Dimri et al., 1995). Here cells were kept at confluency; however, 
these effects dissipate after two days and these cells had been non-confluent 
for 4-10 days. Additionally, no group has yet observed naturally occurring 
senescent cells that do not express the enzyme. Because there will always be 
exceptions, it is generally observed that a single infallible marker of senescence 
does not exist, and that to genuinely prove senescence that several markers 
must be used.  
This thesis has shown both the expression of SA-β-gal and the presence of 
large long lived foci that are indicative of cellular senescence. In the paper 
shown in the appendix (Nelson et al., 2012), we also showed a decrease in the 
marker Ki67, and co-localisation of PML and γ-H2AX, in bystander cells as 
additional markers of senescence. Further work could include examining p16 
and p21 levels in bystander cells; however, the combination of markers used 
here is good evidence that bystander cells are being induced to senesce by 
senescent cells. 
Another study, showed that oncogene induced senescent cells also induced 
senescence in bystander cells (Acosta et al., 2013). Importantly, as discussed 
previously, this phenomenon was considerably more potent than the bystander 
effect observed here. 
In this study the transfer of medium from senescent cells was sufficient to 
induce senescence in bystander cells, whereas here a significant increase in 
focus formation was not observed. However, medium from the secondarily 
senescent cells did not induce senescence in a tertiary group of bystanders, but 
it did slow the growth of these cells. Plausibly, this outcome results from the 
induction of DNA damage in this tertiary group, which causes the cell to become 
quiescent whilst the damage is repaired. 
Although our system was not sensitive enough to observe the increased 
damage from senescent cell medium, it is at least possible that the bystander 
effect that we observe from the replicatively senescent cells, is the same as the 
bystander effect observed by the secondarily senescent cells in the other study. 
Both cell types are likely to senesce from the induction of DNA damage without 
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the aberrant activation of an oncogene, and therefore the evidence suggests 
that, unless they have some other difference in the level of activation of p53, 
that they will have a similar SASP (Coppe et al., 2008). Interesting further work 
would be to co-culture these secondarily senescent cells with more bystanders 
under the conditions used in this study to examine whether damage or 
senescence is induced.   
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5 The Pathways Underlying the Bystander Effect 
 
Initially, several candidate pathways were identified using the literature which 
could potentially explain how senescent cells induce a DNA damage response 
in bystander cells. As described in the introduction, the hub molecules of these 
pathways are p38, NF-κB and mTOR. Therefore, to test the involvement of 
these molecules specific inhibitors were added to the co-culture. For mTOR the 
inhibitor torin-1 was used at 10nM, for NF-κB the inhibitor Bay11-7082 was 
used at 1µM, and for p38 the inhibitor UR-13756 was used at 1µM. All inhibitors 
were replenished every two days with a change of medium, and co-culture was 
continued for 21 days. As indicated in figure 5.1, all three inhibitors abrogated 
the bystander effect. Additionally, the presence of two inhibitors in the same co-
culture had no combinatorial effect. 
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Figure 5.1| Inhibition of TOR signalling through torin-1 (TOR), NF-κB 
signalling through Bay11-7082 (BAY), and p38 signalling through UR-
13756 (UR), or combinations of the same inhibitors (BAY TOR, BAY UR 
and TOR UR) all abrogate the increase in foci found in bystander cells. (A) 
Images of cells in presence of inhibitors. (B) Quantification of data. The 
use of dual inhibitors has no additional effect. Data are mean ± SE (n=3-5), 
with approximately 100 cells per group. As determined by ANOVA with 
Dunn’s post hoc test, only the bystander cells in the presence of DMSO or 
PBS (NOT) were significantly different to control cells in the presence of 
DMSO. All inhibitors are dissolved in DMSO and compared to DMSO alone 
(DMSO), which is not significantly different to the absence of DMSO 
(NOT).  
 
All three pathways are necessary for the bystander effect, making each one 
dependent on the presence of the other two, in order to induce the DDR. One 
possibility is that they all regulate the production of the same damaging agent or 
agents. As discussed in section 1.3.7, all three pathways stimulate the 
production of reactive oxygen species. 
* 
* 
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5.1 Reactive Oxygen Species Mediate the Bystander Effect 
 
To test the involvement of reactive oxygen species in the bystander effect, two 
antioxidant enzymes, superoxide dismutase and catalase were added to the co-
culture. Superoxide dismutase catalyses the conversion of the superoxide 
radical to hydrogen peroxide, and catalase converts hydrogen peroxide to water 
(Figure 5.2). 
 
 
Figure 5.2| Reactions catalysed by antioxidant enzymes. 
 
The addition of antioxidant enzymes completely abrogated the increase in focus 
formation between two and four days (Figure 5.3B), and foci per cell at 21 days 
(Figure 5.3C). Images of the nuclei under the different treatments are shown in 
figure 5.3A. 
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Figure 5.3| Antioxidant enzymes abrogate the bystander effect. (A) Focus 
formation during 2-4 days of co-culture in bystander cells in the presence 
of superoxide dismutase and catalase antioxidant enzymes (BYS ANTIOX) 
is completely abrogated. Control cells in the presence of these enzymes 
(ANTIOX) were not significantly affected. (B) The number of foci in cells in 
co-culture for 21 days was reduced to control levels by the presence of 
antioxidants. In (A) statistical analysis is determined by Kruskal-Wallis 
ANOVA on ranks with Dunn’s post hoc test, P<0.05). Data are n=1-2, with 
20-25 cells per group. In (B) data are mean ± SE (n=3-5), with 
approximately 100 cells per group. As determined by ANOVA with Dunn’s 
post hoc test, only bystander cells in the presence of DMSO were 
significantly different from controls in the presence of the same. 
 
In the previous chapter it was found that the difference in focus formation was 
mainly down to the large foci. ROS are considered to mainly be involved in the 
production of short lived reparable lesions (Passos et al., 2010). Therefore, it 
was examined whether antioxidants had affected large or small foci more 
significantly, and it was found that antioxidants had more of an effect on the 
large foci (Figure 5.4). 
* 
 121 
 
 
Treatment
CON ANTIOX BYS BYS ANTIOX
F
o
c
u
s
 f
o
rm
a
ti
o
n
, 
p
e
r 
c
e
ll,
 p
e
r 
h
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Large foci
Small foci
 
Figure 5.4| Antioxidant enzymes significantly reduce the formation of 
large foci in bystander cells. Data and statistics are as in figure 4.9. 
 
Notably, the presence of antioxidants significantly increased the average focus 
lifespan per cell in both control and bystander cells (Figure 5.5A), and again this 
was primarily down to its effects on large foci (Figure 5.5B).  
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Figure 5.5| Both bystander and control cells have longer lived foci in the 
presence of antioxidants. (A) Average lifespan of all foci. (B) Average 
lifespan of large and small foci separately. In (A) statistical analysis is 
determined by Kruskal-Wallis ANOVA on ranks with Dunn’s post hoc test, 
P<0.05). In (B) statistical analysis is determined by two way ANOVA with 
Holm-Sidak method for multiple comparisons. Data are n=1-2, with 20-25 
cells per group. 
* 
* 
* * * * 
* * 
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Due to their size, the antioxidant enzymes were not expected to be internalised 
in the cells, and thus would mainly function to remove ROS within the medium. 
Therefore, it was tested whether the presence of both antioxidant enzymes and 
an inhibitor against gap junctions had any combinatorial effect. As shown in 
figure 5.6, this was not the case.  
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Figure 5.6| The presence of both antioxidant enzymes and octanol  
(ANTIOX OCT) has no additional effect over the presence of either 
treatment alone on the number of foci in bystander cells at 21 days. Data 
are mean ± SE (n=3-5), with approximately 100 cells per group. As 
determined by ANOVA with Dunn’s post hoc test, only bystander cells in 
the presence of DMSO were significantly different from controls in the 
presence of the same. 
 
* 
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5.2 NF-κB Regulates the Bystander Effect 
 
5.2.1 Nuclear p65 is Increased in Senescent but not Bystander Cells 
 
The use of inhibitors against mTOR, p38 and NF-κB clearly implicated all three 
signalling pathways in the increased foci found in bystander cells. Due to time 
constraints only the NF-κB pathway was selected for further analysis. As the 
inhibitors affect signalling in both the inducer and reporter cells, although the 
damage induced in bystander cells is clearly abrogated, the mechanism by 
which this occurs cannot be determined by this system.  
NF-κB could be involved in either the production of the signal in the inducer 
cells, or the recognition of the signal in the reporter cells, or both. In order to 
elucidate which of these pathways require NF-κB signalling, the pathway must 
be inhibited exclusively in either the inducer or reporter cells within the co-
culture.  
Staining for p65 in senescent, bystander and control cells demonstrated that, 
consistent with previous studies, nuclear p65 and the nuclear:cytoplasmic ratio 
is significantly increased in senescent but not bystander cells (Figure 5.7). 
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Figure 5.7| Senescent cells (SEN) as well as TNF-α stimulated controls 
(STIM) have significantly higher levels of nuclear p65 (A), and a higher 
nuclear:cytoplasmic ratio (B). Data are mean ± SE (n=3), with 50-100 cells 
per experiment, and statistics were ANOVA with Dunn’s post hoc test.  
 
The results suggested that NF-κB signalling via p65 was primarily driven in the 
inducer cells. To test this, a construct designed by Glyn Nelson was used, as 
described in the next section. 
 
5.2.2 ΔIκBα Expressing Senescent Cells Do Not Induce a Bystander Effect 
 
An N-terminal deletion in IκBα had been previously created by Glyn Nelson 
which removed the first 40 amino acids, including the two serine residues (32 
and 36) required for the induction of its degradation, thereby causing it to be 
constitutively active (ΔIκBα) in its repression of NF-κB. Recombined into a 
destination vector, it was transuced into senescent and replicating MRC5 
fibroblasts, as described in section 3.5.1. 
To test whether the ΔIκBα construct effectively repressed NF-κB signalling in 
transduced cells, young cells were stimulated with 10ng/ml TNF-α and 
* 
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compared with control cells (transduced to express mCherry). As shown in 
figure 5.8, at the three time points tested the ΔIκBα expressing cells had 
significantly less nuclear p65 and a lower nuclear:cytoplasmic ratio than 
mCherry expressing cells.  
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Figure 5.8| Cells expressing ΔIκBα (IkBa) have reduced levels of nuclear 
p65 (A) and a reduced nuclear to cytoplasmic ratio (B) compared to 
* 
* * 
* 
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control cells expressing mCherry (mCherry), upon stimulation with TNFα. 
As determined by ANOVA with Dunn’s post hoc test, at all time points 
IκBα cells have significantly lower nuclear fluorescence (A) and 
fluorescence ratio (B). Data are mean ± SE (n=3), with approximately 100 
cells per experiment. 
 
In most normal cell types TNF-α is only weakly pro-apoptotic, but this results 
from the pro-survival effects of NF-κB (Van Antwerp et al., 1996). Consistently, 
because of the activation of TNF-α during embryonic development, 
homozygous p65 mutant mice are embryonic lethal due to the widespread 
apoptosis, which is rescued by the inhibition of TNF-α (Beg and Baltimore, 
1996, Beg et al., 1995, Doi et al., 1999).  Therefore, in cells expressing ΔIκBα, 
TNF-α should also induce apoptosis, which was evidenced by membrane 
blebbing of stimulated ΔIκBα cells (data not shown). Importantly, there was no 
evidence of apoptosis or membrane blebbing in the unstimulated ΔIκBα 
expressing cells, nor in the senescent cells expressing the construct.  
Therefore, the senescent ΔIκBα expressing cells were co-cultured with reporter 
cells and compared to senescent cells expressing mCherry. The results of a 14 
day co-culture demonstrated that ΔIκBα expressing cells did not induce a 
bystander effect in reporter cells compared to the mCherry expressing cells 
(Figure 5.9). 
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Figure 5.9| Senescent cells expressing ΔIκBα do not induce a bystander 
effect, whilst mCherry expressing senescent cells showed a normal 
bystander effect compared to other untransduced senescent cells (Figure 
4.4). As determined by ANOVA with Dunn’s post hoc test, only bystander 
cells cultured with senescent cells expressing mCherry were significantly 
different from controls. 
 
5.3 Stimulation of Canonical NF-κB Signalling Enhances the Bystander 
Effect 
 
To understand the effects of over-activating NF-κB on the bystander effect, 
senescent and replicating control cells were stimulated with TNF-α for one hour 
before washing the cells and replacing with normal medium. Reporter cells were 
then added to pre-stimulated cells and co-cultured for up to 20 days (Figure 
5.10).  
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Figure 5.10| Senescent cells were pre-stimulated with TNF-α, then washed 
before addition of the reporter cells 
 
For the initial time point, cells were imaged every 15 minutes for 12 hours 
between one and two days after inducer cell stimulation and subsequent 
addition of reporter cells. Then single measurements were made at seven and 
21 days. No significant effects of pre-stimulation or the presence of senescent 
cells were observed between 1-2 days, or at seven days (Figure 5.11A and B), 
though there was a clear tendency between 1-2 days for senescent cells to 
increase the average number of foci per cell, (Figure 5.11A), consistent with 
figure 4.3.  
Most interestingly, at 21 days there was a clear and significant increase in the 
number of foci in bystander cells cultured with senescent cells that had been 
pre-stimulated with TNF-α, over the normal bystander effect observed from 
unstimulated senescent cells (Figure 5.11B). At no time point was there any 
significant effect of pre-stimulating young replicating cells, though there was 
perhaps a tendency at seven days (Figure 5.11A and B). 
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Figure 5.11| Pre-stimulation of senescent cells (BYS TNF) increases the 
number of foci induced in bystander cells during co-culture compared to 
unstimulated (BYS UNSTIM) cells. (A) The average number of foci per cell 
over a 12 hour period within 1-2 days of co-culture. There is no difference 
between reporters co-cultured with senescent stimulated cells and 
unstimulated senescent controls, or young stimulated cells (CON TNF) 
and unstimulated young controls (CON UNSTIM). Data are n=1 with 
* 
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approximately 20 cells per treatment. Statistics are determined by ANOVA 
with Dunn’s post hoc test. (B) Number of foci in control and bystander 
cells at the different time points of co-culture with stimulated and 
unstimulated cells. At seven days no treatment is significant, whilst at 21 
days there is a significant bystander effect of senescent cells, and a 
significant effect of stimulation on senescent cells, as determined by 
ANOVA with Dunn’s post hoc test. Data are n=3-4 with between 40-200 
cells counted for each treatment, with error bars showing standard error.  
 
To test whether TNF-α stimulation affects the focus frequencies in directly 
stimulated cells, both senescent and young replicating cells were stimulated 
with 10ng/ml TNF-α for one hour, washed three times and then cultured for the 
same periods of time as the co-cultures. Interestingly, a similar trend is followed 
by senescent and bystander cells, with senescent cells having more 53BP1 foci 
than controls. There is also a tendency for stimulation to increase the number of 
foci in both senescent and control cells at one day, and a clearer tendency to 
increase the number of foci in senescent cells at 21 days. However, it must be 
noted that none of these changes are significant (Figure 5.12).   
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Figure 5.12| Direct TNF-α stimulation of cells does not increase DNA 
damage foci in senescent cells (SEN TNF) up to 21 days after stimulation, 
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over unstimulated senescent cells (SEN UNSTIM). Neither was there a 
significant increase in number of foci in directly stimulated young cells 
(YOUNG TNF), over untimulated controls (YOUNG UNSTIM). Data are n=3 
with approximately 100 young cells and 20-40 senescent cells per 
experiment. Statistics are determined by ANOVA with Dunn’s post hoc 
test. Data are mean ± SE (n=3-5), with approximately 100 cells per group. 
Notably, using a two way ANOVA with Holm-Sidak method for multiple 
comparisons to compare the results across time points, day 1 is 
significantly different to days 7 and 21. 
 
Taking into account that at 21 days the incerased number of foci in pre-
stimulated senescent cells is bordering on significance (p=0.048), it is difficult to 
conclude whether direct stimulation induces DNA damage in senescent cells 
without further repeats. As the number of senescent cells is generally lower 
than the control cells, it might simply be a question of power.  
To examine whether the increased bystander effect resulting from pre-
stimulation is also dependent on reactive oxygen species, similar to previous 
experiments, SOD and catalase were added to the medium during the co-
culture. Thus, antioxidants were not added during the initial stimulation, but 
were present for the entirety of the co-culture as before (Figure 5.13). 
 
 
Figure 5.13| After stimulation with TNF-α and washing, both reporter cells 
and antioxidants were added together.  
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As shown in figure 5.14, the bystander effect of pre-stimulated senescent cells 
is completely abrogated by the presence of antioxidant enzymes, suggesting 
that the additional increase in damage is also dependent on ROS. 
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Figure 5.14| When antioxidant enzymes are present in the co-culture, they 
abrogate the additional bystander effect of senescent cells pre-stimulated 
with TNF-α (TNF ANTIOX). There was significant bystander effect of 
senescent cells, and a significant effect of stimulation on senescent cells, 
but this was abrogated in both cases by the presence of antioxidants, as 
determined by ANOVA with Dunn’s post hoc test. Data are n=3-4 with 
between 40-200 cells counted for each treatment, with error bars showing 
standard error. 
 
5.4 IL-6 Stimulation on the Bystander Effect 
 
The effects of TNF-α stimulation were surprisingly potent. However, TNF-α is 
not one of the most prominent secreted factors of the SASP. Therefore, positive 
feedback by this system, whereby senescent cells stimulate themselves in an 
* 
* 
* 
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autocrine fashion with TNF-α to become increasingly damaging is unlikely to be 
dramatic. 
Therefore it was tested whether stimulation with IL-6, one of the most prominent 
members of the SASP, and a known pro-inflammatory cytokine, also had the 
same effect. Just as with TNF-α, cells were stimulated with 15ng/ml IL-6 for 1 
hour. However, unlike the DDR stimulating effects of TNF-α, IL-6 had the 
opposite effect. Senescent cells pre-stimulated with IL-6 had a tendency to 
reduce the bystander effect, although the effect was not significant (Figure 
5.15).   
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Figure 5.15| Pre-stimulation of cells with IL-6 (IL6) does not significantly 
affect the bystander effect of senescent cells or controls at 21 days of co-
culture, but does prevent significant increase between the two, as 
determined by ANOVA with Dunn’s post hoc test. Data are n=3-4 with 
between 40-200 cells counted for each treatment, with error bars showing 
standard error. 
 
To ascertain which of these signals was more predominant in the bystander 
response, IL-6 and TNF-α were added as co-stimulants. When added together 
* 
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at the same doses as before, the bystander effect was reduced by IL-6, but not 
significantly (Figure 5.16), suggesting that TNF-α was mostly epistatic to IL-6.  
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Figure 5.16| Co-stimulation of cells with IL-6 and TNF-α (IL6 TNF) before a 
21 day co-culture induced a bystander effect that was not significantly 
different to that of unstimulated or TNF-α stimulated senescent cells, as 
determined by ANOVA with Dunn’s post hoc test. Data are n=3-4 with 
between 40-200 cells counted for each treatment, with error bars showing 
standard error. 
 
5.5 Discussion 
 
5.5.1 NF-κB, p38 and mTOR in the Bystander Effect 
 
As shown in figure 5.1, the inhibition of mTOR, NF-κB and p38 signalling using 
specific inhibitors all abrogated the bystander effect. 10nM Torin 1 inhibits both 
mTORC1 and mTORC2 signalling, but is otherwise thought to be very specific. 
UR-13756 was used at 1μM to inhibit p38 MAPK. Unlike SB203580, UR-13756 
is highly specific to p38 over c-Jun kinases, at the concentration used (Bagley 
* 
* 
* 
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et al., 2010). However, as this inhibitor has not been widely tested it is possible 
that there are still some off-target effects yet to be discovered. Bay 11-7082 is 
also thought to be highly specific at concentrations five times higher than the 
1μM used in this experiment (Mori et al., 2002), although it can become non-
specific at higher doses (Koh et al., 2010). Notably, Bay 11-7082 is an IKK 
inhibitor poorly specific for IKKα or IKKβ, which both have targets other than 
NF-κB, and another study did identify toxic effects of the inhibitor independent 
of the prevention of IκBα phosphorylation (Rauert-Wunderlich et al., 2013). 
Another important limitation of this research is that these inhibitors were not 
tested to ensure that they induced the desired effect on their target molecule 
within MRC5 fibroblasts. Whilst Glyn Nelson has shown Torin1 reduces mTOR 
signalling in MRC5s (Dalle Pezze, Unpublished), and Bay 11-7082 has been 
used previously in this cell line by our lab (Nelson, Unpublished), UR-13756 has 
not been tested in these cell lines. This could be tested using antibodies against 
p65, phospho-S6 and MAPKAPK-2 or HSP-27 for Bay11-7082, Torin1 and p38 
respectively.   
Preliminary experiments revealed that 10µM Bay 11-7082 induced high levels of 
apoptosis in both senescent and young cells after extended culture, as defined 
by the appearance of floaters and excessive loss of attached cells. This was not 
the case with the other two inhibitors, nor with Bay 11-7082 at 1µM, indicating 
that cells were not undergoing cell death in these co-culture experiments. 
However, it should be noted that level of apoptosis was not quantitated, and low 
level cell death is potentially still a confounding variable in these experiments, 
especially when considering the increased stress undergoing bystander cells 
that may contribute to inducing cell death. Further analysis of cell death in 
control, senescent and bystander cells using an apoptosis assay caspase-Glo, 
TUNEL or Annexin V, is required. 
An additional factor for consideration when analysing this inhibitor data is that 
both inducer and bystander cells are affected. Notably, all three inhibitors had a 
tendency to reduce the number of foci below that of the control cells in the 
presence of DMSO, although the difference was not significant. This suggests 
that the inhibitors may be having other less potent effects reducing DNA 
damage in cells through mechanisms which are not specific to the bystander 
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effect. However, these did not produce significant effects, whilst the bystander 
effect was significantly and completely abrogated by the inhibitors, 
demonstrating that their targets are necessary for the induction of the DDR in 
bystander cells.  
All three pathways have been implicated in cellular senescence, as described in 
the introduction. Although their role in the bystander effect is still open to 
interpretation, the results suggest that they are dependent on each other, as 
each inhibitor completely abrogates the bystander effect, and there are no 
combinatorial effects. It is possible that lower drug doses might reduce the 
inhibition of the bystander effect shown by each drug and thus allow better 
observation of any combinatorial effects; however, the difference in number of 
foci between bystander and control cells is at best one focus per cell, 
suggesting that this system is not sensitive enough for observing smaller 
differences in bystander signalling. 
Alternatively, the dependency of the bystander effect on all three signalling 
pathways could result because the networks are interconnected, regulating the 
same inducer of damage. As described in the introduction, there are multiple 
different sources of damage. Firstly, there are various forms of mutagen that 
directly affect the structure or sequence of the chromatin and DNA. 
Alternatively, some agents can induce damage indirectly by stimulating rapid 
error prone synthesis of the DNA, or affecting the activity of a protein involved in 
accurate DNA synthesis or chromatin maintenance. Therefore, these molecules 
could induce damage by increasing the level of mutagens or by deregulating the 
processes that maintain and synthesise the chromatin, making it more 
susceptible to damage.  
The MAPK p38 is most commonly associated with the stress response 
pathways (Obata et al., 2000); however, it is also necessary for the stimulation 
of cell proliferation in response to various growth factors such as fibroblast 
growth factor (FGF), hepatocyte growth factor (HGF) (Maher, 1999, Awasthi 
and King, 2000), and cytokines such as granulocyte colony stimulated factor 
(GCSF) or IL-2 and IL-7 (Rausch and Marshall, 1999, Crawley et al., 1997), and 
can induce DNA synthesis and proliferation in response to GPCRs, through 
calcium mobilisation and PKC activation (Clerk et al., 1998, Dehez et al., 2001). 
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Therefore, p38 could induce DNA damage indirectly via cell cycle stimulation 
similar to RAS.  
Equally, mTOR is an inducer of cell growth, and responds to multiple growth 
factors. Short term glucose stimulation of rat islet cells induces DNA synthesis 
and cell proliferation (Kwon et al., 2004), indicating that mTOR may induce DNA 
damage via stimulating synthesis. Interestingly, chronic glucose stimulation 
induces increased DNA synthesis, but reduces the number of cells in G2/M 
phase, indicative of S-phase block (Kwon et al., 2006), which is highly 
consistent with the indirect induction of DNA damage through rapid synthesis. 
Whether this is also true in human fibroblasts remains to be seen.  
Lastly NF-κB is also implicated in cell cycle control. Importantly, p65 
overexpression stimulates increased cyclin D1 (Guttridge et al., 1999), and 
although the presence of a similar ΔIκBα super repressor used in this 
experiment was found not to affect a host of factors in serum stimulated MEFs, 
including cyclin E, cyclin D2, cyclin D3, CDK2, p15, p16, p27 and p21 (Guttridge 
et al., 1999), it did delay and reduce the expression of cyclin D1 (Hinz et al., 
1999). As a result, ΔIκBα inhibits pRb phosphorylation, entry into S-phase and 
DNA synthesis, and reduces cell growth and proliferation (Guttridge et al., 
1999). NF-κB also induces transcription of the proto-oncogene c-myc (La Rosa 
et al., 1994), suggesting that it could also induce DNA damage by stimulating 
cell cycle. 
Therefore, all three proteins could potentially induce DNA damage indirectly via 
stimulating synthesis. Additionally, all three proteins have another function 
which may also lead to an apparent increase in bystander damage, via the 
inhibition of apoptosis in damaged cells. The important role of NF-κB in cell 
survival has been discussed in the introduction. mTOR is also important in cell 
survival in response to stress (Hung et al., 2012), and growth factor withdrawal 
(Edinger and Thompson, 2002), whilst p38 is also important in survival of 
oxidative stress, and necessary for activation of the p70-S6K downstream of an 
mTOR related survival pathway (Gutierrez-Uzquiza et al., 2012). This latter 
observation is also an indication of the interconnectedness of these pathways, 
which may explain why they are all necessary for the bystander effect, and 
cannot induce it independently of each other.  
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Another study examining the bystander effect of oncogene induced senescent 
cells found that, whilst medium from these senescent cells was sufficient to 
induce the bystander effect, addition of Bay 11-7082 to the medium after it was 
removed from the senescent cells was not sufficient to reduce it (Acosta et al., 
2013). Consistent with the results shown here, this suggests that NF-κB 
signalling is not important in bystander cells, although this may reflect 
differences in cell type or stimulus. Also the study tested for BrdU incorporation 
rather than number of DNA damage foci, so potentially DNA damage could 
have been increased in these cells, but its anti-growth effects were offset by the 
pro-cell cycle effects of NF-κB, discussed previously in section 5.5.1 (Guttridge 
et al., 1999, Hinz et al., 1999, La Rosa et al., 1994). However, this seems 
unlikely given the high sensitivity of cell cycle arrest to DNA damage. Important 
further work will involve examining the bystander effect of oncogene induced 
senescence in MRC5 fibroblasts, and secondly co-transducing fibroblasts with 
ΔIκBα and mCherry-53BP1 to examine the importance of NF-κB in bystander 
cells in our system.  
Notably, the p38 inhibitor SB202190 also had very little effect on the bystander 
effect of oncogene induced senescent cells when added to the medium after 
being removed from senescent cells (Acosta et al., 2013), suggesting similar 
mechanism to that of NF-κB. However, in the Appendix data from Glyn Nelson 
showed a significant increase in phospho-p38 in bystander cells, indicating that 
it may also play a role in receiving and amplifying the bystander signal (Nelson 
et al., 2012). The mTORC1 inhibitor Rapamycin dramatically reduced the 
growth rate of bystander cells, but rapamycin is a potent cell cycle inhibitor 
(Fingar et al., 2004), and would therefore be expected to slow cell cycle 
regardless of the bystander effect. Further work, will involve specifically 
inhibiting NF-κB, p38 and mTOR specifically in the bystander cells (and 
senescent cells for the latter two) and examining whether this reduces the 
bystander effect.  
 
 
5.5.2 Reactive Oxygen Species in the Bystander Effect 
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Notably although the pro survival/proliferation roles of p38, NF-κB and mTOR 
may be important in the bystander effect, their pathways have also been 
implicated in the production of mutagens, specifically reactive oxygen species.  
Here, for the first time ROS are shown to be necessary for the senescent cell 
bystander effect, as the addition of superoxide dismutase and catalase 
antioxidant enzymes completely abrogates both the increase in focus formation 
and number of foci per nucleus at the time points measured. Neutralisation of 
ROS appears to have little effect on the small foci, which is not surprising when 
considering that the numbers of small foci are not significantly changed in 
bystander cells compared to controls, and therefore are unlikely to be affected 
by alterations in bystander signalling.  
A previous study demonstrated that ROS were important in maintaining the 
senescence growth arrest by producing short lived foci which would temporarily 
activate the DNA damage response until the damage was repaired, only to be 
replaced by another lesion elsewhere (Passos et al., 2010). This also indicates, 
as discussed previously, that the large foci are not all representative of 
telomeric persistent foci, which likely forms a small subgroup of these. Thus, it 
is also not surprising that antioxidants increased the average focus lifespan of 
foci, because ROS generate short lived foci, and removing these foci will 
therefore cause the average lifespan to increase. However, although these data 
indicate that this effect is occurring, there is also some evidence that 
antioxidants are actually increasing the lifespan of the longer lived foci. 
Importantly, there is evidence that cells regulate their DNA damage response 
and repair machinery according to the level of ROS within a cell independently 
of the induction of damage (Guo et al., 2010). Thus, although less damage may 
occur as a result of antioxidants, any unavoided damage is likely to persist for 
longer. 
It should be noted that all inhibitors were dissolved in DMSO which is a mild 
antioxidant. However, at the concentration used, DMSO did not alter the 
bystander effect (Figure 5.1). Unlike the antioxidant enzymes used, DMSO can 
cross cell membranes and has therefore more potential to neutralise ROS 
inside senescent cells; however, the high concentrations of the antioxidant 
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enzymes and the low concentration of DMSO used are more than sufficient to 
explain this discrepancy.    
These data provide a strong argument that ROS are necessary for the induction 
of the DDR in bystander cells. Notably, the results do not necessarily implicate 
that ROS are necessary to induce senescence in bystander cells, which could 
result from damage independent processes as described in the introduction, 
only that they are necessary to activate the DDR. However, there is also 
substantial evidence that ROS are involved in both the induction and 
maintenance of senescence (Passos et al., 2010). 
What these data describe is that ROS are necessary for senescent cells to 
induce a DDR in bystander cells. Notably the antioxidant enzymes are too large 
to be efficiently transported into the cells, and therefore cannot directly 
neutralise intracellular ROS. Similar to the use of the inhibitors discussed 
above, the antioxidant enzymes could be affecting the ROS levels in the 
senescent inducer cells, the bystander cells, both, or neither. It is known that 
hydrogen peroxide can cross cell membranes (Antunes and Cadenas, 2000). 
Therefore, it is possible that senescent cells produce it internally and the 
molecule crosses the membrane where it is detoxified by the antioxidants 
before it can affect the bystander cells. This short half-life of superoxide will 
generally prevent its externalisation, when produced internally. Alternatively, 
NADPH oxidase enzymes in the membranes of senescent cells could be 
generating superoxide, and therefore hydrogen peroxide, straight into the 
medium (Chen et al., 2009). Multiple studies have implicated a role for NADPH 
oxidases in accelerating replicative senescence (Lener et al., 2009), and 
inducing senescence in response to RAS (Weyemi et al., 2012, Kodama et al., 
2013), and other stimuli (Hannken et al., 1998, Shiose et al., 2001), including 
resveratrol (Schilder et al., 2009). However, there is little evidence that NADPH 
oxidase activity actually remains upregulated in senescent cells. One study in 
HUVECs found that the mRNA levels of several Nox genes, and the relative 
Nox4 activity, were reduced in senescent cells compared to proliferating 
controls (Lener et al., 2009). If this is also true in fibroblasts then it is unlikely 
that NADPH oxidase enzymes play a role in the bystander effect, which would 
indicate that the relevant ROS produced by senescent cells are mainly internal 
and result from the by-product of metabolism, particularly the mitochondrial 
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electron transport chain, which is known to be dysfunctional in senescent cells 
(Passos et al., 2006, Passos et al., 2007, Moiseeva et al., 2009, Passos et al., 
2010).  
Both superoxide dismutase and catalase antioxidant enzymes were added to 
the medium. However, it is unlikely that superoxide generated within senescent 
cells escapes into the medium due to the short half-life of the anion. The 
importance of SOD will therefore depend on the activity of membrane-bound 
NADPH oxidases in fibroblasts which is yet to be established. It would have 
been interesting to add each of the antioxidant enzymes separately and 
observe the changes to the bystander effect. Notably, the addition of SOD or 
catalase alone were both sufficient to inhibit the RIBE (Lyng et al., 2006), 
suggesting that both hydrogen peroxide and superoxide may be important, but 
this cannot rule out that superoxide is important due to its conversion into 
hydrogen peroxide. 
The detoxification of hydrogen peroxide by catalase is likely to be much more 
important in preventing the bystander effect. Potentially the ROS could cross 
the membranes of bystander cells and oxidise the DNA through the production 
of more reactive species generated by the Fenton reaction (Imlay et al., 1988). 
However, there is also evidence that membrane composition, particularly 
aquaporin (Bienert et al., 2007), and ergosterol (Bienert et al., 2006) levels 
affect the permeability of membranes to hydrogen peroxide. Thus potentially 
hydrogen peroxide could oxidise components of the membrane and induce 
bystander signalling from there.  
It is important to remember that although most early research into ROS 
regarded them exclusively as inducers of damage, further work has shown them 
to be highly important signalling molecules (D'Autreaux and Toledano, 2007). 
Thus, although NF-κB, p38 and mTOR may induce a DDR in bystander cells via 
the production of ROS, it is also possible that ROS induce a bystander effect via 
the induction of NF-κB, p38 and mTOR. 
One study demonstrated that hydrogen peroxide activated p38, which then 
induced expression of several antioxidant enzymes (Gutierrez-Uzquiza et al., 
2012). They suggested that this was a pro-survival mechanism, by which p38 
prevented apoptosis. Thus, p38 could then induce senescence as it does in 
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response to RAS, by inducing the p16-pRb pathway independent of damage 
(Brookes et al., 2002, Deng et al., 2004). It is more difficult to understand how 
this pathway might cause hydrogen peroxide to induce a DDR, as is described 
here. Notably, this phenomenon runs in stark contradiction to another study 
showing that p38 increases ROS levels and creates a positive feedback loop 
which includes activation of the DDR (Passos et al., 2010). Plausibly, the 
upregulation of antioxidant enzymes by p38 is a response to supraphysiological 
levels of hydrogen peroxide between 0.1-1mM, which induce abnormal 
responses. It should be noted that p38 is a hub molecule and likely has multiple 
different effects depending on the cellular milieu.  
There is also significant evidence that hydrogen peroxide can activate the 
PI3K/TOR pathway (Radisavljevic and Gonzalez-Flecha, 2004, Bae et al., 1999, 
Huang et al., 2002), as well as Akt in response to growth factor stimulation (Liu 
et al., 2006a). Additionally, mTOR regulates oxygen consumption and oxidative 
capacity of mitochondria (Schieke et al., 2006), and activating and inhibiting 
mTOR increases and decreases ROS levels respectively (Kim et al., 2005, 
Tunon et al., 2003). Thus, similar to p38 mTOR could also be involved in a 
positive feedback loop with reactive oxygen species.  
As described in the introduction, the relationship between NF-κB and reactive 
oxygen species is complex. Depending on conditions within the cell NF-κB can 
either inhibit (Djavaheri-Mergny et al., 2004, Jones et al., 1997, Rojo et al., 
2004, Schreiber et al., 2006, Xia et al., 1996), or induce (Chopra et al., 1992, 
Anrather et al., 2006, Deng et al., 2003, Inoue and Tanabe, 1998) ROS 
production, and equally ROS can both activate (Schieven et al., 1993, 
Schoonbroodt et al., 2000, Takada et al., 2003, Kamata et al., 2002, Li and 
Engelhardt, 2006), or inhibit NF-κB (Panopoulos et al., 2005, Reynaert et al., 
2006, Wu et al., 2009). 
Potentially p38, mTOR, NF-κB and ROS could all be involved in a network of 
positive feedback activating the DDR through a combination of direct induction 
of DNA damage through ROS, and inducing DNA replication through the other 
components. Notably, there is even evidence that ROS can increase the rate of 
DNA replication, indirectly contributing to DNA damage (Weyemi et al., 2012). 
 
 144 
 
5.5.3 Gap Junctions, ROS and Inflammation 
 
The last factor that was shown to be necessary for the bystander effect was gap 
junction mediated transfer. When an inhibitor of gap junction mediated transfer 
is added alongside antioxidants, there is no combinatorial effect (Figure 5.5). 
Notably, both treatments were sufficient to abrogate the bystander effect alone, 
and therefore the lack of combinatorial effect demonstrates that both treatments 
are specifically inhibiting the bystander mechanism. Additionally, both pathways 
may be regulating the same processes. Octanol may reduce the transfer of 
ROS, or simply the production of ROS in senescent cells, possibly through the 
inhibition of the same signals via which the extracellular antioxidant enzymes 
worked. However, it should be noted with caution that despite the potent 
inhibition of increased number of foci at later timepoints (Figure 4.8), at early 
time points octanol did not abrogate the increase in focus formation (Figure 
4.7), whereas the extracellular antioxidants did, suggesting that the mechanism 
is not entirely the same, although this does not contradict a role of gap junction 
mediated transfer in regulating the levels of intracellular ROS in senescent cells.     
The importance of gap junctions only at later time points could reflect the 
increased confluency of the cells. Alternatively, the increase in foci found in 
bystander cells at later time points of co-culture may result from a threshold 
effect that requires both ROS secretion and passage through gap junctions. 
Potentially, the secreted pathway in sub-confluent conditions is enough to 
stimulate the increase in focus formation, but not enough to overwhelm the 
repair machinery and increase the number of foci per cell. At confluency the 
additional passage of ROS through gap junctions increases the level of damage 
and the number of foci begins to increase in bystander cells. This hypothesis 
could be tested at early time points by observing the rate of focus formation in 
bystander cells at confluency in the presence of octanol. If they are increased, it 
will suggest that bystander induced damage, like senescence itself, is a 
threshold effect. Speculatively, the oxidation of the cell membrane could induce 
death receptors, tyrosine kinases and transient receptor protein (TRP) 
channels, which could potentiate the ROS levels within the cell, and induce 
other cellular changes such as the activation of JNK and mitochondrial 
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dysfunction (Morgan et al., 2007), whilst gap junctions could allow a more direct 
passage of ROS from senescent to bystander cells. 
Similar to the response to oxidative stress or oncogenic activation, cells 
respond to inflammatory signals by closing gap junctions. IL-α, Il-1β, TNF-α and 
LPS all instigate the closure of gap junctions (Hu and Xie, 1994, van Rijen et al., 
1998), and the connexin43 promoter does contain a κB element (Echetebu et 
al., 1999). However, there is evidence that although senescent cells have fewer 
gap junctions, they do not downregulate them in response to stimuli such as 
EGF, as young cells do (Xie and Hu, 1994). Thus, senescent cells may be 
forced to transmit signals that healthy replicating cells would not.  
As described in the previous chapter, gap junctions not only propagate the 
inflammatory or oxidative signal; overexpression of connexins can protect 
against various forms of cellular stress (Lin et al., 2003), whilst their inhibition 
induces increased apoptosis and inflammation following ischemic brain injury in 
mice (Nakase et al., 2004). Thus, it should be noted that gap junctions do retain 
some function even under stressful and inflammatory conditions. 
Consistently, the RIBE is also dependent on gap junctions, without which the 
induction of damage and cell death did not occur in several studies (Azzam et 
al., 1998, Azzam et al., 2001). In both humans and mice, resistance to 
bystander induced damage does not correlate with a healthy phenome, which 
includes increased genomic instability and tumour formation (Mothersill et al., 
1999, Mothersill et al., 2001). Therefore, it is likely that the bystander effect 
exists for a reason rather than as a result of ineffective inhibition. The closure of 
gap junctions during senescence, inflammation and oxidative stress is then 
perhaps a mechanism to prevent a necessary signal from being too strong.  
 
5.5.4 Stimulating Senescent Cells with Inflammatory Cytokines Affects the 
Bystander Effect 
 
In this study senescent and control cells were stimulated with TNF-α, to observe 
if this had any effect on DNA damage, as predicted by the positive feedback 
loops described in the introduction. Notably, this is not the same as 
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overexpressing a subunit of NF-κB for two main reasons. Firstly, the stimulation, 
although at supraphysiological levels, is withdrawn; secondly TNF-α stimulation 
is a potent activator of canonical NF-κB signalling, but will still have effects 
outside the activation of this transcription factor, such as the activation of the 
inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) through p38 and JNK 
(Furusu et al., 2007).   
Interestingly, at the two early time points there was little tendency of TNF-α pre-
stimulation to have any effect on the number of foci in bystander cells. It was 
only at the latest time point, by which time it was initially hypothesised that any 
effect of stimulation would have dissipated, that the effect became observable 
(Figure 5.11), whereas it never occurred in stimulated controls. Thus, rather 
than a transient increase in damage from a temporary activation of NF-κB 
signalling, this suggests that TNF-α stimulation of senescent cells has a 
gradually occurring but permanent effect on senescent cells, much like the 
senescent phenotype itself. However, it cannot be ruled out that absence of any 
effect at the earliest time point was just a result of the level of noise, from the 
recent plating and decreased time for intercellular communication which helps 
produce a more homogenous population. Consistently, the number of cells 
examined at the earliest time point was lower than subsequent measurements, 
although each cell was examined in more detail over a period of twelve hours, 
rather than a single measurement per cell.  
It would be interesting to see if pre-stimulation increases the early induction of 
focus formation seen in bystander cells. Potentially, stimulation does increase 
focus formation early on, but similar to the unstimulated bystander effect, the 
cell tolerates it by increasing repair. Thus, stimulation could still instigate a 
transient effect on senescent cells, with a delayed manifestation once cells 
receive chance hits to easily damaged  genomic regions such as telomeres.  
The results shown here are too preliminary for a detailed discussion of how 
TNF-α might induce damage in bystander cells, except with an outlook to further 
research. The role of NF-κB in inducing DNA damage is still controversial, and 
is likely dependent on many factors. However, there are multiple mechanisms 
by which NF-κB could potentially induce DNA damage, and reciprocally DNA 
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damage induces NF-κB. Thus, the idea of a positive feedback loop between 
NF-κB and DNA damage is worth further investigation.  
Importantly, an early study demonstrated that repeated stimulation of fibroblasts 
with TNF-α or IL-1α accelerated the induction of replicative senescence in these 
cells in a process dependent on ROS (Dumont et al., 2000a). This is highly 
consistent with the idea that TNF-α stimulates the production of ROS through 
NF-κB, which then induces DNA damage and senescence. Equally, the 
additional bystander effect shown here was dependent on ROS, implicating a 
similar mechanism.  
If there is no positive feedback and the effect is not transient, then it might be 
worth investigating NF-κB oscillations in senescent cells. Potentially, IκBα, and 
the other inhibitors A20 and CYLD could be inhibited or deregulated preventing 
the normal dampening of oscillations and maintaining a higher level of NF-κB in 
senescent cells, as is shown here and elsewhere (Chien et al., 2011, Freund et 
al., 2011). 
It is still too early to know for sure whether TNF-α stimulation increases DNA 
damage in senescent cells, as the data were bordering on significance. If this is 
found not to be the case, then it is inconsistent with the proposed positive 
feedback loop which should also increase DNA damage in senescent cells. 
However, the senescent cells could be more resistant to DNA damage. 
Senescent cells have increased levels of heterochromatin (Narita et al., 2003, 
Braig and Schmitt, 2006), which can be resistant to damage (Yan et al., 2011). 
Alternatively, senescent cells could have a defective DDR, thus preventing foci 
from forming at sites of damage, which could also be the result of 
heterochromatisation (Kim et al., 2007, Karagiannis et al., 2007, Di Micco et al., 
2011). 
A recent study suggests that increased NF-κB related inflammatory signalling 
increases the level of DNA damage and ROS levels within senescent cells (Jurk 
et al., unpublished). They used p50 knockout mice, which increased 
inflammatory signalling by preventing the inhibitory function of p50 homodimers 
including the binding of HDAC1 (Elsharkawy et al., 2010, Oakley et al., 2005), 
although it also disrupts p65-p50 heterodimer induced canonical NF-κB 
signalling. Consistent with this study, the inhibition of p38 reduced ROS levels 
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in senescent cells, but had markedly reduced effect in p50 knockout cells, 
suggesting that p38 induces this function through NF-κB. Oppositely, inhibition 
of COX-2 reduced the levels of ROS and DDR only in the p50 knockdown cells, 
suggesting that it has little role in the normal senescent phenotype, but is likely 
to have a prominent role in the increased inflammatory phenotype of senescent 
cells with stimulated NF-κB signalling, and definitely merits further research to 
elucidate whether COX-2 inhibition would reduce the increased bystander effect 
of TNF-α stimulated senescent cells to either unstimulated senescent or control 
levels.  
Importantly, the same study uses irradiated cells to examine the bystander 
effect in primary mouse adult ear fibroblasts (MAFs) shows that p50 knockout 
senescent cells have an increased bystander effect compared to wildtype 
senescent cells, which is consistent with the idea shown here that upregulated 
NF-κB signalling can increase the bystander effect.  
Stimulation of senescent cells with IL-6 does not mimic the effects of TNF-α on 
bystander cells. This is not altogether surprising because, as described in the 
introduction TNF-α and IL-6 activate very different pathways. TNF-α potently 
activates canonical NF-κB signalling, whilst IL-6 activates mainly the JAK/STAT 
pathway as well Ras, ERK, JNK, p38 and PI3K/Akt. 
What is surprising is that pre-stimulation with IL-6 not only does not increase the 
bystander effect as does TNF-α, but also has a tendency to decrease it, 
although this is not significant (Figure 5.15). It cannot be ruled out that this was 
down to experimental error, as the repeats were not entirely consistent.  
IL-6 has been well established as a pro-inflammatory cytokine, and its role in 
lipid oxidation and lipolysis (Petersen et al., 2005) indicate its potential to induce 
damage. Additionally, STAT3 signalling inhibits apoptosis and activates cell 
cycle (Shi et al., 2002), activating a highly overlapping repertoire of genes with 
NF-κB (Grivennikov and Karin, 2010). Indeed, a recent study has identified the 
importance of STAT3 signalling in maintaining constitutively active NF-κB, 
through the hyperacetylation of p65 which inhibits the binding of IκB (Lee et al., 
2009). The study suggested that cancer cells would primarily activate NF-κB 
through the IKK complex mediated by cytokines such as TNF-α which induce 
canonical signalling, then NF-κB would upregulate IL-6 and activate STAT3, 
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which had been shown to induce cancer development (Naugler et al., 2007), 
causing NF-κB to become constitutively active. Thus, this study suggests that 
TNF-α and IL-6 should co-operate strongly to induce a more potent and long 
lasting inflammatory signal. Other studies reinforce this idea, suggesting that 
STAT3 can bind cytoplasmic NF-κB, displace IκB, and allow NF-κB to enter the 
nucleus in the absence of IKK signalling (Yang et al., 2007). 
However, there is accumulating evidence for an anti-inflammatory role of IL-6 as 
well. Some studies have suggested a role for IL-6 in the inhibition of TNF-α 
(Petersen and Pedersen, 2005), whilst others have shown that it stimulates 
production of both IL-1ra (IL-1 receptor antagonist) and IL-10 (Pedersen, 2007). 
The latter is a potent inhibitor of IL-1α, IL-1β and TNF-α as well as the 
chemokines IL-8 and macrophage inflammatory protein α (MIPα). Some studies 
have suggested that there are two types of IL-6 signalling: If IL-6 is bound to a 
secreted form of its receptor IL-6R which then binds membrane bound gp130 
proteins, then the resultant complex induces trans-signalling which is pro-
inflammatory. Inhibition of trans-signalling only reduces inflammation and 
autoimmune disease (Atreya et al., 2000, Nowell et al., 2003). Contrarily, if IL-6 
binds membrane bound IL-6R, this initiates classical signalling, which is thought 
to be mostly anti-inflammatory and regenerative (Becker et al., 2004, 
Barkhausen et al., 2011), although notably there are some inconsistencies 
(Malchow et al., 2011). Thus, as cells were only stimulated with IL-6, and not IL-
6R, it might explain why the result was anti-inflammatory. Interestingly, not all 
cell types express membrane bound IL-6R, which makes them incapable of 
classical signalling. Synovial fibroblasts did not respond to IL-6 alone (Mihara et 
al., 1995), but dermal fibroblasts had a slight but significant response (Mihara et 
al., 1996), although both cell types responded significantly more to IL-6 and IL-
6R combined. Notably, in the latter case trans-signalling also had anti-
inflammatory effects, repressing TNF-α and IL-1β (Mihara et al., 1996).  
Clearly, there is much about IL-6 which is still not understood, but this evidence 
does make a case for the slight non-significant decrease in the bystander effect 
observed in these data, through its repression of the pathways such as TNF-α 
which are shown to increase the bystander effect.  
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Interestingly, TNF-α stimulation also inhibits IL-6 mediated STAT3 activation, 
partially through synthesis of SOCS3 and activation of p38 MAPK (Bode et al., 
1999). Additionally, NF-κB may also inhibit STAT3 binding to some promoters, 
although it can also act as a co-activator (Bode et al., 2001a, Zhang and Fuller, 
1997). Therefore, it is likely that the bulk of IL-6 inhibition by TNF-α results from 
NF-κB independent pathways such as via SOCS3. This is consistent with the 
data shown here, that IL-6 has a tendency to reduce the effect of TNF-α, but the 
latter appears to be dominant over the former (Figure 5.16).  
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6 Discussion 
 
6.1 The Senescent Cell Bystander Effect and Signalling Pathways 
 
These results demonstrate for the first time that senescent cells are capable of 
emitting a signal which induces a DNA damage response in healthy replicating 
cells. Important previous studies have shown that senescent cells induce cell 
growth of preneoplastic cells, and indicate that this may have resulted from their 
transformation, and thus would most likely result from DNA damage (Bavik et 
al., 2006, Krtolica et al., 2001, Liu and Hornsby, 2007). However, they observed 
no similar effect in healthy cells. Notably, the amount of cell death induced by 
irradiated cells is much greater in immortalised pre-neoplastic cells than in 
normal cells. Experiments using medium from γ-irradiated cells often showed no 
effect on healthy fibroblasts (Mothersill et al., 2004), but significant cell death in 
immortalised cells. When our data are combined with these previous 
experiments it suggests that healthy cells are not immune to the induction of 
damage, but that they are better at responding to it.  
The data presented here suggest that although the induction of damage is 
increased in bystander cells after very short co-culture periods, these cells are 
repairing the damage very quickly and the number of foci per cell does not 
begin to increase until the length of co-culture is extended. Eventually however, 
the DNA becomes damaged in places that are difficult to repair. Recent 
evidence inserting telomeric DNA into the genome suggests that some feature 
of the sequence inhibits repair (Fumagalli et al., 2012), which would most likely 
have evolved to prevent chromosomal fusions in the event of uncapping. 
Therefore, it is possible that the increase in DNA damage foci in bystander cells 
reflects damage that has occurred at a telomere and cannot be removed, 
although it is also possible that this reflects a detiorating cellular phenotype due 
to increased levels of non-telomeric damage from extended co-culture.  
The results of this thesis suggest that the bystander effect is dependent on the 
production of reactive oxygen species, NF-κB, p38 and mTOR, which is highly 
consistent with previous research. The necessity of each of these molecules 
suggests that they are all dependent on each other, and therefore are likely to 
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all form part of an interacting network. A host of previous studies have 
suggested that NF-κB, p38 and mTOR are likely to positively regulate both each 
other and the production of reactive oxygen species. Importantly, ROS are not 
necessarily the end point of these pathways, and a host of evidence suggests 
that ROS function as signalling molecules which are also capable of activating 
p38, mTOR and NF-κB. Thus, the bystander effect could reflect a combination 
of the direct damage from ROS as well as the indirect effects of these other 
molecules which make the DNA more likely to be damaged, through replication 
or other independent pathways.  
Since the publication of our work into the bystander effect on replicatively 
senescent cells, there has been another much more detailed experiment 
demonstrating the bystander effect of oncogene induced senescent cells by 
Acosta et al. (2013). Although this has been referred to repeatedly throughout 
this thesis, it would not be complete without a more in depth discussion of 
similarities and differences between the two bystander phenotypes. 
Importantly, they found there was an increase in 8-oxoG in bystander cells, 
which is a marker of DNA oxidation, which suggests, as discussed previously 
that 53BP1 foci are representative of actual oxidative damage. Additionally, they 
demonstrate the induction of senescence in bystander cells using SA-β gal as 
well as the additional markers p21, p16 and IL-8. Thus, in these respects the 
two phenotypes appear very similar.  
The main difference is that the oncogene induced senescent cell bystander 
effect is much more potent than that produced by replicatively senescent cells. 
This may reflect that, in their work, the inducer cells were undergoing 
senescence, whilst the replicatively senescent cells used here had been 
senescent for months. However, the data shown here from cells undergoing 
irradiation induced senescence suggests that this should have little impact on 
the bystander effect, or even reduce it. Importantly, there are several 
differences between oncogene induced senescent cells and both replicatively 
and irradiated senescent cells, which may explain this difference: although the 
SASPs are qualitatively very similar, there are several factors which are 
expressed at significantly higher levels in oncogene induced cells. These 
include IL-7, GM-CSF, MIP-1α and GRO-α, which are all secreted in high levels 
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in replicatively senescent cells, and even higher levels in RAS induced 
senescent cells, suggesting that they may be important in the bystander effect, 
and potentially causal in amplifying the bystander signal from oncogene induced 
senescent cells. Interestingly IL-1β, which is not upregulated in response to 
radiation or replicative senescence, is highly upregulated in oncogene induced 
senescence, and is a potent inducer of NF-κB signalling.  
Fittingly, this suggests that IL-1β is not necessary for the bystander effect, but 
its stimulation and likely the subsequent activation of NF-κB might increase the 
bystander effect, which is concordant with the data described here suggesting 
that TNF-α stimulation can increase the bystander effect.  
It has been suggested that the reason oncogene induced cells induce a more 
potent SASP, might be at least partially due to repression of p53, as its 
inhibition prior to induction of senescence produced a SASP similar to that of 
RAS expressing cells. However, knockdown of p53 in cells prior to RAS 
expression produced the most potent SASP of all suggesting there are other 
factors involved. Thus far, no one has compared ROS levels between oncogene 
induced and replicatively senescent cells, which should be considered important 
further work.  
Using unbiased quantitative proteomics Acosta et al (2013) compared the 
secretory profiles between RAS expressing and non-expressing cells, and 
consistent with previous studies showed upregulation of IL-6 and IL-8 amongst 
others. Interestingly, they also identified TGF-β, which a previous study had 
shown to remain fairly constant after induction of senescence (Coppe et al., 
2008). Although Coppe et al. (2008) did not state at what point after oncogene 
induced senescence that they profiled the cells, it can be assumed that if they 
followed the same protocol as the irradiated cells that they allowed the cells to 
become fully senescent. Perhaps TGF-β is mainly involved in the induction of 
senescence, at which point it is downregulated again. If it is also specific to 
oncogene induced senescence it could help explain the difference in potency. 
The addition of inhibitors against TGF-β R1, and also VEGF-R2 to cells cultured 
in the medium from RAS expressing cells, caused a significant increase in 
growth of bystander cells over DMSO, whilst having little effect on RAS 
expressing cells (Acosta et al., 2013). This indicated that the arrest induced by 
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the medium had been inhibited, and thus implicated TGF-β and VEGF in the 
bystander effect. Notably, even the most successful inhibitors did not restore 
growth to control level suggesting that senescent cells can still induce a 
bystander effect in the absence of TGF-β, consistent with the idea that TGF-β 
might be partially responsible for the amplification of the bystander effect in 
RAS induced senescing cells.  
The fact that Acosta et al. (2013) found no effect when they added p38 and NF-
κB inhibitors to the medium after it had been removed from senescent cells is 
consistent with these data showing that NF-κB is mainly important in senescent 
cells, and suggests that the signal transmitted to the bystander cells will be the 
products of these pathways, principally the SASP and ROS. This is inconsistent 
with the idea that NF-κB acts within the bystander cells to induce damage by 
stimulating DNA replication and cell cycle, though this could still occur indirectly 
via the SASP, ROS or other NF-κB dependent signals from the senescent cells. 
However, the growth curves of bystander cells co-cultured with RAS expressing 
cells are not significantly faster than controls (Acosta et al., 2013), suggesting 
that if the pro-cell cycle signals of these molecules does play a role in the 
induction of damage and senescence, that it is minor.  
 
6.2 The Implications of the Bystander Effect 
 
Senescent cells have long been hypothesised to be involved in the ageing 
process, and recent studies have provided clear evidence that they play a 
causal role in age related diseases. However, prior to this work the main 
hypothesis as to the mechanism involved was through the autonomous 
depletion of functional cells. This had been thought to result from stem cell 
exhaustion as these cells are responsible for replacing large numbers of cells in 
multiple tissues, and their loss can be seriously detrimental to tissue function. 
However, there is little evidence that stem cells deplete with age. Whilst they 
decline in functionality and differentiation potential, this does not appear related 
to the autonomous depletion of stem cell numbers. In fact, there is a wealth of 
evidence that stem cell function is maintained at least partially non-
autonomously by the niche environment (Spradling et al., 2001).  
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Therefore, if senescence is to play a role in the ageing process it must happen 
through some other means. Consistent, with the various hypotheses that ageing 
is the result of DNA and molecular damage, the bystander effect shown here 
provides one possible mechanism by which senescent cells could contribute to 
ageing, via the spread of molecular damage. 
It has already been shown that the presence of senescent cells contributes to 
transformation of preneoplastic cells. Here is described both a mechanism by 
which this process could occur, through the induction of DNA damage in 
unstable cells, but also an underlying mechanism by which senescent cells 
could contribute to the ageing process and the accompanying increase in both 
preneoplastic and neoplastic cells that are responsible for the cancers of old 
age.  
Additionally, through the induction and spread of the senescent phenotype, 
senescent cells could contribute to ageing via the induction of chronic 
inflammation, consistent with more recent hypotheses on the ageing process, or 
potentially through the induction of mTOR, at least partially consistent with 
programmed based theories of ageing, although notably the primary stimuli 
would result from DNA damage, which is entirely inconsistent.  
Importantly, the potent bystander effect of oncogene induced senescence 
demonstrated by Acosta et al (2013) is diminishing. Although their neighbours 
receive a potent stimulus to senesce, cells >1mm away from the initial stimulus 
were unaffected. We have not tested whether this also true of the replicative 
senescence induced bystander effect; however, its reliance upon gap junction 
mediated transfer suggests that it will also have a limited range. More 
importantly, the medium from the bystander cells from the RAS induced 
senescent cells failed to induce senescence in a group of tertiary bystander 
cells, despite the fact that a large fraction of these secondary cells had become 
senescent. Therefore, although these cells could potentially have a prolongued 
non-autonomous effect on the cells within 1mm distance, because the effect 
dissipates, the RAS induced senescence stimulus has a limited potential to 
influence the ageing process non-autonomously. However, it is important to 
note that the medium from the secondarily senescent cells still slows the growth 
rate of tertiary bystanders, which is highly suggestive of reversible arrest 
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induced by damage. In these experiments, a significant effect on focus 
induction was not observed from medium alone, which suggests that the 
secondarily senescent cells observed by Acosta et al. (2013) still produce a 
relatively potent bystander effect. What remains to be elucidated is whether the 
bystander induced senescence shown here also dissipates. This will have 
important implications for the roles of both oncogene induced and replicatively 
senescent cells in the non-autonomous influence of the ageing process. 
Although speculative, it is unlikely that the bystander effect shown here 
dissipates similarly to that of RAS expressing cells. The secondarily senescent 
cells shown by Acosta et al. (2013) are likely to differ from the primary inducers 
through their reduced levels of RAS expression, which suggests that they were 
induced to senesce via DNA damage, and their SASPs will therefore be similar 
to the replicative and irradiation induced senescent cells studied in this thesis. 
Importantly, the SASP and ROS are necessary to maintain growth arrest, which 
prevents immortalisation and neoplasia. Therefore, it could be expected that the 
bystander effect at least per cell is unlikely to dissipate. However, the high 
numbers of senescent cells used in both these studies suggests that the 
bystander effect is highly likely to dissipate due to the decreasing number of 
senescent cells as you get further away from the initial inducers.  
The real test for the relevance of these in vitro studies, is whether the same 
phenomena also occur in vivo. The initial study by Krtolica et al. (2001), clearly 
identified that injection of preneoplastic cells in the presence of senescent cells 
was more likely to induce tumours in mice than in the presence of young 
replicating cells (Krtolica et al., 2001). In our study we used a 4-hydroxynonenal 
staining, which has been previously shown to be a good marker for in vivo 
senescence (Nelson et al., 2012), to demonstrate that senescent cells had a 
significant degree of clustering, indicative that senescence was not an 
autonomous process and could be spread to neighbouring cells. This was 
reaffirmed by Acosta et al. (2013) using p16 and p21 stainings, and they also 
showed that mouse papillomas and human sessile serrated adenomas had 
large numbers of senescent cells just outside the papilloma, which heavily 
indicated bystander induced senescence in vivo (Acosta et al., 2013).  
These data suggest that the bystander effect is a real phenomenon in vivo, and 
could therefore contribute to both cancer and ageing in living organisms. 
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7 Conclusion 
 
Here is shown for the first time that replicatively senescent cells induce a DNA 
damage response and senescence in bystander cells. It requires cell 
communication through gap junctions and cannot be transmitted by medium 
alone. It is also dependent on reactive oxygen species which may directly 
induce damage in bystander cells. Use of specific inhibitors suggests that 
mTOR, p38 and NF-κB form an interconnected network in which all three 
components are necessary to induce a DNA damage response in bystander 
cells. NF-κB is upregulated in senescent cells and not bystanders, and 
knockdown exclusively in bystander cells is sufficient to abrogate the bystander 
effect, suggesting its importance in signal production over response. Lastly NF-
κB stimulation can significantly increase the bystander effect in a process 
dependent on reactive oxygen species.  
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